<SEC-DOCUMENT>0001445305-12-002836.txt : 20120907
<SEC-HEADER>0001445305-12-002836.hdr.sgml : 20120907
<ACCEPTANCE-DATETIME>20120907161937
ACCESSION NUMBER:		0001445305-12-002836
CONFORMED SUBMISSION TYPE:	DEFA14A
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20120907
DATE AS OF CHANGE:		20120907
EFFECTIVENESS DATE:		20120907

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NeoStem, Inc.
		CENTRAL INDEX KEY:			0000320017
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
		IRS NUMBER:				222343568
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEFA14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33650
		FILM NUMBER:		121080278

	BUSINESS ADDRESS:	
		STREET 1:		420 LEXINGTON AVENUE
		STREET 2:		SUITE 450
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10170
		BUSINESS PHONE:		212-584-4171

	MAIL ADDRESS:	
		STREET 1:		420 LEXINGTON AVENUE
		STREET 2:		SUITE 450
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10170

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PHASE III MEDICAL INC/DE
		DATE OF NAME CHANGE:	20030819

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CORNICHE GROUP INC /DE
		DATE OF NAME CHANGE:	19951117

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	FIDELITY MEDICAL INC
		DATE OF NAME CHANGE:	19951025
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEFA14A
<SEQUENCE>1
<FILENAME>definitiveproxyletter-2012.htm
<DESCRIPTION>DEFA14A
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using WebFilings 209e729 -->
		<!-- Copyright 2008-2012 WebFilings LLC. All Rights Reserved -->
		<title>Definitive Proxy Letter - 2012</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<a name="s41145117a69f42a3854c2fb040f6b50b"></a><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">UNITED STATES </font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">SECURITIES AND EXCHANGE COMMISSION </font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Washington, D.C. 20549 </font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">SCHEDULE 14A </font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Proxy Statement Pursuant to Section 14(a) </font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">of the Securities Exchange Act of 1934 </font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Filed by the Registrant </font><font style="font-family:Wingdings;font-size:12pt;">x</font><font style="font-family:inherit;font-size:12pt;">&#32;</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Filed by a Party other than the Registrant </font><font style="font-family:Wingdings;font-size:12pt;">&#168;</font><font style="font-family:inherit;font-size:12pt;">&#32;</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Check the appropriate box: </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:87.6953125%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td width="4%"></td><td width="96%"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;text-align:center;">&#168;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Preliminary Proxy Statement</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;text-align:center;">&#168;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;text-align:center;">&#168;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Definitive Proxy Statement</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;text-align:center;">x</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Definitive Additional Materials</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;text-align:center;">&#168;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Soliciting Material Pursuant to &#167;240.14a-12</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">NEOSTEM, INC. </font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(Name of Registrant as Specified in its Charter) </font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">______________________________________________________________________________________</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant) </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td width="3%"></td><td width="6%"></td><td width="91%"></td></tr><tr><td colspan="3" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Payment of Filing Fee (Check the appropriate box):</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;text-align:center;">x</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">No fee required.</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;text-align:center;">&#168;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Title of each class of securities to which transaction applies:</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Aggregate number of securities to which transaction applies:</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Proposed maximum aggregate value of transaction:</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total fee paid:</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;text-align:center;">&#168;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fee paid previously with preliminary materials.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;vertical-align:top;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;text-align:center;vertical-align:top;">&#168;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amount Previously Paid:</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Form, Schedule or Registration Statement No.:</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Filing Party:</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date Filed:</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><br><hr style="page-break-after:always"><a name="s884EB3AD0891ADF4458A9CF055B50AAB"></a><br><div style="line-height:120%;text-align:center;"><img src="neostemlogohiresjpeg.jpg" style="height:78px;width:229px;"></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">September 2012</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Dear NeoStem Shareholders,</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The past year and a half has been a truly transformational time for NeoStem, Inc.  We are emerging as a technology and market leader in the fast developing cell therapy market. Our multifaceted business strategy combines a state-of-the-art contract development and manufacturing organization (CDMO) with a medically important cell therapy product development program, enabling near and long-term revenue growth opportunities. Our service business and pipeline of proprietary cell therapy products work in concert, giving NeoStem a competitive advantage that we believe is unique to the biotechnology and pharmaceutical industries. Supported by an experienced scientific and business management team and a dynamic patent and patent pending (IP) portfolio, we believe NeoStem is well positioned to succeed.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">We would like to take a moment to update you on some of our more significant recent developments and to report to you on important near term catalysts being pursued:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Cell Therapy Focus</font><font style="font-family:inherit;font-size:12pt;">&#32;-- In order to focus our efforts in cell therapy, we are exiting the generic pharmaceutical business.  A definitive agreement to divest the Company's 51% ownership interest in Suzhou Erye Pharmaceutical Co. Limited was signed on June 18</font><font style="font-family:inherit;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">th</sup></font><font style="font-family:inherit;font-size:12pt;">. The divestiture will bolster NeoStem's cash position through the receipt of the cash purchase price of $12,280,000, eliminate $35 million in short-term and long-term debt obligations and allow us to hone our focus on cell therapies.  Of note, as of September 6, 2012, the entire cash purchase price has been paid to us or deposited into an escrow account. The transaction is expected to close in the 4</font><font style="font-family:inherit;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">th</sup></font><font style="font-family:inherit;font-size:12pt;">&#32;quarter, subject to the satisfaction of various closing conditions, including China regulatory approvals. </font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:24px;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Value and Liquidity --</font><font style="font-family:inherit;font-size:12pt;color:#010000;">&#160;The sale of Erye will also return approximately 1,040,000 shares of the Company's Common Stock and cancels 1,170,000 Common Stock options and&#160;640,000 Common Stock warrants.  </font><font style="font-family:inherit;font-size:12pt;">Additionally, between July 16</font><font style="font-family:inherit;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">th</sup></font><font style="font-family:inherit;font-size:12pt;">&#32;and August 14</font><font style="font-family:inherit;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">th</sup></font><font style="font-family:inherit;font-size:12pt;">, 2012, 730,250 Class A public warrants expired. Liquidity in NeoStem shares continues to rise with a three month daily trading average of</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">&#32;</font><font style="font-family:inherit;font-size:12pt;">1.2 million shares, which is leading most other NYSE MKT listed stem cell companies and, we believe, is an indicator of growing investor interest in our mission and accomplishments.  The Company is asking shareholders at the 2012 Annual Meeting of Shareholders to approve an amendment to the Company's certificate of incorporation (in the event it is deemed by the Board of Directors to be advisable) to effect a reverse stock split which continues to provide the Company the flexibility it has had (but not utilized) for the past two years.  Additionally, should the right opportunity present itself, in order to maintain flexibility and pursue our growth plans, we recently filed a &#8220;shelf&#8221; registration statement on Form S-3 with the Securities and Exchange Commission for $150 million of securities.     </font></div></td></tr></table><br><hr style="page-break-after:always"><a name="s884EB3AD0891ADF4458A9CF055B50AAB"></a><br><div style="line-height:120%;text-align:left;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#160;</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Progress </font><font style="font-family:inherit;font-size:12pt;">- A key mission for NeoStem is to introduce the first cardiovascular cell therapy product to treat the aftermath of an acute myocardial infarction (AMI).  In January 2012, our AMI therapeutic product development team achieved its forecasted goal of enrolling the first patient in the PreSERVE Phase 2 clinical trial. We continue to open new clinical sites and expect to achieve full enrollment in 2013 with six months initial data read out near the end of 2013. In anticipation of future studies, we have positioned strategically our IP with the goal of covering broad indications beyond AMI, giving the Company strong positions in both the cardiovascular and non-cardiovascular cell therapy markets.</font></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Growth</font><font style="font-family:inherit;font-size:12pt;">&#32;- Our Progenitor Cell Therapy (PCT) CDMO service business continues to grow and has added new clients in later stage clinical trials, setting the stage for expansion into larger and substantially more lucrative commercial manufacturing contracts. Each new client and business development opportunity affirms our belief that we have a unique technology platform capable of supporting both our internal development as well as the global cell therapy market. Great science and technology innovation comes from people who are committed and dedicated to their crafts. I am proud to say, and our results demonstrate, that the NeoStem team's expertise, quality and work ethic is unsurpassed in the cell therapy industry and we look forward to bringing this expertise to bear on the European market as we seek to expand our CDMO services to that region. </font></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">New Leaders</font><font style="font-family:inherit;font-size:12pt;">&#32;- In June 2012, Martin Schmieg joined the NeoStem leadership team as Vice President, Corporate Development. Martin's focus is to ensure that we capitalize on strategic opportunities that support NeoStem's mission of leading the cell therapy industry and creating maximum shareholder value. Martin brings to NeoStem his expertise in business development for health care product and medical technology companies, ranging from early-stage privately funded ventures to market driven public companies, over his 25 year career. While originally trained in accounting and finance, Martin also has expertise in financings, mergers and acquisitions, and the development of companies with novel technologies from lab to market. Martin was formerly the President and CEO of Freedom-2, Inc. Selected transactions include the multi-billion dollar sale of Advanced Bionics Corporation to Boston Scientific and the development and market launch of the Cytoscan instrument for observation and measurement of the human micro-circulatory system. </font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">In April 2012, Jonathan Sackner-Bernstein, MD, FACC joined the Company as Vice President of Clinical Development and Regulatory Affairs. Jonathan brings to the Company over 20 years of experience as a clinical cardiologist and medical researcher with leadership in healthcare management. Jonathan joined the team to advance Amorcyte's PreSERVE AMI Phase 2 trial and to provide regulatory support for NeoStem's product pipeline. His experience as Associate Center Director for Technology and Innovation at the U.S. Food and Drug Administration's Center for Devices and Radiological Health and as CMO of Clinilabs, where he established a Phase 1 research unit, coupled with his experience as a cardiologist, make him a welcomed addition to the management team at NeoStem. Jonathan also served as assistant professor of medicine at the </font></div><br><hr style="page-break-after:always"><a name="s884EB3AD0891ADF4458A9CF055B50AAB"></a><br><div style="line-height:120%;text-align:left;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Columbia University College of Physicians and Surgeons from 1993 to 2003. His academic accomplishments include contributions to medical therapy of heart failure and patients following heart attack as well as leadership in changing the paradigms of drug development in heart failure, giving him the academic credentials to effectively dialogue with physicians at the clinical trial sites and get cardiologists excited about our new therapy.</font></div><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Just this week Jeff Liter joined PCT as Chief Operating Officer.  In this role, Jeff will lead the Operations, Quality and Project Management Departments as the Company grows in scope and breadth as a worldwide, premier CDMO.  Jeff will be based in PCT's Allendale headquarters, travelling frequently to PCT's Mountain View facility to provide leadership and support to this team.</font></div><div style="line-height:120%;text-align:left;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Jeff is a proven Senior Executive with multi-functional expertise in operations, finance, M&amp;A and Sales, spanning multi-national publicly traded companies to emerging medical technology companies. He has extensive International work experience in North America, Europe and Asia and brings a wealth of experience at helping companies integrate complex acquisitions across the globe, ranging from Onyx Pharmaceuticals, Beckman Coulter Genomics and, most recently, Haemonetics.  Jeff's most recent assignments include working as a Managing Director of On Point Consulting -- a consulting firm specializing in post-acquisition integration -- as  Director of Business Development, Strategy, &amp; Licensing for Beckman Coulter Diagnostics, and as Vice President of Corporate Development for ADC Telecommunications.  </font></div><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Optimization</font><font style="font-family:inherit;font-size:12pt;">&#32;- We continue to make great headway in integrating IT systems within our operations to maximize efficiencies. We believe that substantial cost savings also will be achieved with the recent closing of our Cambridge facility after lease expiration and the consolidation of the Cambridge group's scientific expertise in stem cell biology, immunology, and hematology with PCT's broad expertise in commercial process and product development for cellular therapies. Merging our NeoStem Cambridge team with PCT's considerable cell therapy product development team creates synergies and efficiencies that enhance our immuno-cell therapy program. Athelos, Inc will seek to build upon data from several in-progress physician-sponsored trials using T cell technology to treat GvHD and other immune mediated diseases. NeoStem's partnership with big pharma was established in 2011 through its co-ownership of Athelos (80% NeoStem and 20% Becton Dickinson). We are actively pursuing additional strategic relationships with major pharmaceutical and biotechnology companies in 2012.</font></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">The Future</font><font style="font-family:inherit;font-size:12pt;">&#32;- The development of our pre-clinical VSEL</font><font style="font-family:inherit;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">TM</sup></font><font style="font-family:inherit;font-size:12pt;">&#32;Technology program is funded substantially through U.S. Department of Defense (DoD) and National Institutes of Health (NIH) grants. In collaboration with investigators at Harvard's Schepens Eye Research Institute, the University of Michigan, and the Roger Williams Medical Center, NeoStem scientists have demonstrated that human VSELs show promising therapeutic potential in animal models of diseases that include retinal pathologies, bone defects, and traumatic and complex wound healing. We recently received a two year grant totaling $595,252 for the "Development of Human, Autologous, Pluripotent Very Small Embryonic Like </font></div></td></tr></table><br><hr style="page-break-after:always"><a name="s884EB3AD0891ADF4458A9CF055B50AAB"></a><br><div style="line-height:120%;padding-left:48px;text-align:left;"><font style="font-family:inherit;font-size:12pt;">(VSELs) Stem Cells as a Countermeasure to Radiation Threat" from the National Institute of Allergy and Infectious Diseases (NIAID), a division of NIH. This peer reviewed grant was awarded to support research to be headed by Denis O. Rodgerson, Ph.D., Director of Stem Cell Science for NeoStem and Mariusz Ratajczak, M.D., Ph.D., head of the Stem Cell Biology Program at the James Graham Brown Cancer Center at the University of Louisville and co-inventor of VSEL</font><font style="font-family:inherit;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">TM</sup></font><font style="font-family:inherit;font-size:12pt;">&#32;Technology.  Additionally, </font><font style="font-family:inherit;font-size:12pt;font-style:italic;">The World Journal of Experimental Medicine</font><font style="font-family:inherit;font-size:12pt;">&#32;recently published our paper on the &#8220;Potential for a pluripotent adult stem cell treatment for acute radiation sickness&#8221; (World J. Exp Med 2012; 2(3): 37-44). </font></div><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Finally, we are pleased to be relocating our corporate headquarters to larger space in our current midtown Manhattan office building.  Our new address is 420 Lexington Avenue, Suite 350, New York, New York 10170.  We look forward to keeping you updated and encourage your questions via the contact information below. Thank you for your continued support of NeoStem and our ongoing transformation.</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Sincerely,</font></div><div style="line-height:120%;text-align:left;"><img src="robin.jpg" style="height:64px;width:112px;"></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Dr. Robin L. Smith</font></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Chairman and CEO</font></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#0000ff;">rsmith@neostem.com</font></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">212.584.4174</font></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><br>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>neostemlogohiresjpeg.jpg
<TEXT>
begin 644 neostemlogohiresjpeg.jpg
M_]C_X``02D9)1@`!`0$!+`$L``#_X2`&17AI9@``34T`*@````@`#0$```,`
M```!!ML```$!``,````!`O(```$"``,````#```(M@$&``,````!``(```$2
M``,````!``$```$5``,````!``,```$:``4````!```(O`$;``4````!```(
MQ`$H``,````!``(```$Q``(````R```(S`$R``(````4```(_H=I``0````!
M```)$NH<``<```@,````J@``$8(<Z@````@`````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M```````````````(``@`"``MQL```"<0`"W&P```)Q!-:6-R;W-O9G0@5VEN
M9&]W<R!,:79E(%!H;W1O($=A;&QE<GDQ-"XP+C@Q,3<N-#$V`#(P,3(Z,#(Z
M,C$@,3,Z,#<Z,#````60```'````!#`R,C&@`@`$`````0``!#Z@`P`$````
M`0```7>D(``"````(0``$6#J'``'```(#```"50`````'.H````(````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M```````````````````````````````Q.31"-S@S.3-!.4$T1#8P.3DR,3-!
M,3-%03%&-#-".`````8!`P`#`````0`&```!&@`%`````0``$=`!&P`%````
M`0``$=@!*``#`````0`"```"`0`$`````0``$>`"`@`$`````0``#AX`````
M````2`````$```!(`````?_8_]L`0P`(!@8'!@4(!P<'"0D("@P4#0P+"PP9
M$A,/%!T:'QX=&AP<("0N)R`B+",<'"@W*2PP,30T-!\G.3TX,CPN,S0R_]L`
M0P$)"0D,"PP8#0T8,B$<(3(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R_\``$0@`-@"@`P$A``(1`0,1`?_$`!\`
M``$%`0$!`0$!```````````!`@,$!08'"`D*"__$`+40``(!`P,"!`,%!00$
M```!?0$"`P`$$042(3%!!A-180<B<10R@9&A""-"L<$54M'P)#-B<H()"A87
M&!D:)28G*"DJ-#4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W
M>'EZ@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(
MR<K2T]35UM?8V=KAXN/DY>;GZ.GJ\?+S]/7V]_CY^O_$`!\!``,!`0$!`0$!
M`0$````````!`@,$!08'"`D*"__$`+41``(!`@0$`P0'!00$``$"=P`!`@,1
M!`4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:)B<H
M*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H*#A(6&
MAXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76
MU]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_:``P#`0`"$0,1`#\`]_HH`**`"B@`
MHH`*Y'QIXNN=!ADATZ&W-Q'$)[BZO2RVUI&Q*HS[06=F92H1`3U)P.M0CS.P
M:;L\@N/C'XBMYOMMGJWVQW^]876E1Q01Y'\+I*9#@],GZU[YH&J?VYX?T_5?
M),/VRW2?RB<[-R@XS@9QGK@9K?$4/9),4:D)KW31HKF&%%`!10`44`%%`!10
M`44`%?)7CKQ;>^,]=N+B>YE.GI(PL[?E5CC!.TE<D;R.2>3DXZ``=N"IJ<FW
MT,ZE5T[.)V7PK\67OAW4],TFXN?/\/:O,\%KYC$O:7`P3'C'<NG3Y3Y@;*G>
MM>S>+?"EAXPT-],OBZ#>)8I8S\T;@$`C/!X)!![$]#@C*I^ZJW1K.TXW[GGF
ME?`.PM[])=4UJ6]MEP3!%!Y.\@@X+;F.",@XP>>"*]<@@AM;>*WMXDBAB0)'
M&BA510,``#H`**^(=9K2R1E3IJ!)17.:!10`44`%%`!10`44`%%`!7RIXQ\!
MZMX9UZYMX]/N9=/:7_1+A$,BLC$[%+`??XP0<'(ST()[<%449-/J85XMJZ.Y
M\.^$=5L_#OA/3;JW$6H3>(TU?R&!WQ6T<8WE^/E.0@P>[H#@G`]RK'$24IMH
MV@K0285P/Q,T/QCK%K:'PMJ3VZ0[FF@AN#!+(W`7#C&0`6R"0/J<8BDXJ:<]
M@E>VFYO^#M.U73?#EG#K5R\M\(@LRF9I@&W,<[WRQ8@C/)4$?*`*WZF5N9VV
M!7MJ%%2,**`"B@#Q7XL>/_$_A3QQ8VFBW86U^Q)<R6S0(ZR$/)NR<;@-JC."
M,`=NM>C^"O&-AXVT!-2LU:*13Y=Q;N<M#)CD9[CN#W'H<@;2II04D:2A:*:+
M'C#4+G2?!NL:A9N([JWM))(G*@[6"G!P>#CWXK%^%7B'4O$W@:#4-6G$]WYT
MD;2A%3<`W&0H`[XX`Z5'*N2_F39<MSM:*@D,XK"/C7PH"0?$VC`C@@W\7'_C
MU-1;V0TF]C0E:PL8KK5I&C1/*\R:X)S^[0$CG^Z`6.!QR3W->:Z%KWC+XC7U
M[?:-JD6@:';L88F-LEQ)*_!^8-TX.3@@#(`W<D;4HQY7.:ND93;NHH=K=]\1
M_!-W:W9NE\4:=*5CD1;(1.C%AQB/)&1P&^89/(SC/9^+O%]IX0\-G5KN&5V<
MB."W'#/*5)"D\A1P<GM@XR<`U*G";C[/2_3L)2<;\W0U-$U`ZOH.G:D8Q$;N
MVCG,8;.W>H;&>^,U>KG:L[&B=T%%(844`%%`'B_C8;OVA_"8_P"G:(_^1)JI
M>)M(UCX1^*Y/%?AV$2^';MP+RS482/)^Z0/NC).QP/E)VD8.'Z4]HOJC>^T7
MU1Z%XJU>SUWX2:OJFGS"6UN=-D=&'^Z<@^A!R".Q!%<A\-_$,/A7X'7&M3Q-
M*MK-*1&IQO8N%49[`L0,]NM0HODY?,A+W;>95T:W\/>*M,75O'OC.WN+R\_?
M#2QJJPP6BD#8!&&R&"@$_7D$@DXWA[Q?_P`(O\2[+0O#VO76O^'KUX;;R[IV
M8P,S;<HQ4#Y2=WRC:0<'D9%V;O&VA=KW5M!_QE\:7-_K<_AFW<?V;:A1<*K$
M>=+PW)4\A>!M_O9)R0N,WPHW@WQC<0Z#KVA6VFWL@$5I?Z<[0Y/&%922I<D'
MYB#G(&`>O4J#C14H[[G%'$RC.W0UO"5QJ'@GQM<?#?Q#+]KT/45:&%Y-R+B0
M':4]`Y)0J#@,3@\',EI8>./A#>7$EK:_VOH4AWR^6&*!5Y+D#F)MJ\GE>1G=
M@8R@X-N$M%+\S7$)\RG$[KPM\7O#WB2XALIO-TZ_EVJL5QRCN0?E5QQVQ\P7
M)(`!/%8/QVTZ&+PW:WZR71EEU"-&1KF1H@/*D^[&6V*>!R`#U]3F:=.5&NHL
MRE)3IMHUK6XM?!OPKM/$D;WLMRNE0>7%->2RQ>8ZH%_=L^T*&(^[C"YQ6!I%
MGX=\2:1'J7CCQK;WU[<J)?L8U-8HK7*C`$8(PX'7CKQ@XR6N;6<5=WML+32+
M>AE>$O%D^A?$BWT+2]=NM?T"[=8(UD#N\0Y`(W8QL/WBORE<G&<!=#Q!<ZEX
MA^-[>%+C6=1M](=0GDVD_E?+]G\T@X&#EO4$X./2M'!*;FUKRWMYD\S<;7ZF
MCXY\&VG@KPW+XA\*7E[I%S9R1M)'%<.Z7`+JN'#,>A(/<$9!!SD.\&>$+;QU
MX4@USQ1J&I:G<7C2LL<ERRQ0$2,N45<`9VY].F`*S]J_9>TLN:]KE<GO<O0S
M/"=[JGA/XO3>"UU2YOM,D4QQ"Z<MY0$)F0@=B!\IQ@'.<<`#TGPI8:O8OJ_]
MJ3W$JSZA+/;">7S-D38VJ.3M`P>!QSP!S48CEO>VZ3*IWV['G?C3_DXCPG_U
MZQ?^AS5[%<VT-Y:RVUS$DL$J%)(W7*LI&"".XK*IM'T.F?0^=?$NEZS\*O[9
MTM&ENO"NMP2Q0MU$4I4[0?[KC&">CJ,\E<+I:+9W%]^S-JL5LF]UE:8C('R)
M*CN>?15)_"MFURJ7=HTNK*7F=;\*!X0\0>%-/EBT?1UUBRB6*Y`MXS,K+\HD
M)*@G<`&SSR2,D@UU7B;QKI_AS4-,TL1M=ZIJ-Q'%#9Q,`P1FVF1O11SC/4C'
M`!(PE&3FTS*2;E9G@_Q;T"71?'=Y<"%EM-0/VF%^2&8X\P9Z9#9..P9?6N&5
MFC=71BKJ<JP."#ZBO:HRYJ<7Y'FS5I,]C\;(=2^,VCW;*<Z)I<>HZBL!#M$(
M6>8IC(Y.4`_ZZ`]*])\#>.['QQITTT$#6MU;MMFMG<,5!^ZP/&0>>PY!]B?)
ME3;I\RZ'?.>L8^1R/QK\.Z(OAEM:,,-MJ@N$1)43#7!/!5L=?E!;)Y^3'>L#
MQU/J-U\"_"\^JG-V]W&2Q;<73RYO+8G)R2FTGW)KHHR<HPYNC.>:LY6['0^+
M=-EU'X`Z885D9[6PL[C8@SE0BAL^P4EC]*TOABOA+6_#%A<6>EZ;_:=C#'#=
M,;6,3+(%QO)QGYL$AN_/<$#.3E[)N+V;*27.K]CH]<\76.CZMIND1H;S4[^X
M2);6$Y:.,D;I7QG:JKD^^/0$CS0_\G0C_/\`RY4J,'%2;ZQ83=VO4[?XN_\`
M)+]8_P"V'_HZ.D^$7_)+]'_[;_\`H^2H_P"8?_M[]"O^7GR.';_DZ%/K_P"V
M5>WT8C['H@I]?4YG4O`^F:IXUT_Q5<377VVQB$<42NHB(!<@D;<YRY[CH/?/
M35@Y-VN:MME#6=&L=?TFXTS4H!-:SKM="<>X(/8@X(-5/"OA>P\(:#%I&GO.
M\$;,^^=@SL6.23@`>W`'2CF=N4+NUCC]8^!O@[5;YKJ-+S3]^2T-G*JQDDDY
M"LK;>N,#```P*U_"7PO\->#;G[78P2W%Z,A+J[<.Z`C!"X`4=^0,\D9P<5HZ
MTG&Q3J2:L=!KN@:9XETQM/U6U6XMV8.`2058=&4CD'KT[$CH2*X>S^"'AJQN
MX[A+G49F3E1.\;*&QPV-@!(.#ALJ<8((.*JGB)TXN*V,94XR=V=MHOAW3M!6
MX-G$3<73![JZE;=+</\`WG;\3P,`9.`*YB\^$GAV75EU/3I=0T:Y7)!TR<1`
M$Y!(R#MX)&%P,=JFG6E!MKJ.<5/<=#\*M$;4HK[5KW5M;DA`$::I=>:JX(/0
M`9''0Y!R<@UU.MZ)8>(=)FTS4H?-M9<;E#%2"#D$$<@Y%.=:4FGM;82@DFNY
MS_ASX=VGABZMI++7==DM[?=LLIKP&W.X'.8PH'5B?KS65JOP3\):I?/<HMY8
MB3EH;211'DDDD!E;'7H,`8&`*I8J<9.22U$Z2:L;GA/X>Z!X.+R:?#)+<OP;
MFY8/(%_NC```^@&>^<"C_A`M+_X3W_A,#<7AU#_GEO7RA^Z\KIMS]WWZU+KS
M<G)]58:II)(U?$F@6OB?0+G1[V2:.WN-F]H"`XVL&&"01U4=J/#F@6OAC0;;
M1[*2:2WM]VQIB"YW,6.2`!U8]JCG?)R=+W'RJ_,9/_"`:7_PGO\`PF'VB\_M
M`'/E;U\K_5>5TV[ON\]>OY5U=$YN=K]%8:BEL?_9_^T9K%!H;W1O<VAO<"`S
M+C``.$))300$``````!('`%:``,;)4<<`@```@``'`)!`#%-:6-R;W-O9G0@
M5VEN9&]W<R!,:79E(%!H;W1O($=A;&QE<GDQ-"XP+C@Q,3<N-#$V````.$))
M300E```````0%=%$!<3C]?'Q5HQ"_.(K`#A"24T$.@``````JP```!`````!
M```````+<')I;G1/=71P=70````$`````%!S=%-B;V]L`0````!);G1E96YU
M;0````!);G1E`````$-L<FT````/<')I;G13:7AT965N0FET8F]O;``````+
M<')I;G1E<DYA;65415A4````&P!#`&$`;@!O`&X`(`!I`%(`(`!#`#,`,``X
M`#``+P!#`#,`-``X`#``+P!#`#,`-0`X`#`````X0DE-!#L``````;(````0
M`````0``````$G!R:6YT3W5T<'5T3W!T:6]N<P```!(`````0W!T;F)O;VP`
M`````$-L8G)B;V]L``````!29W--8F]O;```````0W)N0V)O;VP``````$-N
M=$-B;V]L``````!,8FQS8F]O;```````3F=T=F)O;VP``````$5M;$1B;V]L
M``````!);G1R8F]O;```````0F-K9T]B:F,````!````````4D="0P````,`
M````4F0@(&1O=6)`;^````````````!'<FX@9&]U8D!OX````````````$)L
M("!D;W5B0&_@````````````0G)D5%5N=$8C4FQT````````````````0FQD
M(%5N=$8C4FQT````````````````4G-L=%5N=$8C4'AL0'+````````````*
M=F5C=&]R1&%T86)O;VP!`````%!G4'-E;G5M`````%!G4',`````4&=00P``
M``!,969T56YT1B-2;'0```````````````!4;W`@56YT1B-2;'0`````````
M``````!38VP@56YT1B-0<F-`60```````#A"24T#[0``````$`$L`````0`!
M`2P````!``$X0DE-!"8```````X`````````````/X```#A"24T#\@``````
M"@``________```X0DE-!`T```````0````>.$))3009```````$````'CA"
M24T#\P``````"0```````````0`X0DE-)Q````````H``0`````````".$))
M30/U``````!(`"]F9@`!`&QF9@`&```````!`"]F9@`!`*&9F@`&```````!
M`#(````!`%H````&```````!`#4````!`"T````&```````!.$))30/X````
M``!P``#_____________________________`^@`````________________
M_____________P/H`````/____________________________\#Z`````#_
M____________________________`^@``#A"24T$"```````$`````$```)`
M```"0``````X0DE-!!X```````0`````.$))300:``````-;````!@``````
M```````"`P``!+`````3`$X`90!O`%,`=`!E`&T`(`!L`&\`9P!O`"``:`!I
M`"T`<@!E`',````!``````````````````````````$`````````````!+``
M``(#``````````````````````$`````````````````````````$`````$`
M``````!N=6QL`````@````9B;W5N9'-/8FIC`````0```````%)C=#$````$
M`````%1O<"!L;VYG``````````!,969T;&]N9P``````````0G1O;6QO;F<`
M``(#`````%)G:'1L;VYG```$L`````9S;&EC97-6;$QS`````4]B:F,````!
M```````%<VQI8V4````2````!W-L:6-E241L;VYG``````````=G<F]U<$E$
M;&]N9P`````````&;W)I9VEN96YU;0````Q%4VQI8V5/<FEG:6X````-875T
M;T=E;F5R871E9`````!4>7!E96YU;0````I%4VQI8V54>7!E`````$EM9R``
M```&8F]U;F1S3V)J8P````$```````!28W0Q````!`````!4;W`@;&]N9P``
M````````3&5F=&QO;F<``````````$)T;VUL;VYG```"`P````!29VAT;&]N
M9P``!+`````#=7)L5$585`````$```````!N=6QL5$585`````$```````!-
M<V=E5$585`````$```````9A;'1486=415A4`````0``````#F-E;&Q497AT
M27-(5$U,8F]O;`$````(8V5L;%1E>'1415A4`````0``````"6AO<GI!;&EG
M;F5N=6T````/15-L:6-E2&]R>D%L:6=N````!V1E9F%U;'0````)=F5R=$%L
M:6=N96YU;0````]%4VQI8V5697)T06QI9VX````'9&5F875L=`````MB9T-O
M;&]R5'EP965N=6T````115-L:6-E0D=#;VQO<E1Y<&4`````3F]N90````ET
M;W!/=71S971L;VYG``````````IL969T3W5T<V5T;&]N9P`````````,8F]T
M=&]M3W5T<V5T;&]N9P`````````+<FEG:'1/=71S971L;VYG```````X0DE-
M!"@```````P````"/_`````````X0DE-!!0```````0````".$))300,````
M`!$/`````0```*````!%```!X```@6```!#S`!@``?_8_^T`#$%D;V)E7T--
M``'_[@`.061O8F4`9(`````!_]L`A``,"`@("0@,"0D,$0L*"Q$5#PP,#Q48
M$Q,5$Q,8$0P,#`P,#!$,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,`0T+
M"PT.#1`.#A`4#@X.%!0.#@X.%!$,#`P,#!$1#`P,#`P,$0P,#`P,#`P,#`P,
M#`P,#`P,#`P,#`P,#`P,#`S_P``1"`!%`*`#`2(``A$!`Q$!_]T`!``*_\0!
M/P```04!`0$!`0$``````````P`!`@0%!@<("0H+`0`!!0$!`0$!`0``````
M```!``(#!`4&!P@)"@L0``$$`0,"!`(%!P8(!0,,,P$``A$#!"$2,05!46$3
M(G&!,@84D:&Q0B,D%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%PJ-T
M-A?25>)E\K.$P]-UX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=7
M9W>'EZ>WQ]?G]Q$``@(!`@0$`P0%!@<'!@4U`0`"$0,A,1($05%A<2(3!3*!
MD12AL4(CP5+1\#,D8N%R@I)#4Q5C<S3Q)086HK*#!R8UPM)$DU2C%V1%539T
M9>+RLX3#TW7C\T:4I(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]B<W1U=G=X>7
MI[?'_]H`#`,!``(1`Q$`/P#U5))))2DDDDE*22224I))5^H9V-T["OS\M_IX
M^,QUECO)HGV_O/=^8Q)3827EQ_QM=:LSW.QNETV8+`Y_V?>[[06,&ZQ_JM_1
M;FL'JO8S'M].O\__``J[W$S\;ZR=`&5TS(?35G5.:RYOMMJ)FJV-?9DT.W_R
M/5_TC$Z6.4:XA5J%$6#8\$/4/KE]6NG9+L3)S6G(KGU*J667N9!B+OLE=_HN
M_DVJYTGK72NM8WVKI>2S)I!VN+9!:X?FV5O#;:G?\8Q>5_6GH/UKQNHOP,+"
MR!TBDAO3J<!KW4"H?1?:*3N^VO=N^UWYGZ>VW_">CZ2Z[_%O]5^J=%JS,[J@
M]*_/],#&)W.:VKU(LO>USF>K9ZWT/\&S^7[*Y)8HQQB7&"3^BM$K-4=.KVB2
M22A7*22224I))))2DDDDE/\`_]#U5))8/UQ^M3?JOTZG-=C'+-UPH%8>*XEE
MEN_>6V?Z+]U$`DT%`7H[R2R/JQ]9<#ZR=,;G8DUO:=F1CN(+ZK!^8Z/I,=].
MJS_",_[;5[J>:WI_3<O/<PV-Q*;+RP&"X5M=;L!_E;4J-TJNC926)]4?K*WZ
MS=)_:0QSB1:^HU%XLU9M]P>&U_O_`+BVT"*T*E+G?\8.'DYGU0ZA5C-+[&BN
MTL')9597?;_X%6]RZ))&,N&0EV-J(L4_.>(_*9EXUN#)RVW5NQ=HW$V[V^AM
M'YVZS:O8?J-A#I^5]8<&@!N#3U)SL=K0`UILKJMLI9'YM+75,6I1]4_J[BY[
MNIXF!13G&2VT-T:X_GLIW"IC_P"75Z;U4ZIU;HGU)Z2'6[[+,BU[VUMVF_)R
M+#ZN1>_^;9N<]V^ZSV4U?HZ:6?T?'4^;+[IB(Q-K(1X`;.[T2H]:ZA;TSI63
MGTXMF;9CLWMQJOIO,Q_*]K?IV>U_Z/\`P=BY^_ZU_6_&PSU"_P"J[FXK6[WM
M;EL=<UG.]V.VG?\`1_P?\XS\];/U<^LG3?K'@'-P"X!CO3NIL`#V.C=#MI<Q
MS7L=OKLK?Z:B,)`618O6C?\`T5UAR/J;]=<CZRV7-.&*FT$"Q['.(;N!->KZ
MVLL^AM=[Z[O^Z_I;[*NL5+IG6>F]6;>_IU[<FO&M-%EC-6;PUMCA6_Z-C=MC
M?>SV*ZA.N(U'A_JI&W=2222:I22222E))))*?__1]57G_P#CGT^K>&1_W,'_
M`)YR5Z`O/_\`'1_XF\3_`,.#_P`\Y*=#YAYI&X:/6<#-^HW4J?K3T.N>D988
MWJF"W^;;NCZ/^AK>]WZM9_VER?T/]&R/078]8ZCA]4^I74>H85@MQLCI^0^M
MX_XJP.:[]VRMWLL9_@[%JU4U7]/91>QMM-M(996\!S7-<W:]CVN]KFN:O+NK
MXV=]0W]2Z>UMEWU:Z[1?5CN'N]#(LJ>RMKMQ_G&_1?\`]R<7]+^ENQ;*T1ZB
M.X_%(U/BZW^+GJN)T;_%_E=3S"1CXM]SWANKB8J:RMD[?TEMCFUL6C@,^O?7
M\*OJQZK5T&G);ZN-A58U>212[WT69.1DN'Z5]?\`H]G_`%I_Z&OD>GT77?XG
MNH"D$FO+]1[0"?8RS'=8=/S:V_I7_P!1=/\`57ZL?4KKO1L+JAQ1F9`J97D>
MM==;LN8UK;Z7577/8S:[Z#?3_FO3]/\`1HR&I/BH]6?U0^N'4[^M9/U7^L)I
M?U+&!-.5CD>G<&AKW"&>WU/2?Z[-C*_T>^NVFFZGW\Q]8?\`&!=U+J-]%=N5
M5TBMY93^S[FXUM@:2PY-F393?8]EO^"QV?9Z_3V>JN[#/JKTSK-'1<#!IHZE
MFTV^_$IK:ZJIK=SK,JUFRRJNUWZ.K_2W+Q2_$R,&^S"R6[,C%>:;6^#F'8?[
M/YS%-R^.$S+B'0:,661C1CI;UYQ.I]/Z9_SI^IO6<S*P:"3FX66XOMJ('Z7[
M32/U>]K&/W6_HOT57ZQ1?9_.*_UW)ZC]:^D=&^MG1J3;E=+L<,O#:#8:[FNI
MNWLI'NNJ]2BMVQGZ;[/?5_PBS?\`%AF>AUW+HN(^Q9&'8[+#HV`4EA;;;/YK
M&6W5_P#75>_Q;?6'IOU>Z/CXO5'OI_;.59;BOB:F5M%6$+LBR?T+;,FFRG^Q
MZEOIT_I$I1./)Z1Q$;>,3ND2$X6='HNB?XT/JYU$-JS7'IF5.US;]:MW\G*;
M[&?^A/V9;.5TG9TWT_J[=1TAMC_7LMIQZ[66-+3O_1356YUOZ/\`3?R$NN?5
M/H/76.^WXS?7(AN77#+VZ;6[;F^YVS_1V^I3_P`&N1_Q9WYN/D=;Z$;CDX'3
MW.%-@^@U_J7TO-/TME>7Z7K^EO\`3W^IL_G+%'43$SA<>&N*$O5%6NQZ]0U_
M\5N'U>[I3\C"ZDW"PZLP'(Q3CLM-@;7C/L_67O8^GU*?T/T/T?\`.K<P.J_6
M7ZW.ORNBY;.C=&IL-6-DNH%]^06_3L%>1MJJQ_W?9ZG_`*+R_P#%A1;D_4KJ
MV/3I;=;;77V]SL;':S7^L56_Q==%^K'7NC?9NI4.NS\&QPLH?=<&[''?78W%
M;:RAK=VZFS]%_/5?I%)DKBR2/Z)`^6,JOK7Z2!L!W'=TZOK/U_ZO_6;&Z%]8
M,FGJ>)GEK:,ZMC:;6.>[T:_6IJ_1>V[V6L_<M]?UOYRE2ZM]8OK+G?71WU5Z
M/=3TZNIK769CJQ=9'I,R+'[+3Z7^%KJKJV?\)ZRUL[$^IGU:&+:>FXS,BZ^N
MK#9316[(?:YS6,-)=^D_1;O4<_?[/^,]-<_B?_EDS/\`B/\`W7Q4V/#*Y<.T
M"=1Z3*/Z7"HV*%[EL?6+JOUM^IM='4<GJ-?6\&ZPTVT74,QWM<6.MK=7;B#\
M[TK/IL_\^?HKE?3_`/&!G=/;U!O7J<7*OK%U>#7B5NI:7#>RC[3=ZU_]>W])
M_P!=53_'%_XE\?\`\.,_\\Y2[#I7_)>'_P`15_U#4":QQE4>(D@^D?H^"?TB
M-7D_JO\`7/JW6OJ];D&ECNH8MS:;7M:=A:YGJ5W.9N_1/<_]#;_@*?Z1_,_H
MUU^#==?B56WL].UXES8+>_M=Z=GZ2K>WW^E9^DJ_FWK@O\37]`ZI_P`?7_U"
M]%3<X$9RB!5%4+(!/9__TO55C?6GZK8/UGP*\'-MMIKJM%S74EH=(:^K:?49
M:W;MM5[JF:[I_3[\X5&]N*PVV5M,.-;/??Z>AW6MI]1]5?\`A;/T7JU?SJSL
MCZQ9&-EX6)?B-9=E"DOK-WOFZST',PFBK;G_`&#^D=2]]'V;%V7_`*5$`[A(
MMVJV"NMM;>&`-$\P!"K=4Z9A]6P+NGYS/4Q\ANU[>X_.:]A_-LK?[ZW+-=]9
MQMSPS&WV]-IRKKJ@_P!P./8^O%KM'IEU/[1HK^U8^[_`_P`WZ_\`.*U3UEUG
M0K.KG&=OJKNL.*PESR:#8TU-W,KL]5_I?S5M-5]3_P!%?35=OK2HJHHOJ]]6
M.G]`Z4_I5#GY.-:][[!D;7%WJ`->QS6,KK]/:W]Q8%G^*W"Q\I^1T/JF=T<6
M_P`Y7CV';M'#&N!KNV_\;;<MO_G&19TFO;C6?M1UC3?3D[Z&^F6MC'O]%GVJ
MRS?[:]E7Z13=]9L5F&_*?Z;11G'!R0;0/2B]V&V^]VW]%OK#,GT[/S+?YS_"
M(^K[5:L/JW]3^D_5TW78WJ9&;D_TC-R7;[GZ[MN^&M:S=[O;_.?X7U-BK_6;
MZA]&^L-OVJPOQ,Z`TY-,>\#1@R*WAS+=G[W\[_PNQ:=/5_4ZYD=)=6UIIJ%K
M'BP/<X'9OWU5M/V;9ZS/Z1979=].BNROU/3LT9GK963C>A=7]E+!ZUC-M=F]
MOJ3C63^E]/\`F[?W+$A*43Q`T4$7OJ\QTS_%MTO`QK,8Y-UK<H!F;8(KLMK!
MG[$+J_=CX-O_`&JJH_6,G_"97H_H5K]<^J?1.N=/JP,N@5UXPVXKZ(K=2(]/
M91#=C:MC=GH;/0^A^C_1UH%GUFR*\+(R;<-M'V?)&&777;:0_=LNR+<AM3O1
MP&[F>C>^OU;7_P`YCXR<?6D;>G[L4UV=2KQ[*:GOAQ-UM5&176W9^E^Q47?;
M+?\`@/YST?YQ$G(9<5^KNKATJM'/K^HW5*\<8+?K+GCIX&T4C8+`P?X-N7'J
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MTL;6TNY(:-HW1"RZ^O6NZQB],?B&L9.,R]UKG$;'O%[_`+-M?4QC[&?9?H>M
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MJ22G_]D`.$))300A``````!5`````0$````/`$$`9`!O`&(`90`@`%``:`!O
M`'0`;P!S`&@`;P!P````$P!!`&0`;P!B`&4`(`!0`&@`;P!T`&\`<P!H`&\`
M<``@`$,`4P`U`````0`X0DE-!`8```````<`"`````$!`/_A#XEH='1P.B\O
M;G,N861O8F4N8V]M+WAA<"\Q+C`O`#P_>'!A8VME="!B96=I;CTB[[N_(B!I
M9#TB5S5-,$UP0V5H:4AZ<F53>DY48WIK8SED(C\^#0H\>#IX;7!M971A('AM
M;&YS.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2)!9&]B92!835`@0V]R
M92`U+C`M8S`V,"`V,2XQ,S0W-S<L(#(P,3`O,#(O,3(M,3<Z,S(Z,#`@("`@
M("`@("(^#0H)/')D9CI21$8@>&UL;G,Z<F1F/2)H='1P.B\O=W=W+G<S+F]R
M9R\Q.3DY+S`R+S(R+7)D9BUS>6YT87@M;G,C(CX-"@D)/')D9CI$97-C<FEP
M=&EO;B!R9&8Z86)O=70](B(@>&UL;G,Z>&UP/2)H='1P.B\O;G,N861O8F4N
M8V]M+WAA<"\Q+C`O(B!X;6QN<SID8STB:'1T<#HO+W!U<FPN;W)G+V1C+V5L
M96UE;G1S+S$N,2\B('AM;&YS.GAM<$U-/2)H='1P.B\O;G,N861O8F4N8V]M
M+WAA<"\Q+C`O;6TO(B!X;6QN<SIS=$5V=#TB:'1T<#HO+VYS+F%D;V)E+F-O
M;2]X87`O,2XP+W-4>7!E+U)E<V]U<F-E179E;G0C(B!X;6QN<SIC<G,](FAT
M='`Z+R]N<RYA9&]B92YC;VTO8V%M97)A+7)A=RUS971T:6YG<R\Q+C`O(B!X
M;6QN<SIP:&]T;W-H;W`](FAT='`Z+R]N<RYA9&]B92YC;VTO<&AO=&]S:&]P
M+S$N,"\B('AM<#I#<F5A=&]R5&]O;#TB36EC<F]S;V9T(%=I;F1O=W,@3&EV
M92!0:&]T;R!'86QL97)Y,30N,"XX,3$W+C0Q-B(@>&UP.D-R96%T941A=&4]
M(C(P,3`M,#<M,C%4,#@Z-#(Z,S8M,#0Z,#`B('AM<#I-;V1I9GE$871E/2(R
M,#$Q+3`U+3,Q5#$U.C$Q.C4V+3`T.C`P(B!X;7`Z365T861A=&%$871E/2(R
M,#$Q+3`U+3,Q5#$U.C$Q.C4V+3`T.C`P(B!D8SIF;W)M870](FEM86=E+VIP
M96<B('AM<$U-.DEN<W1A;F-E240](GAM<"YI:60Z0S-!-S5"1$%".3A"13`Q
M,3@R.49!0S9%,C@U-S,Q.3@B('AM<$U-.D1O8W5M96YT240](GAM<"YD:60Z
M,$(X,#=#0S1#-3DT1$8Q,3DT0SA&,C8T1#<X-C8V,D(B('AM<$U-.D]R:6=I
M;F%L1&]C=6UE;G1)1#TB>&UP+F1I9#HP0C@P-T-#-$,U.31$1C$Q.31#.$8R
M-C1$-S@V-C8R0B(@8W)S.D%L<F5A9'E!<'!L:65D/2)4<G5E(B!P:&]T;W-H
M;W`Z0V]L;W)-;V1E/2(S(B!P:&]T;W-H;W`Z24-#4')O9FEL93TB<U)'0B!)
M14,V,3DV-BTR+C$B/@T*"0D)/'AM<$U-.DAI<W1O<GD^#0H)"0D)/')D9CI3
M97$^#0H)"0D)"3QR9&8Z;&D@<W1%=G0Z86-T:6]N/2)C<F5A=&5D(B!S=$5V
M=#II;G-T86YC94E$/2)X;7`N:6ED.C!".#`W0T,T0S4Y-$1&,3$Y-$,X1C(V
M-$0W.#8V-C)"(B!S=$5V=#IW:&5N/2(R,#$P+3`W+3(Q5#`X.C0R.C,V+3`T
M.C`P(B!S=$5V=#IS;V9T=V%R94%G96YT/2)!9&]B92!0:&]T;W-H;W`@0U,U
M(%=I;F1O=W,B+SX-"@D)"0D)/')D9CIL:2!S=$5V=#IA8W1I;VX](F-O;G9E
M<G1E9"(@<W1%=G0Z<&%R86UE=&5R<STB9G)O;2!I;6%G92]B;7`@=&\@:6UA
M9V4O:G!E9R(O/@T*"0D)"0D\<F1F.FQI('-T179T.F%C=&EO;CTB<V%V960B
M('-T179T.FEN<W1A;F-E240](GAM<"YI:60Z,$,X,#=#0S1#-3DT1$8Q,3DT
M0SA&,C8T1#<X-C8V,D(B('-T179T.G=H96X](C(P,3`M,#<M,C%4,#@Z-#0Z
M-3<M,#0Z,#`B('-T179T.G-O9G1W87)E06=E;G0](D%D;V)E(%!H;W1O<VAO
M<"!#4S4@5VEN9&]W<R(@<W1%=G0Z8VAA;F=E9#TB+R(O/@T*"0D)"0D\<F1F
M.FQI('-T179T.F%C=&EO;CTB<V%V960B('-T179T.FEN<W1A;F-E240](GAM
M<"YI:60Z0S-!-S5"1$%".3A"13`Q,3@R.49!0S9%,C@U-S,Q.3@B('-T179T
M.G=H96X](C(P,3$M,#4M,S%4,34Z,3$Z-38M,#0Z,#`B('-T179T.G-O9G1W
M87)E06=E;G0](D%D;V)E(%!H;W1O<VAO<"!#4S4@5VEN9&]W<R(@<W1%=G0Z
M8VAA;F=E9#TB+R(O/@T*"0D)"3PO<F1F.E-E<3X-"@D)"3PO>&UP34TZ2&ES
M=&]R>3X-"@D)/"]R9&8Z1&5S8W)I<'1I;VX^#0H)/"]R9&8Z4D1&/@T*/"]X
M.GAM<&UE=&$^#0H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@(#P_>'!A8VME="!E
M;F0])W<G/S[_X@Q824-#7U!23T9)3$4``0$```Q(3&EN;P(0``!M;G1R4D="
M(%A96B`'S@`"``D`!@`Q``!A8W-P35-&5`````!)14,@<U)'0@``````````
M`````0``]M8``0````#3+4A0("``````````````````````````````````
M`````````````````````````````!%C<')T```!4````#-D97-C```!A```
M`&QW='!T```!\````!1B:W!T```"!````!1R6%E:```"&````!1G6%E:```"
M+````!1B6%E:```"0````!1D;6YD```"5````'!D;61D```"Q````(AV=65D
M```#3````(9V:65W```#U````"1L=6UI```#^````!1M96%S```$#````"1T
M96-H```$,`````QR5%)#```$/```"`QG5%)#```$/```"`QB5%)#```$/```
M"`QT97AT`````$-O<'ER:6=H="`H8RD@,3DY."!(97=L971T+5!A8VMA<F0@
M0V]M<&%N>0``9&5S8P`````````2<U)'0B!)14,V,3DV-BTR+C$`````````
M`````!)S4D="($E%0S8Q.38V+3(N,0``````````````````````````````
M````````````````````````````````````6%E:(````````/-1``$````!
M%LQ865H@`````````````````````%A96B````````!OH@``./4```.06%E:
M(````````&*9``"WA0``&-I865H@````````)*````^$``"VSV1E<V,`````
M````%DE%0R!H='1P.B\O=W=W+FEE8RYC:```````````````%DE%0R!H='1P
M.B\O=W=W+FEE8RYC:```````````````````````````````````````````
M``````````````````!D97-C`````````"Y)14,@-C$Y-C8M,BXQ($1E9F%U
M;'0@4D="(&-O;&]U<B!S<&%C92`M('-21T(``````````````"Y)14,@-C$Y
M-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92`M('-21T(`````````
M````````````````````9&5S8P`````````L4F5F97)E;F-E(%9I97=I;F<@
M0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0``````````````+%)E9F5R96YC
M92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR+C$`````````````
M`````````````````````'9I97<``````!.D_@`47RX`$,\4``/MS``$$PL`
M`UR>`````5A96B```````$P)5@!0````5Q_G;65A<P`````````!````````
M`````````````````H\````"<VEG(`````!#4E0@8W5R=@````````0`````
M!0`*``\`%``9`!X`(P`H`"T`,@`W`#L`0`!%`$H`3P!4`%D`7@!C`&@`;0!R
M`'<`?`"!`(8`BP"0`)4`F@"?`*0`J0"N`+(`MP"\`,$`Q@#+`-``U0#;`.``
MY0#K`/``]@#[`0$!!P$-`1,!&0$?`24!*P$R`3@!/@%%`4P!4@%9`6`!9P%N
M`74!?`&#`8L!D@&:`:$!J0&Q`;D!P0')`=$!V0'A`>D!\@'Z`@,"#`(4`AT"
M)@(O`C@"00)+`E0"70)G`G$">@*$`HX"F`*B`JP"M@+!`LL"U0+@`NL"]0,`
M`PL#%@,A`RT#.`-#`T\#6@-F`W(#?@.*`Y8#H@.N`[H#QP/3`^`#[`/Y!`8$
M$P0@!"T$.P1(!%4$8P1Q!'X$C`2:!*@$M@3$!-,$X03P!/X%#04<!2L%.@5)
M!5@%9P5W!88%E@6F!;4%Q075!>4%]@8&!A8&)P8W!D@&609J!GL&C`:=!J\&
MP`;1!N,&]0<'!QD'*P<]!T\'80=T!X8'F0>L![\'T@?E!_@("P@?"#((1@A:
M"&X(@@B6"*H(O@C2".<(^PD0"24).@E/"60)>0F/":0)N@G/">4)^PH1"B<*
M/0I4"FH*@0J8"JX*Q0K<"O,+"PLB"SD+40MI"X`+F`NP"\@+X0OY#!(,*@Q#
M#%P,=0R.#*<,P`S9#/,-#0TF#4`-6@UT#8X-J0W##=X-^`X3#BX.20YD#G\.
MFPZV#M(.[@\)#R4/00]>#WH/E@^S#\\/[!`)$"800Q!A$'X0FQ"Y$-<0]1$3
M$3$13Q%M$8P1JA')$>@2!Q(F$D429!*$$J,2PQ+C$P,3(Q-#$V,3@Q.D$\43
MY10&%"<4211J%(L4K13.%/`5$A4T%585>!6;%;T5X!8#%B86219L%H\6LA;6
M%OH7'1=!%V47B1>N%](7]Q@;&$`891B*&*\8U1CZ&2`911EK&9$9MQG=&@0:
M*AI1&G<:GAK%&NP;%!L[&V,;BANR&]H<`APJ'%(<>QRC',P<]1T>'4<=<!V9
M'<,=[!X6'D`>:AZ4'KX>Z1\3'SX?:1^4'[\?ZB`5($$@;""8(,0@\"$<(4@A
M=2&A(<XA^R(G(E4B@B*O(MTC"B,X(V8CE"/"(_`D'R1-)'PDJR3:)0DE."5H
M)9<EQR7W)B<F5R:')K<FZ"<8)TDG>B>K)]PH#2@_*'$HHBC4*08I."EK*9TI
MT"H"*C4J:"J;*L\K`BLV*VDKG2O1+`4L.2QN+*(LURT,+4$M=BVK+>$N%BY,
M+H(NMR[N+R0O6B^1+\<O_C`U,&PPI##;,1(Q2C&",;HQ\C(J,F,RFS+4,PTS
M1C-_,[@S\30K-&4TGC38-1,U336'-<(U_38W-G(VKC;I-R0W8#><-]<X%#A0
M.(PXR#D%.4(Y?SF\.?DZ-CIT.K(Z[SLM.VL[JCOH/"<\93RD/.,](CUA/:$]
MX#X@/F`^H#[@/R$_83^B/^)`(T!D0*9`YT$I06I!K$'N0C!"<D*U0O=#.D-]
M0\!$`T1'1(I$SD42155%FD7>1B)&9T:K1O!'-4=[1\!(!4A+2)%(UTD=26-)
MJ4GP2C=*?4K$2PQ+4TN:2^),*DQR3+I-`DU*39--W$XE3FY.MT\`3TE/DT_=
M4"=0<5"[40914%&;4>92,5)\4L=3$U-?4ZI3]E1"5(]4VU4H5755PE8/5EQ6
MJ5;W5T17DE?@6"]8?5C+61I9:5FX6@=:5EJF6O5;15N56^5<-5R&7-9=)UUX
M7<E>&EYL7KU?#U]A7[-@!6!78*I@_&%/8:)A]6))8IQB\&-#8Y=CZV1`9)1D
MZ64]99)EYV8]9I)FZ&<]9Y-GZ6@_:)9H[&E#:9II\6I(:I]J]VM/:Z=K_VQ7
M;*]M"&U@;;EN$FYK;L1O'F]X;]%P*W"&<.!Q.G&5<?!R2W*F<P%S77.X=!1T
M<'3,=2AUA77A=CYVFW;X=U9WLW@1>&YXS'DJ>8EYYWI&>J5[!'MC>\)\(7R!
M?.%]07VA?@%^8G["?R-_A'_E@$>`J($*@6N!S8(P@I*"](-7@[J$'82`A..%
M1X6KA@Z&<H;7ASN'GX@$B&F(SHDSB9F)_HIDBLJ+,(N6B_R,8XS*C3&-F(W_
MCF:.SH\VCYZ0!I!ND-:1/Y&HDA&2>I+CDTV3MI0@E(J4])5?E<F6-):?EPJ7
M=9?@F$R8N)DDF9"9_)IHFM6;0INOG!R<B9SWG62=TIY`GJZ?'9^+G_J@::#8
MH4>AMJ(FHI:C!J-VH^:D5J3'I3BEJ:8:IHNF_:=NI^"H4JC$J3>IJ:H<JH^K
M`JMUJ^FL7*S0K42MN*XMKJ&O%J^+L`"P=;#JL6"QUK)+LL*S.+.NM"6TG+43
MM8JV`;9YMO"W:+?@N%FXT;E*N<*Z.[JUNRZ[I[PAO)N]%;V/O@J^A+[_OWJ_
M]<!PP.S!9\'CPE_"V\-8P]3$4<3.Q4O%R,9&QL/'0<>_R#W(O,DZR;G*.,JW
MRS;+MLPUS+7--<VUSC;.ML\WS[C0.="ZT3S1OM(_TL'31-/&U$G4R]5.U='6
M5=;8UUS7X-ADV.C9;-GQVG;:^]N`W`7<BMT0W9;>'-ZBWRG?K^`VX+WA1.',
MXE/BV^-CX^OD<^3\Y83F#>:6YQ_GJ>@RZ+SI1NG0ZEOJY>MPZ_OLANT1[9SN
M*.ZT[T#OS/!8\.7Q<O'_\HSS&?.G]#3TPO50]=[V;?;[]XKX&?BH^3CYQ_I7
M^N?[=_P'_)C]*?VZ_DO^W/]M____VP!#``(!`0(!`0("`@("`@("`P4#`P,#
M`P8$!`,%!P8'!P<&!P<("0L)"`@*"`<'"@T*"@L,#`P,!PD.#PT,#@L,#`S_
MVP!#`0("`@,#`P8#`P8,"`<(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`S_P``1"`$H`UX#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#]_****`"B
MBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`***
M*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH
M`****`"BBD9MHS0`M%-:3'8G-4-=\2V/AG2Y[_4;RVTZPM4,DUS<RI##$H&2
MS,Q```[DXH2Z(%KL7^GI09`*^*OV@O\`@X5_9#_9TNYK34/C!HGB;4HP?]$\
M*PS:Z6/=?.ME>!3[-(M?,GC#_@\/_9\TJZD31/`'Q;UQ$.%F>RL[19/<;K@L
M!]0*ZZ6!Q%3X(-F]/"U9_#%L_6_=\V.,TO'J/RK\<]'_`.#R;X.S3@7_`,)/
MBE:QL<!H);&<X^AE6O:_@[_P=5?LB_$ZXB@U?Q%XO\!32X`.O^'9S%N/8R6O
MGJ![L0/>JJ9;B8*\H,J>#K1^*+/TCH)Q7#?!3]HSP'^TGX1CU_X?>,O"_C?1
M9#M%[H6J07\*-C)5FC8[6'=6P0>",UV:3[FV%2#C-<;BT[,YGIHR:BFK)N/0
MTX'(I`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!
M1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%
M%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`444
M4`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110
M`4444`%%%%`!1110`444$9%`"$X&<8Q6=JVMVNA:7<WU_<VUG9V<;S3W$\BQ
MPP(@RSNYP%50,DG@<U'XD\0V7A'0[W4M2NH;#3=.@DNKFYF8)%;Q(I9W=CP%
M`!)-?S'?\%T?^"\?B/\`X*%^.=2^'WP[U&\\/_`W1IC$/+=H;GQC(C$?:;GH
M1;9'[N#IT=\L52/NR_`3Q4^6&RW?8ZL)A9UIV6W<^\/^"FG_``=?>%/A!?W_
M`(1_9ZTRR\>:];LT$WB?4-PT:T<<9@08:Y(/?*I[FOQ/_:V_;\^,7[<?B.74
M/BCX_P!?\3QR/YD>GO.8=,MO01VJ8B4#UP3ZDFO=/^"<G_!!/X[?\%&(+76M
M+TN'P#\/I6!/B?Q!%)''<+GG[);*/-N6QGD;(N,&0'BOU?\`#?\`P0R_8=_X
M)3?#*W\:?'S78?&%U9J2U[XON2MK=RCG;;:9!GS<]HR)CZY-?24W@L')4J<>
M>?EJV>M*M@\&M?>?<_G3\-:->^*KX66C6-]JMR>EO96[W$@_X"@)_2O0-._8
MV^,.K6RW%K\*/B7<0OP)$\-7F&_\AU^Q_P`8O^#GCX<_!*S?P[^S3^S_`*+9
M:7:?N[?4]<M8M&M&QP#%8VJF4KZ&1XCZJ*^5_B+_`,')'[7'CZ>1K7QOX<\)
MVSG*V^C>&[;"`]@\_FM[<G\*^CPN"S6NE*%)07]YZ_<KV/(K\;4:;Y4KV['Y
M[^-/@9XY^&\,DOB/P5XQT"*#[\FH:+<VR)]6=`!^=<O#<"=-T4B.O^P<XK[V
MA_X+J_M;Q3!I/C9K=XH.?*N]'TR>$^Q4VW/XC%<A\2O^"@#?M&F3_A;OPB^#
M_CVYF7#:QINBCPIKZ'^\+S3RJ.1U`FAD7VKO659C'XXQ?HW?\41A^.\/*5JL
M7%=SYI^`O[0GC?\`9>^(EOXM^'?BS6_!WB*U((N],N&A,H'\$JCY94]5<$'T
MK^BK_@A/_P`'`]O_`,%!KN+X7?%"#3]"^+MI`9+*[M1Y=EXIB1<NR(?]7<``
MLT8R",E<8('\Z?Q1\):)9:NUWX4;6VT68;A::J(FO;`_W'DB^29?2150G^)%
MK*^'7Q'UWX-_$+0_%OAC4)M+\1^&;Z'5-,O(6PUO<1,'1O<9&".A!(/!KQ,W
MR?VL7SQM+HSZ#_9,PH>UP[3MV[^9_<1%)O7J"1QQVJ1>5->8?L:?M$V7[6_[
M*GP^^)FGQ"WM_&^@VFJF#)/V:62,&6+_`(!)O7_@->H(,9K\VE%Q;BSYIIIM
M,=1110(****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`
M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*
M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`I"P!I:C?EB#0`\
ML![TW?Z<5Y!^UI^W7\*/V'?`_P#;_P`4O&FC>%+.12;>&XEW7=X1_##`N9)#
M_NBORG_:5_X/)_#.B:A/8_"+X/:KXDC4E8]6\3ZDNF19[,MM$DLC*?\`:>,^
MU=.'P->L_P!W%LWIX:K4^"-S]N!*"<<YIOG`U_.0W_!XE^T$;XR+\-/@\MON
M_P!68M1+X]-_VCK[X_"O>?V;_P#@\ET/5+V&S^+?P<U'0XCC?JOA?51J"*<\
MEK69(W51_LR2'VKKJ9)BX1NX7.B>68B*ORG[@[Q@>]`.:\5_9`_X*"?"+]O'
MP;_;7PM\;:1XGAC0&YM(Y/*OK$GM-;OB1#]1BO98GWY/(&.]>7*+@[25CA<6
MG9DU%%%`@HHHH`_'K_@[7_;]O/@E^SEH'P5\/WYL]2^)I>ZUR2)\2+I<+#]U
MZ@2RX!]50CH37D__``0,_P"#=#3M>\,Z+\;?VA=":[^VJE]X6\%WB%(HXB`4
MO+^,\LS<%(#P``S@D[1Z?^T/^Q5%_P`%$O\`@YN-OXLMA?\`P_\`@MX.TK6;
MVSE4F&\E9I'MX&&>4:8[V'0B+!!!-?L+'"L:!0`JC&%`P%'3`_*O7J8QT,-'
M#T=&U=OKZ'?+$>SHJE#KJSXV_P""N_\`P5:\+_\`!+#X%61L[*RUGQ_X@B:U
M\,>'PPCB"H,&YE5>4MH^!P!N.%'J/YIOVD/VF/'?[7_Q9OO'/Q(\1WOB?Q'?
M,?WLYVP62=/)MXA\L,0`&%4>Y).:]=_X+!_M.ZG^UG_P4;^*/B&^GF-CH>L3
M>&])@<Y6UM;*1H<`=/FD5W/'4BOFJ,8Z_P#UJ_6>%L@I8+#QK35ZDDFWZZV7
M;S/S?-<QG6JN"^%:`#BC:3VI]%?6/NSQ[(CVGCBEQSSQ3Z1_NFG=A9#*Y3QC
MHRZ?=)<1+MBGSN`Z*>^*ZLDD^_:I-&^%VN?&[QKX=\%>&;-]0\2>+]4@TG2[
M<9_>3S-L!.!PHSN8]`H)[5Y>;0A]6E4G]E7/HN%\;4P^.BHOW9:-']0__!NU
M%=1?\$9O@:+L@NVE731\$8C-_<E.O^SBOMA6R*\Z_9/^`NF_LL_LU^!/AOI+
M-)I_@C0[31HI",&?R8E1I#R>68%CSU->BI]T5_/5>:G5E)=6S[&I*\FQ:***
MS)"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH
M`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`
MHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"B
MBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`IKG`'/>G4CG"]<4`0-.5/!_2
MOS7_`."Y'_!?71?^";^FS_#SP";#Q)\:M0MED:"7$EIX6B=04GNL<-*RD,D.
M02"&;"E=WMG_``6E_P""E]M_P3+_`&/;WQ-IRV][\0?$LC:/X/T^4;UGO67+
M3NO\44"_O&[$[5_BK^5W7I]1\<>,=6\2^)]2NO$/B;7;R74=3U&\<R2W=U*Q
M>25B>K,Q)S_0"OJN&^'9YA/VLO@7XLQJ8_#X1>TKZ]DMW_P"C\;_`(X^._VI
M?B5?^,O'WB#6O%WB347+37]Z[2E1V1!]V-!T"H`!7(364ULN7BF4'N8R*]`#
M$8P2.^!Q0SLW<G/KR#7ZC3X?IP@HP>QST^/9Q?N44H]KN]O78\Y8'`R.O>A#
MGHW-=U-X<T_4+A&NH)50MF0VSA)".^,@C/UZ^W6O0?&'[!.O:K\%+OXE_#6^
MC^(_@O2`/[?6Q@9-7\*L>GVZSY=8S@XG3=&>>17E8_"2PMG-Z=SZW*>*<)C7
MR_#/L_T9Y=\&OC1XO_9V^(]AXP\">)-4\*>)=*<26VH:=.895_V6QPZGH58$
M'/(K^C/_`((=?\'"VC?M\RZ?\,/BF]AX:^,BQ$6<R`0V'BU47+&'G$=R%!8P
M_P`0!*9`('\T*`N`58$=00>M7-(U2Y\.ZO::A87=WI^HZ=<1W=I=VLQAN+2:
M-@Z2QR+\R.K`%67D$`UX&8972Q<&[6ET9ZN-R^G7C>*L^Y_<O;L7/+9Y/:I>
M.:_.;_@WY_X+&#_@I-\")_"WC:[MT^,?@""./52`(AX@M/NQZC&@X#$@+*JC
M"N<@!7"C]&%^8&OSRO0G1J.E4W1\=5IRIR<)[H?11G-%9D'F'@S]G'3?!/[3
M?CGXE6[H=3\<:;IVG7*[<%5L_-"G/OYOZ5Z4X"K]<5(5'<`_A3)!^[/!)HDV
M]P=V?R1_\%7/V<=7_99_X*)?%?PQJ\,L0OM>N=?TZ5EPMY9WLK3QR*>X!=D/
MH5KY]4_-CVK^IW_@K-_P2&\&_P#!47X:VHN[IO#/Q!\.1O\`\(_XBBB$GEAN
M3;7*=9;=CR0"&4_,IZAOYV_VR_\`@F3\;?V#_$MQ9^/_``1JJZ3"Y$7B#2X7
MO=)NEZ[Q*H.S/=7"D&OVWAKB7#8O#QI5)<M2*LT^MNJ_R/B,SRVI2J.45>+V
M\CPBBH8+Z"9?DFC?Z.#4GFC;U&/K7UR:>QXU@D[4VHWO(C,(Q(AD?Y0H.YC[
M;1R:^G/V0/\`@C]^T)^VQJ-N?"GP^U32=#D(+ZYXAA?3+%%/\0\S#R<<X1>:
MYL3CL/AX<]>:BEW-J6'J5)6IQ;?X'S++,L*@LV,G:``26;T`'7\.M?NO_P`&
MX?\`P1CU3X/W=O\`M"?%K1GT_P`4:A:E/!VAWD>)](M9!\U[,I_U<\JG"H?F
M1#S@M@?1/_!+S_@W^^&7[`7V?Q1XE\KXE_%!H@IU;4+938:/G[R6-LV0A/>5
M]TAQQL!*U^@,*D,<Y/N:_*>)^+EBXO#832'5]7Y+R/K<IROV#=6I\3V\E_F/
M$0!S3@,"BBO@K(]T****8!1110`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%
M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`$X%,<
M948]:<PR*\[_`&L?C/;_`+.O[,GC[QU<N(X?">@WFJ;B<#=%"S+_`./`4Z=-
MSFH1W;M]Y,FDKL_G+_X.(_VQW_:P_P""CFN:3:79N/#/PJC/AO3$5LQ^?D->
M2C'\3287/7$:CM7PM&=PYZXYI]_K]]XLU&ZUC5)7N=4U>>2_O96.6DGE8R2$
M_P#`F--3[OTK^B\JP,,)A88>"^%?>^Y^>8W$3K57.;]/)!L%*!BBBO0.08W]
M:]!_9:_:C\9_L:?&W2O'_@._^Q:UI9V36\I)L]6MB?WEI<IT>&0<$'D9R.17
MGY3DFD*8&2`1Z>M95J$*T'3J*Z>C3+IU)4Y*47JM4?HM_P`%!_\`@E[X*_;B
M_9'B_;$_90T5[#3+E))O'WPZ@7?-H=Y'S=O:HHX:(MN>)0`\966,`'8?RC1Q
M,@D4@YK]5O\`@VP_;MG_`&7OVX(OAUK-X%\"_&7&G7,4Q'DVNKHI^R3XZ`RC
M=`WKYD1/W!7+?\')7_!*"+]A']H^/XB^"=-^S?"_XEW,DJP0K^ZT/4^6FMQC
M[L<G,B#M\RCI7YE.,LOQCP-5WB]8/R[/S6Q^P<,YX\134*KU_4^*OV(_VN_$
M?["G[47A'XJ>%Y)3?>&KL/<VR-M&H6C?+/;MZAT+#ZX/:O['/@)\;="_:.^"
MOA7Q[X8N5O-`\7:9!J=C*#UCE0,`?<'Y3[@U_$6`47!Z']:_HA_X-"_VP9?B
M3^RUXQ^#^IWCSWWPUU%+_2T=\L-/NRQVC_9299..V\5X_$F#O!8A+5:,]'/,
M+=*JNFY^PD9R5^E24V-<?A3J^-/FPHHHH`*IZGIL.J6LEM<PPW%M,NV2*5`Z
M./0@@@CV-7*:T>XY[T)A8^>/BM_P2D_9R^-M^]WXE^#/@&^NY<EYX]+2WE8G
MJ=T>TUP=I_P00_9'L;B.5/@IX99D.0'>9E/U!?!K[#\OWH]CS7;#,\7!<L:L
MEZ-F#PU%N_*ON/%_@_\`\$^/@A\`I(Y/!_PJ\":!+'G;+;Z1$95^CL"U>QI#
MY:87`7H!V'TI_E[L<]*<1@`'!KEJUZE27-4DY/S;;_$TC3C'2*MZ#AP**.M%
M06%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110
M`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!
M1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%
M%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`(3R*^+_P#@X2\3
MR^&/^"0GQC>(D-?6%MI['_9GNX8F_1C7V>?O`5\>?\%\_!<OCG_@D;\:;>%#
M))8Z.NI;0,DBWGCF/Z(:[LJ:6,I<VW,OS1SXJ_L96WLS^6`_-FGH,`_6F%@Q
MR#D$9!['WIR_=;ZFOZ-6R/S;MZ#J***8PI'^X:6D?[IH`GT3Q/>^"]<L-;TZ
M5H=0T6YCO[613ADEB<2*1COD5_4O\?O@IHW_``60_P""1XTFX-L+KXC^$K?5
MM)NW`VZ=JRPB2";/.%6<;6QR49QD9K^5YE#X!&0>M?T[_P#!N/XWG\=_\$B/
MAB)W,CZ*U[I0)[+#<R!1^`(K\\\0*%J%'$QWB[??K^A])PU6<:LHI^?XG\IN
MMZ+?>'=8O-)U2VFL-3TNXDL[RUE7;);3QN4DC8=F5U8'Z5^@_P#P:Z_'6X^#
MW_!7/PKHIF,>G?$?1M1\.W(9L(72W:]A/UWVNT?]=#ZUQW_!Q;^SE#^S=_P5
MN^)<%G$(=,\;FW\86JA=N6O$)N"/^WE)S_P*O%_^"7?C:?X>?\%+?V?M6AF^
MSB'XAZ'!-)GI#->Q03?G%*X_&O,K26)R]R[Q_0_7JC5?!N3ZH_LN1N?K3ZBC
M.6Z=,U+7YPE9'QH4444P"BBB@`HHHH`*,9HHH`****`"@G%%,>50V">10`NY
M<\8S2Y]OUK@/CO\`M,_#W]F+PH-;^(?C/PYX-TIB0D^K7R6PF(P2(PQW.1D<
M*">:^(/BK_P=,?LB_#:_EMK+Q-XK\8M$VW?H.@2R1M[J\YB!'O6M/#5:FL(M
M_(TA1G/X4S]'B?>DW^YK\N-,_P"#N']E6^NXXYK#XLV"/@&6?P]"43ZA+AC^
M0KZ'_9V_X+L?LJ_M-7]M8Z!\7O#^GZM<MMCL=<6329B?0&=50GV#&M)8&O%7
ME!I>A4L-4BKN+/L+(]115.RU"#4K**>":*:WG02121N&216&0RL."""""/6K
M*N`Q`Y-<OD96'T444Q!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444
M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`
M4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1
M110`4444`%%%%`!1110`4444`%%%%`!1110`TMA17(_'OX76GQN^"?BSP??(
MLMGXIT>ZTN52<`B:%D_K78'IS45P"%&/6G"3C)2CNB9)-69_%=XI\#:C\,/%
M>K>%]7B>'5?#=[-I5XCKM820.8R2/?;G\:IITK])?^#FW]A>?]F_]L^#XH:9
M;,OA+XO;I9)$7$=KJL2#SHV]#(F)%SUP_P#=-?FU&..>IYK^BLHQ\,7A*>(A
MU6OD]K?>?G>,H2HUI0D.HHHKT3E"D<?+2TC'`H`:OWATZ]S7],O_``;0Z)-H
MG_!(GP&TZE?M]_J5W'D8RC7;X/Z5_,R;>:\(@MXVEN;@B*%%ZN[':H'XD5_7
MK_P3M_9_/[+?[#GPN\`R`K<>'?#UK#=#;@B=E\R7/OO=A^%?GGB#6C'#4Z/5
MRO\`=_PY]#P[2;J2GTM8_%__`(/,?`46F?M)?`_Q2L)$VL^&]1TJ67LPMKJ&
M5!]1]J?\Z_+[]@;3I=;_`&\O@98P#,][\1/#\,0SU9M2MU'ZFOUO_P"#T:]B
M;6OV=+;>/.$?B"4IW"_\2\9_.OSY_P""!/P<;XW_`/!7[X'::T#36VBZQ+XD
MN6QE85L+::YC8^G[](5'NPKY[+JO+E7.^B9^KX.?+@')^9_7'&?WA%/9<U''
MRX.:EKX<^7"BBB@`HHHH`****`"BBB@`HHHH`:>_O7R3_P`%F?\`@HHG_!,S
M]B/7?'MC:6NI>+K^=-'\-6=SDP27\P.V24`AC%$BM(RC&_:J97?D?6S<"OSN
M_P"#F/\`8\US]K3_`()JZO=>%K2ZU+7OAOJ,7B=+"W0R37UK&C)<K&HY9UB<
MR@#D^40,DBNC!1A*O"-39LUH<CJ+GV/YK/C5\</B+^V/\3K[QK\1_%6K^,/$
MNI2,TVIZI("D>3GRX8E`CAC7G;%$JHHX"BNN^$4GPE\!2)<>+/A_XJ^)%P(]
MKVS^*AH%AN['$$$D[#V\Q<UQ]B89+&%K<QM;L@\ME^ZRXX(^O/Y&G[1GC\J_
M=L-D6%C24+75NA\OF'%F,E-TJ'N16B2WMY];GU9\/_VF/V-DU*-/%G[$&ZSX
M$DND_%S7Y)@.YVRW"*3[9%?6?[/_`/P3;_X)P_\`!4VX;0_A7XF^(7P8^($\
M>ZW\-ZCJ[2RN>O[I+TS?:5&.1%-N]<5^4)&&SS4EG?7&EZA;WMG=7%C?64JW
M%K=02&.:TE7E9$<8*LIY!!S7!C>$\/.-\-*4)=[MK[FV<F%XDQ=.2<Y77F?L
MQH?[*/[:?_!OI?CQ+X"\2W'[17[/NG2&36?"863[786O)::&W8N]NZKEMUN[
M(<?O$(Y'Z_?LE?M,>$OVQOV>O"WQ,\#WPU#PUXMLQ=VSG_61,&*202#^&2*1
M7C9?X60CM7C_`/P1O_:8\2_M??\`!-[X:>./&):?Q+?64MG?7;)@ZB]M,\'V
M@CUD$89L<%BV.*],_9=_91T/]E'5_B'!X686GAOQQXED\50:.D>RWT:YN+>&
M.Z2$=!%+-"T^T8"O/+@`&OQ_'-^TE3J)<T6TVNI]A]85:"J-:O4]>HHHK@)"
MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`I'4,.:6FR9P,>M`'C/[=G[%_A/]OG]F7Q%\,O%L7EV.
MLQ"2ROHD#7&D7J9,%W%Z.C>XW*74\,:_E+_:R_9/\;?L2?'G6_AU\0--;3]<
MT>5C%.@/V35K;)\N[MF(P\4BX/JIRK`$5_8N(^ASSFOG3_@HO_P3+^&__!2W
MX4?\([XWLI;35;$,^B^(+$*NHZ+*1]Z-C]^,G[T;95AZ'FOJ>%^(Y994<*EW
M3EOW7G_F>3F>6QQ,;QTDOZL?R5[<C)ZYJ2OK;]OC_@B3\>?V!-7OKO4?#%_X
MZ\!P,S0^*_#5I)>6Z1#H;NW0-+:D<99E,>3@28KY"AU.WN@3%/#(!W60'%?L
M^#S"ABH>TH24EY?UH?&5<+5I.U169(_WC0V<<]JBN+Z"UYEEBCSTW,!GV^OM
MW[5]J_\`!-[_`((8?&;_`(*"Z_8ZE=:1JGPV^&;.K7'B?6;-K>:\B[BPMI0'
MF8]!*5$0/\3$;:6-S'#86FZM>2BEW_0*&%J5I<L$SJ/^#>?_`()U7W[:7[9^
MG^,M8TXR_#;X47":GJ<TR9AU'40-UI9+QAB&`EDXP$4`\N*_IC'`R202?PKS
M?]DO]E'P1^Q3\"="^'?P^TI-)\.Z''A03OGO)C@R7$TG625SRS'Z<``#N?%W
MB33O!?AC4-:U>\MM-TK2;66\O;RX<1PVL$:%Y)'8\*JJI))Z`&OPSB#.9YGB
MW52M%:17EW]7U/NLNP2P])4UN]V?SJ_\'@'QF@\;?M^^`O!UO('_`.$'\'^=
M<@?\LY[VX9RI_P"V4,1_X%7J7_!G;^R%+?\`CCXD_'34K4"UL[5?"6AR.O5W
M=9[MU^@2%,^["OS@_:'\6^,_^"QW_!47Q+J/@RPN]5UKXK>)FM]`MG4YM=.C
M_<VS29^XD=M&KN3@##9K^J?]@O\`8XT#]@O]E'P=\+O#:K):>&;)4N;HC#W]
MVWS3W#>[R%C[#`[5UYA56&P,,*OBDKGU6)JJCA8T%N]6>S*!GCM2TV-2.M.K
MY@\0****`"BBB@`HHHH`****`"BBB@``Q44B`G/0@YS4I.!43`LW3B@-=T?E
M;_P4D_X-D?!'[3WC'4/&WP?U:S^%_BS5YGN=3TJ6V:30]1F<Y:58T^:VD8DE
MO*^1B2=@.2?R]^,7_!OU^UI\'-4EA;X8/XKM%8A+SP[J4%VDJYX8(2KKGT89
MK^I4K\G%"YV]\U]/EO&&88."IIJ45W7Z[GE8G*:%>3FU9OJC^2WP]_P1_P#V
MI?%&H"UM/@3X_60,$8W%JENBG/4L[`8]37V1^Q#_`,&KOQ2^)GB6UU+XY:GI
MW@#PK"ZO/I.E7:WVL:@G4QB1/W5N#P"V689/'<?T%;#CJ:/+;%=V,X[S"M!P
M@HPOU2N_Q,:&18>#O)M^IS'PG^%6@?`[X:Z%X/\`"NE6NB^&O#5C'IVG6%NN
M(K:"-0JKZD\9+'))))R2374(`N2`!2.#GI^M/`&/K7Q+DY.[W/:C%)60M%%%
M,84444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`
M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%1S,5Q@D?A2;`>N
M3U%#`GI7,>(OBYX5\'7K6VK^)_#^E7(Y\F\U&&%P/]UF!JB/VBOA_@?\5QX/
M/_<:MO\`XNJ4)=$-1D];';45B>%O'VB>-H7DT;6M*UB./AWL;R.X"?783BM=
M&+=#FD]'9BL244BG(I:`"BBB@`HHHH`****`"DV"F.Q#=2!63XF\;Z1X(LEN
M=:U;3=)M6;:)KVZCMT)],N0/PH6KL@2;V-D@COFD^:N+7]HOX?GKXX\'_P#@
MYMO_`(NMGPO\0]!\<QROH>M:1JZ0\2&QO([@1_783BFX26K13C);HW:*9&3G
MDT^D2%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%1OR]24
MA0$T`0&#'\1Y%>._%7_@GC\"_CAJ3WOBSX1?#S6[V0EGNI]"M_M#D]29%4,3
M[DU[.J]\9I<Y[XITJU2F[TW;T9$H1E\2N>)_"G_@G7\"?@=J<=_X3^$/P\T.
M_B.8[N#0X/M$9'0B1E+`^X->S&#?CD]>:E``.<_I00%'7M55*U2H[U)-ONW<
M(0C%:*PV0[(P>IK\B?\`@X?_`."@'B+XMW,7[&OP$LK[Q=\3/'ZI#XJ32?G;
M2[!V!-I(XXC,HQYI8@+%D,?GQ7Z?_'?P3XJ^(_@"YT3PKXM/@>]U(^1-K4-B
MMW>V4)'S&V5SY:SGHKR!U0G=L8@"N*_8[_X)^?"W]A[PY>VG@3P[Y>KZO(T^
MM>(M3G-_KOB"=B6>:[O),R2LS$G&0HSPJCBKP]2-.7M)*[6R.BE.,)<S5V?,
M_P#P0[_X(C:)_P`$O/AY/XC\2RV7B/XQ^)[98]4U&%-UOHL!P38VA/)7<!YD
MG!<J.`H&?T&0Y&/:FB%5Z#':GC&VIK5YU9NI4=VR:E2523G-W;'44CG"TP,0
M>OX5E=$#SDCI1M%,9B1FO+?CY^VM\)OV6=.^T_$3XC^#/!\8!*IJ>J0PS28[
M+'NWL?95-52IU*DN6G%M]DKO\"9245=L]4ZGTI?NCK7YW_$;_@Z!_9+\#W$D
M6F>*?%WC1X\Y.A>%[MXR?023K$A^H)'O7E>L?\'=7P/A=A8?#+XQWH#8#R6V
MF6ZL/7F[)_`BO7I</9E47NT9?=;\SEJ8_#P=I31^L@!]?THY%?E'X?\`^#N?
MX#7LRIJ?P[^,NF*<;I$L-/NE7U^Y=YX^E>O?#+_@YB_9%^(T\<%YX]UGP=<S
M8`C\0^';VU4?658WB'U+XJ:N09C37OT9?=_D.&.H3^&:/OX=..,4,/;->=?!
M7]J?X<?M%Z0M_P"`_'?A+QC:2#B32=4ANL>Q5&)!]B!7H(<A?0FO*G3E!\LT
MT_-6.F,E)7BR6BHR^3P33P<D<]JFZ*%HHHI@%%%%`!1110`4444`%%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%
M`!1110`4444`%%%%`!1110`4444`%%%%`!1110``8KY4_P""UW[3WB7]CC_@
ME]\7/B'X/G%IXGTG3(+/3KHKN-E->7D%D)U'0O&+@NN<C<BY!%?52DGK7PC_
M`,',"X_X(F?&D>VB_P#I\T^ML+!3K0B^K7YFE"*E4BGW1_*EXO\`$.H>/O$E
MQJNO:CJ&NZK=N9)[S4+A[F>9R<DL[DDDFLTV5LV1Y$8'^Z*G+<G@=:1#\O2O
MU%4J:T27W'WT:,%HDON.]_9O_:<^('[(7Q%L?%7PU\5ZMX1UFPE$P>SG*P7&
M#DI-#]R5"."K`Y%?U,?\$6?^"MGA_P#X*H?L[-?S"TT?XE^%1';>*]#C)`B=
MA^[NX`>3;S;25ZE6#*>@)_DKY#`\CZ5ZO^Q1^V5XU_8%_:0T'XG^`KP0:QHS
M&.YM')%OJUFQ'G6DP'6-P!_NLJL,$"O(S7*(8FG>FK26QYF8Y=&I#F@K-']I
MD9!&00>]/`&/:O$OV"_VZ/!'_!0C]FS0_B5X)NB;'4HPE[82L#<Z1=*!YMK,
M!_$IZ'HPPPX->UQ_+]#7Y].,HR<9:-'R4DXNTMQ]%%%,D****`"BBB@"-AA2
MW4U_*E_P<F?M"^*_C-_P50^(?AO7=7O+CPYX$EM]+T72O-;[)9QB!'9Q'G;O
M=W8EL9Z=ABOZL"<"OY&?^"^W_*8/XY?]A>'_`-)HJ]WAZ$98KWE?1GJY+&,L
M1:78^.#96^/]3%_WR*^R?^"!OQL\0_`__@J[\&HO#NI75A9^*]>70=7LTE86
MVHVMS%)&R2Q@[6VL5=21\KHI[5\>G%?2O_!&@_\`&V+]GG_L=[+_`-FKZS,:
M,5AIZ+;L?19C3BJ$M$?V'J>@]*<GW13%_P!<:>GW17YJCXA"T444P"BBB@`H
MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`H;H:**`&H`1TH
M0Y8\8IU%`!0>E%1<B,Y[4`*\@102<#ZUX1^WE_P4-^&'_!.SX6KXG^(^N):-
M=EX]*TFVQ+J6LRJ,LD$.<D`$%G.$0$;B,C-+_@I+_P`%`?#/_!.7]EW6/B#X
M@C-]>(?L>BZ2CA)=6OG!\N$'/"_Q.W\*@]Z_EC_:C_:A\<?MF?&_5_B%\1-8
MDUGQ+JQV9Z6^GP`DI:VZ=(X4S@*/O$DMEB2?JN&N&)YG+VM32FM_/R1X^9YI
M'"KECK)GV#^WA_P<;?';]K6^O])\&WA^$W@B9FCCM=(DW:M<IDC]]=]5)[K&
M`!ZU\!ZS?W/B37)M3U.ZN]4U.X8O+>7<SW,\I[EI')8GZFHQECR.WY5]<?\`
M!+O_`((W?$O_`(*A:Z^HZ2\'A'X;:9<_9M4\57UN94DD!&^WLH>!<3*#R<A%
MXW-G"G]7C1R_*<.YM*,5N^M_S;/E'/$XRIRW;9\BRS+"FZ1P@`SN<X`'U-4Q
MXETXL<7ENXQG*-O`_$9K^I3]E#_@W]_9C_93L;20?#^P\?\`B"!09-9\8*-6
MED?'WE@D'V>/GILC!'J:^OO#_P`/M!\*:<MGIFB:1IMK'\JPVMG%#&H]`J@`
M#%?)XKQ#HQE:A2;7=NU_S_$]:EP[)J]25G]Y_%C;:U9W[;8;NVD8_P``E7=^
M6<U:!*X/(S^M?V*?%_\`8Z^%/Q^TN6S\;?#7P+XJ@F7:W]J:';7+J/\`9=DW
M*?0J017YG_M_?\&K'@?QOHFH:_\`L\ZG-X%\2(K2IX;U2[ENM%OSU\N.5]TU
ML3SCETS@%5'(Z<OX_P`+5GR8B#A?K>Z_S1&(R&K!<U)I^5M3\)/#.OW_`('U
MV+5=#U#4-$U.!LQWFG7#VMQ&?4.A!S[&OO[]B+_@Y'^/?[+M]::=XUNX?B[X
M1CVI)!JS>5JL"<<Q72CYCCM(#GUKX;^+_P`(?$_[/_Q,U?P;XTT._P##GBC0
MI?(OM/O$VR1'JK`]&1A@JRY#`\5S@;*GCVKZS$Y;@L=2_>Q4HO9_Y,\BG7K8
M>7N.S/ZT/^"??_!3[X3?\%(?!3ZG\/\`7`NLV$:RZOX?OB(=4TK=QN>+/S1[
MN!*F5/J#Q7T?&X+8!SQ7\8OP8^,_BO\`9T^+&B^.O`VNWOASQ=X=F\^PU*U;
M#H3PT;CI)$Z_(\;Y5U)!%?U&?\$A?^"F.E?\%.?V6[?Q3]FBTGQEH$PTOQ3I
M<9REK=A01+%U)AE7YTSR.0?NY/Y'Q/PK/+6JU%WIO[UZ_P!>1]=EF:QQ"Y9_
M$?65%%%?(GLC3@COQ2,X7`R!23XCC+'/'I7@_P"W=_P41^%W_!.WX5R>*/B-
MK9MGE4KINC686?5=:E[16\.06)/5F*HO5F`JZ%&I6FJ=.+;>R6Y$ZD8)RF[)
M'M>N>(;'PWH]UJ&HW=K86%FAEN+BYE6*&!`,EG=B%50.I)Q1H.OV7BC2[?4-
M,O+74+"\C$MO<VTJRPSH>C(ZDJP/J#7\KG_!3K_@L'\4?^"G7BR:UUN>3PK\
M-K:;S-,\'6%R3;X'W9;V08^TS_4>6G(5<_,?V;_X-==4N=1_X)-Z#!+,\D.G
M>(]7M;5&)(@B%R6"+Z*"QP.P-?1YGPO6P."CBJ\ES-VY5TNNYYV%S2%>LZ4%
MI;<_1D=****^9/4"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`*^#_\`@Y>_Y0F_&GZ:+_Z?-/K[PKX/_P"#E[_E";\:?IHO_I\T^NK`_P"\
M4_\`$OS-L-_%CZH_E'/WG^IIN<=.E./WG^II$^8_05^H+;0_0$&"Q'K2'(?D
MX-?:/[.'_!)/7/VP?^"7?BWXU_#]+_4?&?P\\1W%OJFB(?,_M/3$@21G@4#/
MG1$D[>=ZYQR!GXPAD6Y@#`Y![UA2Q-*LY1@]4]3"CB(56XQ>J/KO_@CG_P`%
M6_$7_!+']I.#6U:\U3X<>(W2U\6Z$A+>?#D`7<"]!<0Y)'3>N4/4$?UA?"3X
MN^'/CI\-M"\8^$-8LO$'AGQ+9QWVFW]K)OBNH7&58=P>Q!P5(((!!%?Q`H2O
M(Z]:_3__`(-U_P#@M++^P=\38_A+\0]3D;X/^,K[?:7<\A(\*:A*0#*OI;2L
M1YBCA7^<=7+>!GN5>T7MZ:]Y;KNCQLVR_F_?4]^I_35156QO([NWCEBE6:*5
M0Z2*X974C(((X((YS5JOBSYD****`"BBB@`K^1C_`(+[?\I@_CE_V%X?_2:*
MOZYZ_D8_X+[?\I@_CE_V%X?_`$FBKW^&_P#>_DSU\B_WGY'Q]7TK_P`$:/\`
ME+%^SO\`]CO9?S>OFJOI7_@C1_REB_9W_P"QWLOYO7U^9?[K/T/I,R_W>7]=
M4?V'I_K#4E1Q_P"L-25^7Q/@UL%%%%4,**0L!W%+D>HH`**,CU%)N'K2N`M%
M&1ZBDR!Z4P%HI`P/<4I.*`"BBB@`HHHH`***,CU%`$6_GG;2^9M]ZANKA+6&
M221TCC12SLQVJH'4DG@#%?!7[<O_``<<_LX_L57]YHD7B"X^)'BVTRCZ5X7V
M7*0N/X)+@D1(?HQ/M6E*A4JRY:46V53I2F[139]^&0[?>FER3P!BOYMOVE/^
M#N;X_P#Q0NIK?X<^&/!OPQTQB0D\D1UK4L=`=\H6$'V\LX]37Q1\6O\`@K!^
MTU\<)93XE^.WQ+N$E/S0V>LR:=;_`(16WEJ.G85[-'AW$R5YVB>G1R:O-7>A
M_9%O+'G`%)O(/&*_B!U;XU>,O$%T)M1\:^,=0F!R)+G6[J5@?JTAKJ?AW^VW
M\9?A)JD%YX8^+?Q)T6>W.8_L_B.[V+_P!I"I_$5U/ABK;XT;_P!@U;?$C^U5
M9"3S_*C>$/)K^5W]G;_@YJ_:U^!.I6_]J>,]+^)&EHR^99>)M+B=W4#&!<0"
M.4$_WB6Y[&OU-_8/_P"#K#X,?M(W=GH7Q0TV[^#WB6X81">YG^V:+.YXXN0J
MM'_VT4`>IKS<3DN*H^\XW7EJ<5?+*]+62OZ'ZLT5F^'O$=EXJTBUU'3;VTU'
M3KV,36]U;3++#<(1D.CJ2K*<C!!K1#`]"*\HX!:CD!P<<FI*IZG>KINGW-R_
MW8(FE/T49/\`*A1O*PG*VI_-7_P<C?MJ77[4'_!0O5/!EA?22>$/@\G]AVUN
M#^ZFU-AOO9\=RI*0@]O*;'6OS]"8[UJ>/?&ES\2OB/XE\27CL]WXCUF]U29B
M<EFFN))#SW^]BLVOZ+RG!0PN$IT(]$K^O4_.<96=6M*4NK/6OV"?V2-1_;L_
M;`\#_"W3Y)K>'Q'>[M4NXQDV.GQ#S+B7/8[1M7_:=:_K6^"OP7\-_L_?"S0?
M!7A'2K?1/#?AFT2RL+*!0J11J.I]6)R23R223UK\!/\`@U#T2RU'_@HEXKO9
MPK7MAX.E^RY`)3?<('(].,"OZ)DY(!ZU^6\?XVI/'*A]F*3^;/J<@HQC0]HM
MV/\`+]Z#$":=17PQ[PU8@M#1!P,]J=0>E`'PI_P6Q_X)`:-_P4E^"<VK>';>
MQTSXQ^%K5Y/#^IMB(:FJ@DZ=<O\`\\I#PKG_`%3D,.-P/\R&N:!J'A;7[_2=
M6L+O2M8TJYDLK^PNHC%<6%Q&Q22&1#RCJP((/IQD8-?VK2QY7D`CWK\^?^"J
M?_!O_P##[_@HGXLE\=:'JTWPY^)DL8CN]3MK07-EKBJN$%W!E27&`!*A#`=0
MW&/M^%.*OJ5\/BF_9]'_`"O_`"_(\/-<J]O'VE/XE^)_-+U/<XK]<?\`@T/B
MUD_M,_%Y[87']@#P_9"\(/[D7)F;RP?]O9N/KBG>#_\`@T0^)-[XGBC\0?&#
MP58:(&`EN-.TNYN;ME]5CD*)G'JU?KO_`,$_/^"?OP__`."<7P,B\#>`K6[,
M4TQO-3U6^<2WVL71`#33.`!T`"J`%4#`'<^YQ3Q1@:^#EAL-+GE+ULEWU2U/
M.RK*Z\*RJU%RI'O*CD_6EI,@#K2YK\KNCZT\._X**?M8-^Q%^Q;X_P#B?'9Q
M7]YX7TYI;*VE)$<UPS".(/CG;O8$X["OY/\`X^_M"^-OVJ?BKJ'C7XA^(K[Q
M-XFU20O-<W,F4MUSQ#"GW8HEZ!5&``.]?TJ_\'$!S_P2*^+6?^>%I_Z50U_+
MP0.U?J_A_A:7U>>(M[U[7\K(^1XBK3]I&E?2UQ,8`K^D3_@UF&?^"4VF\XQX
MJUC_`-'BOYNP,`"OZ1?^#68@?\$I]-)[^*M8_P#1]=_'R7]GK_$OU,<@_CNW
M;]3]'Z**0N!WK\9NC[06BC(]11FF`44$XI-P/?I0`M%)O'K2YQ0`449'J**`
M"BDW#UI<CU%`!11D>HH)Q0`4444`%%%%`!12%P.XH#`T`+11D>M&1ZB@5PHH
MI-X]:!BT4FX8SD4N1ZB@`HHR/44A8`T`+12!P>XI<CUH`**,CU%&:`"BBC(]
M10`4444`%%%%`!12;AG&12@Y%`!1110`5\'_`/!R]_RA-^-/TT7_`-/FGU]X
M5\'_`/!R]_RA-^-/TT7_`-/FGUU8'_>*?^)?F;8;^+'U1_*.?O/]32'[PI3]
MY_J:0'=CVK]0CT/T!JZ/Z-O^#/@;OV!/'F.O_"9RG_R7BKY;_P"#E'_@AU)\
M#]>U3]HKX1Z,!X,U.=I_&VAVD?\`R`KEVS_:4"+_`,NLC$B51@Q.0X!1V\KZ
MD_X,\@7_`&!_'?;_`(K.7_TGBK]8?$7AVS\5Z)>:;J-K;WVGZC"]M<V]Q&)(
MIXG!5T=3PRD$@@]C7Y[5QM3#8Z52'?4^+JXB5'%2G!]3^&D`,>,'(SQTIKH"
MN"`0>*_13_@OK_P1<O?^";/Q@;QIX*L;FX^"_B^[;[%(JEQX;NW);[#*W4(>
M?*8]0-N<BOSLQD^W\Z^ZPN+IXFDJD-CZS#8B%>FI+J?O%_P;*_\`!;)?$7]F
M?LT_%K6?^)G&@A\`ZY>29^WJ.NE3.>DH',+$X<!H\[Q&)/W"B<.K>QK^&&RO
MY](U""\M;BXL[RSE2>WN+>1HYK>5&#)(C`@JZD`@@@@@&OZ>?^#?+_@M';_\
M%$?@]'X"\>W]O'\:/!MHHO7<K&?$UJGRB^C7C]Z!@2JHX;Y@`K87Y+/,K=.3
MQ%)>Z]UV?^1\WFN7^SDZD-OR/TJ'2BF"3Y`<<FG@YKYH\4****`"OY&/^"^W
M_*8/XY?]A>'_`-)HJ_KGK^1C_@OM_P`I@_CE_P!A>'_TFBKW^&_][^3/7R+_
M`'GY'Q]7TK_P1H_Y2Q?L[_\`8[V7\WKYJKZ5_P""-'_*6+]G?_L=[+^;U]?F
M7^ZS]#Z3,O\`=I?UU1_8?'_K#4E1Q_ZPU)7Y?$^#6P4F`#[TC/@UYA^UG^UQ
MX&_8G^!NM?$'XAZU!HGAS1H_F=VS+=RD'9!`G625R,!1SU/0$U48N4E&.[*B
MFW9'H=_J,.GZ=+<3S0P6\*F2661PD<:CDEF/``&<DU^<'[=/_!T)^SO^R3JM
M_H/A*XU#XR>+;(M%)!X;9!I-M*/X9=0?]VWO]G$V""#@BOQI_P""KW_!=SXJ
M?\%+M?O=`M;N[\#_``CCE(M/#5C.8Y-10<+)?2KS,Q'/E_ZM3V)&:^&&98D&
M,(HP`!V^@KZK`\.-KGQ#^2/=PF377/6=O(_47X]_\':/[2GQ.NY4\&Z;X(^&
MVGOD(MO9'4KH#MNEG^7/N$%?,OC#_@N#^UKXXNC)=_'KQ[:EC]W3;I;!?RB5
M0*WOV./^""O[37[:VDVVKZ'X$F\,>&[L;HM6\3.=-BG4_P`4<;#S7'OM`/&"
M:^U/!'_!FS\0;RUCD\0_&7PGI\C`;H['3)[C;ZC+%0:]"4LKP_N65_O_`,SL
MYL!2]W3\S\ZK#_@K7^U#I\[R0_M`?%E))/OM_P`)'<-NYST+5Z;\-/\`@X;_
M`&O_`(67<<D/Q@U+78X^L.N6-O?(_P!2R;O_`!ZOK3XJ?\&='Q6T+39KCPA\
M4_!OB">-28[6^M)K)I3Z;OF4?C7YS?ME_P#!.7XT?L">(DL/BGX'U/0;:=]E
MKJT:_:-+O#Z)<IE,_P"RQ#>U;4:F78A\L;-^B_X!K3J8*L^6*5S]-?V6/^#Q
M7QCX>U&VL_C/\,-+\0Z6<+-J?A2<V=]$,\O]GG8Q2''\(DC^M?KO^PI_P5&^
M"?\`P48\-->?"[QI9ZEJ5L@DO="O%-GJ^G9Z^;;2?,5'3S(]\9/1C7\<@<[N
M.E;7@#X@Z]\)_&^F^)/"VM:IX=\1:1*+BQU'3KAK>ZMG!R"KKS^!X/<8-88W
MAVC4BY4?=?X&.*R6G/6EHS^XE6R=H()'44^(GG-?E#_P09_X.#(/VXWL?A-\
M8+G3M*^+MO#C3-315M[3Q<B@9^7[L=YCYBBX5^2H'W1^KL3Y!KXS$X>I0FZ=
M16:/FZU*5.3A-:DE'6CI4;3;.3T%8F0-((Q\QP*\6_;>_;R^&G_!/?X+77CS
MXG:\FD:2I,-E:Q#S;_6;C;D6]K`"#)(<>H51EF95!:I/VZOVV/!7[`?[-VO_
M`!*\<W@ATS28BMK9HP^T:M=,#Y5K"#U=V_(9)X%?RJ?MF_MB?$C_`(*M_M*7
M/C[XBZ[9Z/IT;-;Z3:W$C+IGARR+9$%O&`6=S@%W`W2,,DX"@>OE.4U,94T7
MNK?O\CIH4(M.I5ERP6[9ZY_P5&_X+_\`Q@_X*,ZGJ&A:=>77PX^%SRD6_A[2
M[DK<WT8/RM>W"X,K$`$QKB,?[6,GX.M8XY)E@ARTC'"QHI9V/;`'-?9'P%T[
M]C[X*W,%WX[T'XM_&_48L&6TM)XO#VC%NX^\;B0?\"2OOO\`98_X+\_LJ?LT
MVMK8>&_V3U\$V\9&;G3(+*YN@<]3*X\U^!U+5]LL!B</#EPN';7JO\[F_P#K
M/EV&_=TFF?CUX4_92^*GCVV$NA?#/XB:U">1)8^&[V=#^*QD5=US]C'XQ^&+
M-KC4_A)\4-/MT&6EG\*WT:*/<F/`K^GW]F7_`(."_P!E[]I;4;;3(/'D7@W5
MYR$2R\40'3`S$XVB5OW7YL*^T=.U2#6-/AN[6XBNK:X198I86#QRHP!#*PX8
M$'@BO#Q6>8S#SY*U'E?G<Z:7$CJ:TTG\S^&S5=/FT*^:UOH;BQNDX,-Q$T,@
M/NK`$?E46WGKD_6O[7_C;^R7\,?VD]%ET_Q]\/\`P=XOMIE*D:KI,-RZY[J[
M+N4^ZD$5^8W[=?\`P:1?"KXG6%WJ_P`#M:O?AIKIRZ:3>SR7^C3''W%+DS0_
M7<X]A6F%XEI2ERU8\OGT.VCGD).U2-C^=@=.:5E##&`1WS7L?[:/[!7Q4_X)
M^?$X^%OBEX6N]!N9B38:@H,NFZL@ZO;W`&Q_=<AE[@<5XVQP>G%?14JT:L>>
M#NO(]RG5A./-%W1]F_\`!*[_`(+7?%3_`()?>+;>ST^[N?&'PQN9PVI^$;^Y
M8PJIP#)9NV?L\V/0;&VC<#U'].7[#W[='PZ_X*%?`JP^('PVUDZGI-T?)N[6
M=/*OM)N0/GMKF+^"1?J58<J64@G^,$*2P(KZ'_X)G?\`!27QS_P3&_:1L?&W
MA.>2\TB[>.V\2:"\F+;7++<-R$=%F49,<G\+=<J2#X.;9+"M%U*2M)?<SQ\R
MRN-1>TI*S_,_L<SD9!Z=:J:_I:ZSH-Y:-C;=P20G/^TI7^M<'^RI^U#X/_;(
M^`/AGXD>!-3BU7PUXGM!<V\BD"6!^DD$J_P2QON1U/1E/M7HS#:,=QS7PR4H
M2UZ'R<U9V?H?Q6:[X<G\'>)]5T6ZC\FZT6_N=/GCQ@I)%,\;#\UJ"OM+_@O_
M`/L;W7[(?_!27Q==6]J\/A7XGNWBW1IMN(O-F;%Y!GINCGRV.RS)7Q67(R#U
M'Z5_1N68N&)PE.M#9I'YSBJ3I590?1GU)_P1A_;'L?V&_P#@HGX*\7ZY<BT\
M*:L9/#VNSG[MK;7.%6=O]F.7RR3V4L>U?U96.H17]O'-!*DT,ZAXW0[ED4@$
M$$<$$$<^]?Q32QB:)E8!E8$$'N,=/\^M?JY_P1B_X.(9_P!ECPSI7PJ^.4NH
MZQX$T]5MM"\3QJT][H4/`6WN5'S30+_"X^=`-I#`#'Q?&O#M7$M8S#J[2LUU
M:77U/9R3,(TTZ55V3V/Z""0*,C&>U<O\*_C!X9^.'@>Q\2^#]?TCQ-X?U-!)
M;:AIMREQ!*",XW*3@C(R#R#P0*Z2.7>,]N17Y-).+Y9:,^MBTU=$M%-WG'2G
M4D[E!1113`*;*,K3J1UW"DP/)_VU?VCX?V0?V5?'OQ.FTQM:3P3H\VJ"Q67R
MC=,@^5-^#M!8\G!XK\5YO^#NSXQ2REX?A-\-(8GY2.2^OG9!Z$@@'ZX%?ME^
MV'^S99_M>_LQ>-_ACJ.H7&E6/C729M+DO($#R6V\<.`>#@@<'K7Y(1_\&?5P
MJ!?^%X@[1C/_``CX_P#CE?6<.2R94Y_VDO>OIOM;R/'S&.+<E]7V^1\Q?MO?
M\'%_Q,_;H_9C\3_"[Q!\/O`>BZ5XHCCCGO=.N;M[B$)(L@*ASM.2N.?>OSYV
M@D\5^G?_``4(_P"#<"7]@_\`9&\6_%.3XJGQ$/"\<,@T_P#L<0?:=\JQXW[S
MC&[/3M7YBU^I\/O+G0D\N^"^NZUT[GRV8_6%47UC>WX#&&&XK[L_X)X_\%]?
MB+_P3B_9QMOAKX8\!^"?$&EV^H76HB\U2XNDN&>X?>5(C.W`[>PKX4.2WI7Z
M-_\`!+W_`(-^I?\`@I-^RG;?$Y/B:?"GGZI>:;_9_P#9/VD)]GDV;]^\?>ZX
MQQ59]]06'3S'X+KOOTV)P"Q#G_L_Q'HI_P"#NKXS?]$I^%^?^OR^_P#BJ:?^
M#NCXS.ZY^%/PO.#VO+_/X?-7I/\`Q!^W/_1<1_X3X_\`CE-/_!GY<@<?'!<^
M_A\8_P#1E?&^TX5[?^E'LN&;6_X*/TS_`."87[:ES_P4&_8S\+?%"]\/Q>&+
MW6S/#<V$-R;B*)XI#&2CD`E3C(R,BOH4<')/U->)?\$^/V+-/_8"_92\,_"[
M3-6NM=BT)97FO[B,1O=2RN7=MHR%&3@#T%>PZIK-MHVF3W=[/#:6MK&TT\TS
MB..)%!+,S'@*`"23VK\ZQBI/$2^K_#=V]+Z'TM#G5./M-[:EMY!M&?R[U\K_
M`+=?_!9/X"_\$^&EL?&_BT:GXK5-T?A?P_$-1UA_]^-2$@'^U.\:G'!)XK\R
MO^"P'_!R3K7C;6M4^&_[..KR:-H5NS6FI^-X5Q>7[`D,E@3_`*N/J//QN/5,
M=:_'^>1[JZGN)I)KBYNI&EFGFD,DT[DY+N[99F/<L237VN1<#SKQ5;&MQ79;
MOU[?F>)C<\C3;A2U:Z]#]:/VCO\`@[5^)OBZ\N+?X5_#GPYX.TXMB&]U^=M4
MOV7/WC'&5B0GT^?'J:^3/B%_P7;_`&L_B5<O+<_&36])1_\`EEH]M;Z>B_38
MF[]:\I_9*_8#^,?[<VL&U^%W@/6/$=K')LGU9U^S:3:MG!#W+X0D=U3<P]*^
M^?A=_P`&EOQD\1V$<_BKXB>!O#4K\M;VD,U\R<9Y;Y5/X5]7*EP_EWN34;^?
MO/[M6>2I9AB?>BW;[D?#]Q_P5,_:6N+Q;A_CY\5C+%]U_P#A(9OE_(XQU[5U
M'@W_`(+6?M7>!+N.:S^.7C*\\L@[-3>*_1L?WA*C5]R>*/\`@T-\96VFE]%^
M-'A^ZO-H.R\T>2*-CW^96)QZ5\:?ME?\$._VBOV)=)NM:UWPA_PE/A6T!DGU
MKPRS7\=J@ZO-"!YJ*`,EMI`'4BM<-CLAQ3]G#D;?1Q2_-(B=#'TO>?,OG<^@
M?@#_`,'6/Q[^'MU#%X\\-^"OB-IZ,!(RQ-H]\R]]KQ[HMWU3%?IW^P5_P<%_
M`#]N/5K'P\^K7GPW\=WO[N/0?%`2W6]DXRMK=J3;S<\!=R2M_P`\Q7\P\-PD
M\0=&5E89!!!!_*B6T2YA,<BB1&Z@]_3\1V/7/>EF'!>78B-Z*Y)=U_EL/#9U
MB*;M-\R\]S^U]9`&Y..]/^^I([U_/#_P1J_X.#/$G[+NOZ3\-OC9JU_XH^&D
M[QVFG:]=R-/J/A?)"JLDA^::T''WLO&!G)'`_H/T37;7Q!HUI?V-U;WMC?0K
M<6\\$@DBGB8`JZL.&4@@@CJ#7Y/F^2XC+JJI5]4]GT9]9@\;#$PYX=#3`P*;
M)VY`I5;<H/K4<Y.!CJ3@5Y+V.P3S%13E@!C/L!7QW^V-_P`%VOV;/V*-1N])
MU[QVOBCQ5:#Y_#WA*W.KWRG.-DC(1!"P])IHS[5^8W_!Q!_P6)\:^-_CUXD^
M`GP\UR[\->#/"DBV/B.[TZ8PW>NW90,]N95.Y((PP!52-S9!.!BOR<M[9+>+
M9&BH.2<#J2>2?7_/6OT+(>!OK%&.)QDFD]DM[>;/G<?GJI2=.G&_F?LO\<_^
M#N_7+^XEA^&'P:L].MP2J7OBO5O-G<=C]GMOE4^WFM7RU\1O^#D[]K7Q\THM
M/&/AOPM!)TCTG0804^C2[V_6OA!P2!D\^_->M_L>_L)_%;]O+Q[)X?\`A?X2
MO=>DM"!J&H2'R--TH'IY]P?E5B.0@RQ].]?:KA[*,'!U)TXI+K)W_,\1YCC*
M\K1D[]D=QXC_`."QG[4_B:8O<_'GXA0%CG_0[U;1?RC5<?E6%#_P5)_:6M[D
MS)\>OBPDCDEF'B";+9_'^E?HS\%/^#17Q%J>GV\_Q"^+MAI5P^#+::%I;7/E
M>WF2,H)'KC%>H2?\&@_P\,+`?&3QP'(^\VFVQ`/TS_6O+GG_``]3?*HQ?I#_
M`(!TQR_,)>\VU\S\Q/!O_!;3]J[P+,DEI\</%U[Y>,)J0BOE./42HQ-?1OP0
M_P"#JK]H?X?7D2>,-%\#?$*Q4CS!):OI5V5[[9(<H#]8S7=_M&_\&E_Q$\':
M/<WWPR^(V@^,9(`633=7M3IUQ-_LK(I9`V/7%?EW\;?@9XQ_9L^)>H>#?'WA
MO5/"GB?3,&:PU"+8Y0])(V^[+&>SH2#SW&*[,/2R',TXTHQOZ6?Z&-6>/PVL
MVU\[G]&/["7_``<9_`3]LK7K/PSK%SJ/PF\:7C*D&G>)FC%C?R'/R6U\A,+M
MT`67RG8GY5;!K]`5F65`RLK!P&!'(([&OXHIHDN(FCD0.C=589!YK[__`&#_
M`/@X=^+W[$_[/>N^`;JWA\?Q6]GY7@Z[UB=GD\/2GC9*WWY[=1DJA.00!NV]
M/FLZX#:_>9<WK]E]O)_YGJ8+/[KEKKYH_H'_`&N/VY?A5^PYX$'B'XI>-=(\
M*6,I(MHIBTU[?L/X+>VC#2S-T^XIQGG%?E)^T]_P=S;KJXLO@Q\*)Y(%)6/5
M_&5R(3(/[RV=NS$#/(WR@XZJ#Q7Y"?'7X[^-/VG?BCJ'C;X@^(]2\5^*=3_U
MU]>MN,:C)$4*#Y88AG`C0`<#@GDYOPS^%_B7XT^.K+PSX.\/ZSXK\1ZF?]%T
MW2K9KFYE'=L#HH[NQ"CN:]/+>",'AJ?M<>^9^;M%?YG-B,\K5)<E!6[=S[&^
M*'_!QE^UK\29)/*^(&E^%X')Q%HFAV\(0'T>0.Y_$UY-K/\`P5U_:AU^5VG^
M/?Q+0OE2MOJK0+S[(`!7U'^S[_P:Q_M"?%33+;4/&&K^$/AS#<*'-I<S-?WL
M0/9UB^0'VW&O=8_^#02]%H/,^.,7G8QA?#_R@_\`?S-=+S#AS#OD7)?RC?\`
M&S,EA\QJ*[O]Y^:VG?\`!4S]I736+0?'KXJQL<*<Z_,<X_$UW_P__P""[?[6
MGPZNXYK?XRZWJBIUBUBTM[]&^N],_D:^EOC?_P`&GWQL\$:;/=>"O&W@WQOY
M0+)93"33IY0.P9MR9^IK\XOCK^S]XW_9@^(]SX1^(GA;6/!_B*U&]K/4("GG
M1YQYL+CY)8^"`R$C(QUXKT\)/)<>[45"7E9)_=:YRU5C*'O3<E\S],OV<?\`
M@[.^*O@Z^M[?XI?#_P`->-]-!`ENM#E;2K\#^\%?="Y_V?D'O7ZS?L!?\%8_
M@K_P4>T-W^'OB5X?$5I%YE_X8UF(66M6`_O&$DK*G_36!I(\\;LY`_DW/*\\
M<8]<5J^`O'FN_"OQSI/BCPQK&H>'_$N@W`N].U.QF,5S9RC^)&'.".&!R&&0
M17G9MP/@\1!O#+DFNVS]5_D=6#SRM3E:K[R_$_M+B<'."#3P<BOB#_@A]_P5
M-7_@I3^S3-)KXM;7XF>"GCL?$=K"`B7>Y<Q7L:]DE`.0.%<,/2OMM9"RCBOQ
M[%82IAJLJ%56<78^NHUHU::J1V95O]6MM*LY[JZN(;:VM8VEFFE8)'"B@DLS
M'@*`"22<#%?)'Q/_`."]_P"R#\(O%4NBZO\`'+PQ/J$#F.4:3:WFKPQ,#@AY
MK2&6-<'KEN*^;_VF9/$7_!:K_@HYXF_9WL]>U;P]^SG\%5B?X@RZ5,;>X\6Z
MD^"FG&5>D2D$$#^ZQY.W&7^SI^U5XCL;'XI^&?V>OV*_AYJ7@+X->)+SPE>1
M6^L6MI?ZD]J3EEC>(M,[)ALNS$EL$DUZV'RB'+^]NY63:3223VNWU?:QA/%.
M_NV2\TW>V^Q^C_[//[67PT_:U\)?V[\,_'/AGQOI2X$DVD7R7#6Y/\,B`[HS
M[.`?:O2(6#1J1TQ7XO>)OAYX;_:*_9?E_;C_`&-]`N?@Y\9/A[/<OXH\+VL2
MV]EXBAM&S?Z?=VJ8B=O+!=6"C=M'1]K+^I/[$'[5VC?ML_LI>!_BEH*"*P\8
M::EXT&[)M)@2DT)]TE5U]\`]ZY,=EZH+GA>U[-/=/L^GHT:TJW-H_5>AZW13
M8W+YR,4ZO..@*^#_`/@Y>_Y0F_&GZ:+_`.GS3Z^\*^#_`/@Y>_Y0F_&GZ:+_
M`.GS3ZZL#_O%/_$OS-L-_%CZH_E'/WG^II$^\/I2G[S_`%-(O4?Y[5^H1Z'Z
M"C^D'_@SZL$@_P"">'C"<;O,G\:W(;)X^6"$#^=?K,>BU^4'_!GY_P`HXO%?
M_8[7?_HB"OU?8X"U^99G_O4_4^!QG\>7J<3\?/@9X6_:7^$GB'P)XUTBUU[P
MMXHLVLM0LIQ\LJ'D$'JKJP#*PY5E!!!%?R=?\%;O^"67BG_@E=^T=)X7U![K
M6O`^N[[SPGXA:+:NHV^[F"8CY5NH<[9%'WAM<`!P%_KZ**WI@UX?^WW^PIX)
M_P""B/[.FL_#GQO9A[6]4RZ??H@^TZ/=J/W5S"W9E)Y'1E)!ZUKE>82PU2[^
M%[HTR_&2P]2]]'N?QDGG(KK_`(%?'+Q7^S5\8/#_`(]\$ZM-HGBKPS>+>V%Y
M'R`XZHX_BC=<JRG@J2*Z_P#;?_8J\;_\$_?VB]<^&OCVR\C4]+?S;.\C4BVU
MBT8D174)/5&`Y'56RIY%>08V>HK]$4J=:G=:Q:_`^S3A7IW6J9_7Y_P26_X*
MB^%O^"I/[,-MXPTA(]&\5:.R6/BK06E#R:3>;0<KT+6\HR\<F!D9!^96`^JU
MQMK^-#_@G9_P4`\:_P#!-?\`::TCXC^#)VGCC'V/6]'>0K;:[8,P,EO(/4'Y
MD?JC@$<9!_K=_9`_:R\%_MN?L_>'OB3X"U,ZCX?\0P"0!CB>RE'^LMIE_@EC
M;*L/;()!!/Y_FV62PM3FCK![/]#X_,,#*A/^ZSU6BFJP)X/:G5Y"=SSPK^1C
M_@OM_P`I@_CE_P!A>'_TFBK^N>OY&/\`@OM_RF#^.7_87A_])HJ^@X;_`-[^
M3/7R+_>?D?'U?2O_``1H_P"4L7[._P#V.]E_-Z^:J^E?^"-'_*6+]G?_`+'>
MR_F]?7YE_NL_0^DS+_=I?UU1_8?'_K#3T^Z*C/5J<,;<G/6ORY.Q\(MC+\9>
M*]/\#^&-2UK6+VVTW2=(M9+V]NKAML5M!&I>21CV55!)/M7\FG_!:/\`X*N:
M[_P5,_:=N-3AGO;#X7^$Y9;/PAHSN0IBSAM0F7`'VB?`/?RT"H"<$M^M_P#P
M=I_MS7'P4_9+T/X.:'>M;:Q\5K@OJOEMAUTJ!@SI["678I]0K#H37\Y)^7@<
M<=*^QX=RZ+7UB:]/\SZ')L$G^^FO0<5(P%5FD8@*JJ69R>@`[D]`/>OZ)/\`
M@@U_P;OZ#^SYX1T/XO\`QRT6#7/B;J4,=_I7A^_A#6OA%&^:,R1DD27I7:S;
MAB$G8`6!<_`O_!L#_P`$_K3]K[]N^3QSXCT]+WP?\'88]6$<R[HKO57;_0T8
M$881[7F(_O)'V-?T[PIR3C&[GI4<09I-3^KTG:VY.;XZ7/[*GMU&I`-N>BKP
M`.@'M4I1<`'M3ZC)R>V*^32/`2&R*K#(&3G/6N9^+/PB\,_&_P"'FJ>%?%^A
M:9XD\.ZU`UO>Z=?P">WG0C!!!Z'T(Y!Y'-=.2,]C0,'K@?TIIM.\06CNC^5;
M_@N[_P`$9+S_`()9_&>RUSPJ][J?P;\<7#KHMQ.?,FT*Z&6;3IWSEP$RT4IY
M9`5.6C9F^!#\N37]C_\`P5+_`&1],_;C_8.^)7P[U"WBEGU'29;O2IF7+6>H
M6X,UM,IZ@B1%!QU5F4\,:_CCE@ELGD@GC,5S`[1RH1RCJ2K#\"#7WN08^5>C
MR5'[T?R/K<GQ;JTW"3U1;\.>)M1\&^(K#6='OKG2]7TFY2\LKNV;9+:S(P9'
M0CH5(S7];/\`P1-_X*/1_P#!2W]B+1/%M_\`9X?&V@M_8GBJUBZ+?1*/WRCJ
M$F0B0`]-Q':OY&1@'I7ZF?\`!I=^U#<_"?\`X*(ZG\-I[EAI'Q3T.X6*W+?*
M;^Q0W,;`=,F!;@9_V11Q!@U5H>T2UC^09QA%*G[1;H_I9&!@Y_*H[EE2!F)5
M0.23T'O3A]Q3G/%?)_\`P68_;T7_`()Y?L'^)_&-F8I/%NM,GAWPO;RC<LNH
MW*OM=A_=AB6:=L\$0X[BOA\+AYUZL:--7<FDCX^I-0BY2V1^&O\`P<&?\%!+
M[]O/]LB[\/6ERZ?#+X9S-I^A6:R'&JW0XN-0D7'`9@4C4Y)1-W1\5\,A1T`P
M`,+TX'M4UW>7&JWTUU>W,MY>W4C33W$AS)-(Q+,Y/J3^5-V"OZ"RG*Z6!H*E
M36JW?<^#QV95<4[2?NK9=$,8Y'<T`'H0,9SBI`,"DV"O5/-^1%+&LZ;7177T
M89'Y5]+_`+!O_!6CXV?\$\M=M1X+\33:KX424-<^%-:D>XTJY3/S!!]^W<]G
MB(P>JMTKYLV#WI2@-<V)P=#$4W3KP4D^CU_KY&U*M.E+G@[,_JD_X)A_\%B/
MAA_P4Z\(M'H4DGA;Q]IT/F:OX2U&X5KRU'0RP.`!<P9Z2(!C^)5/%?6^T2]<
M\?A7\7/PZ^(?B#X/^/='\5^$]:U#PYXET"Y6[T[5+"4Q7%I(#G@]U/1E(*L,
M@@@XK^E+_@B9_P`%E-*_X*4_#>3P]XG:RTCXP>&+57U:PB'EPZO#P/MULO\`
M=)X=!G82.Q%?D'$W"<L"GB,-K3ZKK'_-'U^6YLJ_[NKI+\SZM_:E_92\`_ME
M_![5?`7Q'\.6/B7PSJT95X)UQ);R8(6>&0?-%*N<K(A!!K^7?_@LC_P1H\7?
M\$IOBK%+%/>>*?A7XCF8:#XA:$"2!^OV.["\+.HZ,/ED`R`IW*O]:`"LH(->
M?_M,_LV>$?VN?@GK_P`/O'>DQ:SX9\26S6US`R_/$<?++&W\$B-AE8=".]?.
M99F4\+-.+]WJO\CZG!8R="5T].J/XG.E#$'/?M7NG_!1G]@[Q1_P3>_:P\0_
M"_Q,'N8K,B]T+5"FV/6M-D9O(N5]&PI1U_AD1QV!/A2_*<'M7Z-0K1K052#T
M9]K1K1J04X[,_4'_`(-D?^"H=Q^R)^U"/A#XHOW'PX^*]TD5MYLN(]&UC`6*
M=0>`DX`BD'&2(V_A(/\`3$`"@!-?PPV]Y<:5>V]S:3O;7=K(LT$T;;7AD4@J
MZGL00"#7]?/_``1Q_;8'[??_``3X\`>.KJ<2^(%M/[(U]<\C4+;$<K$?[>`_
M/4/7QO$.!4)JO!;Z,^9SK"*$_:):/<3_`(*V?\$T=%_X*:_LOW/A:>>#2?&&
MBNVH^%]8DCWBQO`N/+D'!,,H^1P#D`AADK@_RV_&;X->*OV=?BEK7@CQOHEU
MX>\5>'9C;W]A<=4/9T;H\;##*XR&!!R:_LY"Y'/.*^4?^"G7_!)#X:?\%./`
MT4?B.U;0?&VD1%=&\46$:B]L\Y_=2C_EM`3R8VZ<E2I)SU\+<4/+G]7K:TF_
MFGW7EW/B<URM5U[2G\2_$_E/0`KUZT;`O([U]'?M^?\`!*3XS_\`!./Q%,GC
MGP])J7A4R%++Q;I,;3Z5=+GY3(0-UO(1C*2`#/1FKYO5PR@@@@C((Y!%?LF%
MQ='$P56A)2B^Q\=6HSI2Y:BLSU+]EC]M?XK_`+$OBLZS\+/&VK^%+B5PUQ:P
MD36%]CM-;/\`NI/J5S[BOU?_`&,_^#MBW\NSTCX_?#^6S?`C?Q/X/)G@D/`W
M3:?+B2,<9+12RY).(U&,_B>1D>HI4&2?;O7EYEP[@,<KUJ?O=UH_PW^9U87,
M:]#X'IV/Z_?V8/V^/@_^V7H2WWPT^('AOQ1P#);6]T$NX">SV[XD0_5:]B5O
MI^5?Q3Z+JUWX9\06^JZ5>7VDZK9MOAOK"X>UNH2.A62,JP(/H:^[/V0/^#C?
M]I#]F+['8:YK5I\5/#EJ%C^R^(U_TU4`P`MT@#DX_O[O<FO@LQ\/ZT+RP<N;
MR>C^_;\CWL/Q!3E955;S/Z;NW7\J4$X]:_.?]B3_`(.4O@#^U%=66B>++V[^
M$GBNY=8EM_$##^S;B0D`".]7]V,G/^MV?4FOT)TG5+?6=-AN[.XAN[6YC$D,
M\4@DCE0C(96!P01W%?"XS`8C"3Y,1!Q?FOU/<HXBG57-3=T:%%-5@*=7*G<W
M"D"[<^_-+13`^(?^#B$?\:B?BT?[MO:?^E47^-?R^U_4)_P<0?\`*(GXM_\`
M7O:?^E4-?R]U^P>'_P#N,O\`$_R1\=Q!_'CZ?J-/WQ7](?\`P:S#_C5+IWOX
MKUC_`-**_F[?[QK^D7_@UE_Y13:;_P!C5K'_`*45KQ]_R+E_B7ZD9!_O#]/U
M/T>HHILG0<XK\:/M!6./I7X8?\',/_!6^YUGQ+J/[-'P[U-X=/L50^/M3MI?
MFN)&`=-*0CHJJ5>8@Y)98^SBOU:_X*,?M>6G[#/[&/CSXF7!B>[T#3F&F0.<
MBYOI3Y=LF.X,C*2/[H-?R.>(?$&H^,?$FJ:UK%[/J6M:W>3:EJ-Y.Q>6]N9G
M:2:5V/5G=F)^H':ON^!\CCB:[Q=9>[!Z>O\`P#P,[QSI0]E!ZLJ(%0*`,*,#
M"\8'?';I7Z/?\$*?^"(A_P""@6KGXE_$R*[L_A#H=R8+6PB+13>+KM#AT#]4
MM$/#L/F<_(",,U?#_P"RO^S?J_[87[2O@CX6Z#*UMJ/CC58]/-T%+?V?;\M<
M7)'?RX5D<#N0!WK^O?X+_"+P]\!/A1X?\%>%--@TGPWX6L(M-TZTB7Y8H8E"
MKD]68XRS'EF))R2:^FXUS^>#IQPN'=I3Z]E_F]KGF9+EZJR]K4U2_,O_``_^
M'>A?"WP;I_A[PYI&G:!H>EPK!:6%A;K!;VZ*``JHH``X_&MHH-N,G^52*H"\
M`4U\%3TS7XZVV[O5GV*5E9;";!3&A61&5@"C`A@W(([CZ4XMZ\4!@``2,TD[
MC5S\6O\`@X&_X(7:.OA36_C[\%-&32M1TL->>,O"UC;A;;4X,Y?4;5%_U4\?
M)EC4;94^8;'0^;^(\$HEB5U8,KC((Z8K^U74=/M]3T^>VN8HYX+F-HID=0RR
M(PPRD=P1Q7\DO_!43]EN']C/]OWXF_#^SA:#1['5&U#1U(P%L;D>=$H]EW,O
MT45^L\#9W5KQE@JSNXJ\;]NJOY'R6>X&-.U:"M?<\$E`;((!!&"/45^X7_!K
M?_P4PNO&6FZC^S=XROFGOM"M'U?P5=3R9:XLE(^TV!SU:$LLB8/,;.,`1\_A
MY7?_`+)_[0E]^R;^T_\`#_XF:=*\4W@O7;749@AP9K7S`ES$<?PO`\H/UKZK
MB'+88_`SIOXEK'R:_P`]CR\MQ3H5XR[Z']DB?<'TI)`".:IZ3J<&L:=;W=O*
MLMM=QK-"ZGAT8`J1^!%72<#'M7\_:IV9^@=#^/+]O2^EU']N[XW7$S;Y9/'N
MM!F[G%VZC]`*\L48%>G?MS#/[<?QJ_['[6__`$MDKRY_EQCWK^DL!_NU/_"O
MR/S;$/\`>R]6=M^SC\!=<_:F_:`\&?#;PY(D&L^-M5ATJWN'C\U+,.<R7#+D
M;EBC#/C(SM`XS7];'[('[)?@O]B7X`Z!\-_`>F1Z=H/A^V6/S"`;C49L#S+J
MX<`>9-(P+,WJ<#```_GM_P"#9GP9;^*_^"LWANXN(XY/[`\.ZIJ$&[G;(42(
M$>^';\Z_IBB0+GTXQ7Y9X@8R;Q4,-?W4KV[M_P##'U/#]"*I.IU;'11`#.,$
M4_;\F/:A5"]*6O@#Z$A\H$8P2*^-O^"T_P#P3,T;_@HG^RMJ<5M90Q_$CPA:
MS:CX6U)8\S&5%+-:,1RT<P&W!X#%6[5]FD?+UXJ.89E7C\:VPF)GAZT:U)VE
M%W,JM*-2#A/5,_BA4.HVRQ-!*A*21MP8V!PRGW!!'X4X1\=3TQ7N/_!3?X96
MOP<_X**_&SPU81>18:=XPOI+:(``)%*_G``>G[RO$*_H["5E5H0JK[23^])_
MJ?G%6')-P[.Q=\)^$-3\?^+])\/Z):F^UK7KV+3K"W'_`"WGE<(BG'/WF'/:
MOZI/^"5__!+OP9_P32^!%GHVF6EIJ?CG58$E\3>(VB`N=1N,9:-&Y*0(251`
M<8&3R37\^'_!$[P_;^)?^"KWP/M[I!)%#KQNPI&1OBADD0_@R@_A7]7`&6S7
MYIX@X^JJE/"1=HM7?GJTONL?2\/T(<LJK5WLO(0+N7D9/?FEV#Z9J1%`4<=J
M7:,YP*_-%?N?3D+H"2#S7S?_`,%//^"<GA'_`(*3_LT:IX.UZ"UL?$=K&]UX
M8UXQ;KC0K\*?+D!&&:%FPLD60'4XX8*P^E.G;-(RCK@<5MAZ]2A4C5INTHNZ
M:,ZE-3BXRU3/XK?%/A?5/`GBK5=!UNS>PUK0KR;3M0M7.XV]Q"[1R)[X93@]
MQ@U3(W=L8K[`_P""^/PQ@^%/_!6+XKVUK&L-OK<UKK:HHP-UQ`I<_BRDU\@%
M`37]&9?B77PU.O\`S)/[T?G&)ING5E!=&?<7_!NG^T+<_`C_`(*G^#=,$S)I
M?Q&MKCPU>Q[]JNYC,T#$="0\>!_O5_3RJD#KWK^0S_@FQJ4NB_\`!1OX!W$!
MQ*GC[24'/9YPC?HQK^O1C\AQ7Y5X@45#&PJ+>4=?DSZSAZ;>'E%]&?F9_P`$
M$+J'PI^TQ^V9X2U*,6WBZQ^)LNH7<<K9E>UE#>4W^[P<'IS7S?\`L=>!_P!J
M#Q%8?MH:C^SY\2?`WA&&P^*NOFZTW5=`:ZO[RX52Q>"[W;86,>U5#1-AESN7
M-?6O_!0']B3XK?`S]L.S_:Q_9JL+?6_&:62Z9X\\#2S""/QKIR8PT))"_:D4
M#;G!)4$$G*MY-^Q;_P`%8/V4?V-X_B*-4T?XR_##Q;\1/$EQXJ\2^'?%?AJ]
MN)XM0F&)8H6CC*M'D8&<9KAC6=2,Z]"//SJ%U9.S6Z:>MM-&=;BHVC)VM?7U
M/6/^")_C'X9Z-_P1:?Q-X>T[4=!TJ&UUJ^\6_P!L:@M_=2:C'YGVZ:68*BL&
M*[@`H`4@8.,FU_P;)>'[[1?^"1O@NXNXI(;;6-7U;4=/1P1_HKWCA"/;Y6QV
MKY/^$OP$\2_MV_#'5O@%^S=X0^)7PG_9?\8^(IO$'CGQQXV5K6\U6&5U>73M
M*MF`<12LHR>F,AF`)1OV/^#WPGT'X&?"[P_X-\,V$>F>'?#&GPZ;86T:@"*&
M)0JCCJ>,D]R2>]<6:5(TZ<Z=[RG)2L]TDG:_GKMY&N'BY-2Z)6]3IX!P><YY
MJ2C&**^?1WA7P?\`\'+W_*$WXT_31?\`T^:?7WA7P?\`\'+W_*$WXT_31?\`
MT^:?75@?]XI_XE^9MAOXL?5'\HY^\_U-(O4?Y[4I^\_U-(O4?Y[5^H1Z'Z"C
M^DC_`(,_/^4<7BO_`+':[_\`1$%?J^W05^4'_!GY_P`HXO%?_8[7?_HB"OU?
M;H*_,\T_WJ?J?`XS^-+U%(.3TILB[EY`-/HZUP/8Y;(^-O\`@L?_`,$EO"W_
M``50_9V;2;CR-'^(GAB.6X\):_MYM;@KS;3XY:UF*JKCJIVNO*X/\HWQF^$'
MB;X`?%+7_!'C/2+K0/%/AB\>QU*QN%PT$JGJ#_$C##*XR&5@02#7]OLBB1L=
M,5^:7_!P7_P13@_X*'?"MOB!X!LK>#XS>#[0BW1%"?\`"3VB`L;*0\?O!R8F
M.>?EZ'CWLES7ZO+V-3X7^!ZV6X]T9<D_A9_,.`<<5]Q_\$/?^"O^L?\`!+K]
MH);76)[O4/A#XQG2'Q'IH)<Z<_W4U"!>TB#[ZC[Z9[A<?$VH:=<Z1J-S9WEO
M-97EG*\%Q;S(4E@D1BK(ZGE65@00><BJP&XD&OM<1AZ>)I\DM4_ZN?45J,*]
M.TM4S^XWP'XVTCXB^$=-U_0=0M-6T36;6.]L+VUD$D-U#(H9'5AP001BMG>,
M8Q7\Y/\`P;8_\%L3^RMXRT_X`_%+50OPW\1WOE^&-4NI,)X9O9G_`./>1C]V
MTF=NIXBD;)PK,5_HSB9B#D8]J_-\=@IX:JZ<EZ,^*Q6&G0J<LB4-E0?6OY&/
M^"^__*8+XY?]AB'_`-)HJ_KGZ`9K^1C_`(+[_P#*8+XY?]AB'_TFBKU>&_\`
M>ODSNR/_`'CY'Q_7TK_P1H_Y2Q?L[_\`8[V7\WKYJKZ5_P""-'_*6+]G?_L=
M[+^;U]?F7^ZS]#Z7,O\`=I?UU1_8=_&:).1P>>U'\1ILK!$+$X"C<?H!FOR]
M]#X3HC^5+_@Y1_:+N?CW_P`%9O'=B9/,TSX?06WAJR0-N13'&LLS#T)DD(/^
M[7P4#W->H?ML>.YOB?\`MG?%OQ#,S.^K^,-5G!)R=OVN15_\=4"O,`,FOU++
MZ?L\/"*[(^\P5/DH1BC^ES_@UI^&6A?L^_\`!+ZV\5:K>Z=I-_\`$77;K5)I
MKJX2#S(HR((A\Y'`"$\>M?;?Q+_X*3_`'X/1R'Q+\9?AOI/EG#+-K]N67VPK
M$YK^-6^\2:AJVF0V%UJ>HSZ=:C$-K+=2-;PC/14)*CD]A629K*WEY:UCQZE0
M3^'>O`Q&0*I5E6J3W9X];*%*HZE2HE=G]87Q'_X.1_V/?AVDF?BK#K<L3$>7
MH^FW-X6QZ%4VD?C7A'Q#_P"#OG]G7PPTJ^'_``K\3/%#`G:R:?!9QR<]<R2`
MC\J_GB\#_!3QM\3)%3PSX+\7>(F;&T:7HMS=YST_U:&O;O`/_!';]JOXFHK:
M1\`OB28W`*R7NF?V>A'7[TY04+)<#3_B3_%`LMPD/CF?IW\1_P#@\\P'3PA\
M`I9.<++K7B=8QCU*0P-^6ZO!/B-_P=[_`+3'BDW,6@>%/A#X5MI2#%(NEWM_
M=Q?\#DNEC;\8:\Q^'?\`P:_?MB>.U@>Y\%^&?"Z3]3K/B2V4QC_:2'S6'X`U
M[M\/O^#./XV:S'&?%/Q5^&?A\-RXL+>\U(I]-RP`_I2]GE%/XFG\[_D2X9=#
MK<^6_B)_P<4_MF?$A9HI_C5=Z1:S<?9](T'3+$(,<[9%@\T?BYKXOU*_FUC4
M[J\NYY+B[O)7GGE<Y:61R69C[DDFOWC^''_!F3X:LE0^+_CIXBU'!RRZ/H,-
MF&'IF1Y2*]S\`_\`!I'^R]X8*MK%S\0O$S#K]JUD0*?PB5:VIYOEU#^%'[DS
M2&98.C_"B?S0O(J')(Q]:^VO^#=;X;>(OB3_`,%@OA%<^'(;EH?"MW=ZQK%Y
M'&7BL;);&XC<R-T7S#(L(]Y1Z5^^G@#_`(-XOV0?A\RF'X/:/J;IT?4[F>Z/
MU^9L5]-?!#]F+X??LV:))IOP_P#!GASP=938,T>E6$=L9L<#>RC<V.V2:X\=
MQ#3JTI4X1>O<PQ><QJ4W3C'<[R.0%%..#7X#_P#!VI^T'<>+/VH_AQ\,X;@G
M3?!VARZW/`",&[O'\M6/?<L,1`ST$C_WJ_?<95<=/>OY@/\`@XP\03Z]_P`%
M@/B4LWW=.LM*M(O9!9HW\V-;<#8=5<SYY?9BVO71?J?#9[4<,,TNKL?$*#YJ
M?34&#^%.K]L/B0HHHH`****`$?[IKK/@'\>O%G[+GQE\/?$#P1J3Z7XH\+72
MW=G-_!*.CP2C^**1<HR]P?6N2D&5I`<#WK*K3A4@X5%=/0<)N,E*.Z/Z[_\`
M@GK^VWX<_P""@7[*/A;XF^',6ZZQ`8M2T_.9-)OXCLN+9QV*N#C/WE*L.#FO
M;RV5(//%?SA?\&SO[>[?LP_MI_\`"K]:O"G@WXSNMG;AWQ'9ZXBG[,^.WGH&
M@..K&'TK^CQ>%'(K\#XBREY?C)4?LO6/H_\`(_0,OQ2KT5/KU/S7_P"#F_\`
MX)W6W[7_`.PC>>/=&T_S?B#\&Q)K-A)"N9;W3FV_;K5NY&P"91R0\``P';/\
MPB,)`'4Y#<@U_<UKNC6OB/1KO3KR-9K2]@>WGC89$D;J593[$&OXP_V_/V<W
M_9)_;8^*'PY*E(/"_B"YM[7C`-LS>9"1[>6Z_E7J<,XJZE0?35'V.18AZTGZ
MGD0'-?N3_P`&;'[04IOOC+\*[B;,*)9^*;")FSC)-O/C\1"3[FOPVK])?^#4
MKQP_A+_@KGINFK(RQ^*?".K:<Z`\2%!#=#(]O(->MG=+GPD[]-3TLWCS89^1
M_3_DN3BE\LY'^-)&V7J2OSFR/C&9NNZ!:>)M(N+#4;2UO["\0QW%M<Q++#,A
MX*LC`A@?0BOSA_;9_P"#8/X%_M'WEYKGP]EOO@UXFN=\KIHRBXT2ZE8YWR6,
MG$1[9MWB'<JQK]+]PQUICC*$9KKP>88G"2Y\/-Q?X?,YZV'IU8VJ1N?RZ?MA
M?\&__P"TC^R%'=ZC_P`(M%\1_#=L2QU3PF6NW51U:2V($R>^`P'K7Q9,KV5[
M);SQRV]S"VV6&:-HY8F[AD8`@_45_:V4&.#CW%?/G[77_!++X$_MQ6\[_$#X
M?Z/?ZK.FW^V+6/[)J2'^]YT>&)_WLU]YEOB#5C:.-CS>:W^[J>#B>'X/6B[/
MLS^2<DXP1CO29QTK]A/VR?\`@TU\3>&$NM7^!/CBU\06RDNOAOQ0PMKH_P"S
M#>("C'L!*@]WK\K?CU^SMX]_9:\>-X8^(_@_7_!>O*6\NWU2U,2W0'5X)!F.
M9?>-F&.]??Y=GV"QO^[U$WVV?W?J>!B,OKT7[\=/P.+>,2H58!E88*D9!'<8
M^GN*^E?V"/\`@K/\;O\`@G1K,"^!_$LFJ>$A(&N_"6NL]WI%PO?RAGS+:3'1
MX649QN5QQ7S8BD'G^5.;H:[L5@Z&)ING7BI1?1F%&O.E+FINS/ZF?^"8?_!9
MWX6_\%,=!:QTJ9O"?Q#LH/,U#PGJ4RFZ4#[TML_`N8O]I!D<;@*^PXY@[#&>
MG3%?Q8>#_%VK_#OQCI7B'P]J5[HFOZ'<)=Z=J-G*8KFRF7HZ..1Z$=",@@@U
M_2%_P0J_X+*Q?\%$_A[<^#?&SVMC\7_"5LDEZJ`1Q>(;3(47L*]F!XD0="01
MPW'Y'Q/PF\"GB<+[U/MU7^:\SZW*\VC7]RII+\S]$-_/>G`Y%01,6/(VGTZX
MJ9#E17PZ=SWCXD_X.(/^41/Q;_Z][3_TJAK^7NOZA/\`@X@_Y1$_%O\`Z][3
M_P!*H:_E[K]B\/\`_<9?XG^2/CN(?X\?3]1C=!7](O\`P:R_\HIM-_[&K6/_
M`$HK^;IN@K^D7_@UE_Y13:;_`-C5K'_I16W'_P#R+U_B7Y,SX?\`]X?I^I^C
MU,D`R*?3)/O"OQ=GVCV/QK_X.[OCU-I/PK^$WPQM;ED3Q#JMQK^H0@@"2.UC
M$<.>^/,E<_A7X:'[GUK],?\`@ZU\;R>(O^"C?A_1BS-#X<\'0*JGHIFFDD)_
M+'Y5^9K8`K]VX/PRI973_O7?WO\`R/@\YJ<V*EY:'ZB?\&I7P7LO%7[:GCCX
M@:GY45M\/?#:VUO-,X5(KB^D*YRW&1%"_P#WU[U^Z7C7]K[X4_"^WW^(?B1X
M&T=4&3]JURVC/Y%\U_'C::SJ&G65Q!::AJ5I;W?^NBM[J2&.?'3>JL`P'.,Y
MQFLBXM],LGWS+81-_>F9`1[Y:O.SGA!9ABGB:M6RLE9+:WG?]#JP.;*A25*$
M+L_JR^(?_!>7]DOX<%TN_C1X7U"6,'Y-+,E^6/H#$K#/XUX;X]_X.I_V8O#9
M(TF+X@^*&&1_H6A&%#CIS,R5_.IX5T6\\:7`MM`T[4M;G<[5BTJPENV/T$2M
M7KW@/_@G+^T+\4E5M"^!OQ4OD?@2OX>GMH^?]J4+Q]:XX\&9315ZU5_-I&SS
MG&3?N0M\F?K!X]_X/`/#5L&7PI\"_$]_)@[7U;7;:R7ZX19#7A_Q"_X.X?CK
MK;G_`(1?X9_"GP[&<X.IRW^K2*/4;)+<9_`BOGKX?_\`!O5^U]\08@R?"F/0
MHR1\VLZ]96I`]=JNS?IFO;/`7_!IY^T5X@6-]?\`%WPJ\,K)]Y([J\U&5!WR
M%BC4GZ,::P7#%!>^TW_B;?Y@J^9U=D_NL>2^._\`@X]_;"\:M(+;XE:+X8AD
M)S'HOA2P3:#V#7*3M^(.?>ODWXY_M`^-_P!ISXB3^+/B%XGU/Q?XDN(DMI-1
MOS'YIB3[B`(JJ%&3@`=Z_7/P%_P9^7/FHWBKX];E(^>/1_#"Q,I]`\TSY_%:
M]L\"_P#!IC\!-!*-KWC#XE>)&7[ZM?16D;_A&@Q^=;T^(>'\(^;#))_W8N_W
MV)J9=F%?^*_O9_/B>#SQ[GBFV^DW7C"ZCT;2[2;5-6U=OL5G96L9FN+N:3*1
MQH@R22S`=._UK^G7P)_P;C_LD>!6B8_#>76Y(_XM4U.XN=WU&X`U]"_`[_@G
MK\$OV9]4CU#P+\,/!WAO4801'>VVG(;F+/7;(V64^X(KGQ?B#AE3:HTVWYV7
M^8Z/#U924JDDD=?^S;X4U3P'^SQX!T+6VW:SHWAW3K#4#G=FXBM8TEY_WE;F
MNX(*I^%*D6ULY/6G-TK\HE+FDY/J?6*-HV/X[/VY_P#D^+XU_P#8_:W_`.EL
ME>8?Q#CN:]0_;G_Y/A^-?_8_:W_Z6R5Y@W4?Y[U_26`_W:G_`(5^1^:5_P"*
M_5GZ*?\`!K4V?^"JT?\`V)VI?^APU_2;US7\V7_!K7_RE6C_`.Q/U+_T.&OZ
M3AU-?CW'7_(S_P"W5^I]ED/^Z_/_`""BBBOC3VPJ.922*DILG:DQ/8_D]_X+
M4C/_``5A^.N.WB0_^B(J^8^M?3G_``6F_P"4L'QV_P"QB;_T1%7S$GW17]%Y
M-_N%%_W8_DC\WQG\>?J_S/K'_@A?_P`I:_@K_P!A:;_TEEK^JS=DD5_*G_P0
MO_Y2V?!7_L+3?^DLM?U5#[WXFOS#Q!UQT?\`#^K/J.'OX,O7]$2I]P?2EI$^
MX/I2U\(?0A4<O)/TQ4E1O]X_Y[4`?S1?\'.$*1?\%9==95"F7PUI;-[G;(,U
M\`5]_P#_``<Z?\I9-9_[%G2_Y25\`5_0?#O_`"+:/^%'YWF7^\S]3V#_`()V
M?\I#/@-_V4#1O_2I*_K[[?\``J_D$_X)V?\`*0SX#?\`90-&_P#2I*_K[/3\
M17Y]XA?[S2_PO\SZ+AS^%/U!XB1^(_#FJE[H%KJ,BO<6MK<2I]UY8E=E^A(K
M0HK\]B[:H^A:ON0);L%`)!QTP,`?A4RC"BEHI6&%%%%,`KX/_P"#E[_E";\:
M?IHO_I\T^OO"O@__`(.7O^4)OQI^FB_^GS3ZZL#_`+Q3_P`2_,VPW\6/JC^4
M<_>?ZFD7J/\`/:E/WG^II%ZC_/:OU"/0_04?TD?\&?G_`"CB\5_]CM=_^B(*
M_5]N@K\H/^#/S_E'%XK_`.QVN_\`T1!7ZOMT%?F>:?[U/U/@<9_&EZCJ***X
M3F$*@TUXP3DCIR*?2-TZ9I60'XG_`/!RQ_P0^?XFVNJ_M&_!_1&D\2V<1G\;
MZ%8Q9;5X4'.I0(.MPB@"55_UB*&QO5B_X#1R"4!E.X'D$5_=))$)8V#*"K#!
M4C(-?SD_\''W_!$(_LH^*;[X\?"K2G/PVU^[+^)=*MT&WPS>2-Q.B@<6LK'G
MM&Y`X##'U>0YMRVP];Y/^OP/>RG,>5JC4?H?DBR"1"K<J1S7]"__``;3?\%L
MV^/7A>Q_9]^*NL@^.=!MQ'X3U6\E^;Q!9HO_`!ZNYZW$2CY<\N@[E3G^>HK\
MP]^E7_#/B;4_!7B?3=:T>_O-(UC2+F.\L;VTE,5Q:3(P9)$8<A@1P:^AS'+X
MXNDXRW6S\SVL?A(XBGY]#^Y4$XY-?R-_\%]S_P`;A/CG[ZQ#_P"DT5?O3_P0
MC_X+&:=_P4]^`O\`9'B2:TT_XQ>";:./Q'8IB)=3B^XFI6Z_\\Y#CS%'^JD;
M'"LA/X+?\%]AG_@L)\<R.VLP_P#I-%7S&0T)TL=*G45FDSPLIIRIXKEDM;,^
M/Z^E?^"-'_*6+]G?_L=[+^;U\U5]*_\`!&C_`)2Q?L[_`/8[V7\WKZK,O]UG
MZ'T&9?[M+^NJ/[#Q]\_C5;5R5TBX*C<1$^!G&?E-61]\_C4=S"+BW>,G[RE?
MS!%?EZ>WR/A%LC^'_P"+#-)\5_%C.A1VUN^+*3D@_:9,C/>N?;J>U=S^T_X8
ME\$?M,_$C1ID,<NE>*M4M&4]BEY**X8]37ZQA_X<?1?D?H6'_@Q]$?T4_P#!
M`C_@EQ^S#^TS_P`$YO`/Q!\4?![PCXH\8W375MJM]J@EOA<313NN6BD<Q+\N
MW@(![5^E_P`,OV+_`(/?!4@^#OA3\./"A!W;M'\-65B<^N8HUYK\Q/\`@SP^
M/L7BK]DCXB?#J:=#>^#/$*ZA#%_$+>\CR&^GF1N*_8=&#]#D8K\YS*56&)G&
M4GOW/B<:YQK2BV]PA@2",(BJJ*,``8`%.V#.:=THKS[G&)Y:^@H\M?04M%`#
M1"H[4H4+_P#KI:*6@"!0*-@I#*J]2!2>>N[;GGTI:+0`*`8&!7\PO_!R#X5?
MPQ_P5V\?R."5UG3-)OXR?0VHC/ZH:_IZ=@R$_A7X)?\`!W!\"I?#W[17PJ^(
M\,)^R>)]&N=`N'`X-Q:2"9`?0F.9L9ZA&]*^PX'Q$:69J#^TFOU_0\;/:3EA
M6UT/R.`Z'VI:;&^[@=!3J_;CX@****`"BBB@!&&11L%+10!-H?B+4/!WB'3]
M:TJYDLM4T6[AU"QN(SA[>XAD66*13V*NBD>I`%?V$?L<_M`6_P"U1^RSX`^(
M=KLV>+M$MM0E5,8CG9`)4'^[(''X5_'<_P!_/^<U_1Y_P:X?%^7XA_\`!,BW
MT*>5YIO`_B&]TI2W186*S(H^GF-7Y[XA8-2PM/$16L7;Y,^AX?KM594NZO\`
M<?I"XPI^N*_E]_X.IOAVG@K_`(*SZKJ44(AB\3^&M-U!B.DDBJT+M_XX*_J%
MD8*A_.OYM/\`@[XO+>;_`(*+^$(XE`FA\%0^<<Y+9N9BOTXKX#AZ5L6K=F?H
M63NV)1^4M?H)_P`&OEG->?\`!9GX?O$FY+;1];EE/]U/L#IG_OIE'XU^?1Y'
M2OUA_P"#0'X1R^*O^"AGC;Q@R,;;P?X,DMMV1A9KRYB"CZ[()*^NSF5L'/T/
MH\TE;#21_2+&H!I]1(XW#D=*<9AG`/-?FJUU/B4A]!&:;YB^M*&!-%T`%`:0
M1@"G44P&>6IR0.?7O7"_'[]G/P+^U'\.+OPE\1/">A^,/#E]CS+'4[59D5N@
MD0GYHY%S\KH0RGD$&N\;H:BSVY_&B,Y1ES1=GW)DKJS5S^>__@K7_P`&X.N?
MLN:)JWQ%^!AU3QAX#L4:ZU'PY,3<:OH<(&6>%OO7,"CDC'F*HS\X!-?E?!,M
MQ&'1@Z,,@CN*_M=G0N3\I.017\Y7_!R/_P`$S=,_8Q_:)TSXD^"K"/3O`WQ3
MGE%S8PJ%@TK5T&^144?=CF3+@=`ZN!U&/U/A#BJI7J+!XMW?V7W\G^C/E\WR
MF,8NO1T75?J?FWL%=I^SK^T1XF_9'^.GA;XD^#KAX/$/@Z]6^@7>0EY&.)K:
M3UCECW(P]P>H%<8ARHI&)#*1P0>#Z&OT6M2C5ING45T]&?.0J2C)2CNC^R;]
MG'XY:)^TQ\"/"?Q"\.3B?0O&&E6^JV;9R565`Q1O]I6RI'8J17<H,CGM7YI?
M\&K?Q>N/B%_P3$E\/74S2-\/_%FHZ+;AB3Y=O((KR-<^@^TL!Z`"OTMB&5_"
MOYSS/"?5L74H+:+:^73\#]&PU95*,9KJ?$W_``<0?\HB?BW_`->]I_Z50U_+
MW7]0G_!Q!_RB)^+?_7O:?^E4-?R]U^J^'_\`N,O\3_)'RO$/\>/I^HQN@K^D
M7_@UE_Y13:;_`-C5K'_I17\W3=!7](O_``:R_P#**;3?^QJUC_THK;C[_D7K
M_$OR9GP__O#]/U/T>IDPR!3Z9*<8K\8/M3^:'_@YO<M_P5DU\%CQX<TO'/3]
MVU?GV1E>U?H__P`'2_A5]#_X*?QZ@R[8M<\)6,\9QU,;21D_I7YQ$93H!Q7]
M`\.3OEE!_P!U?@?GN9K_`&F?J?IC_P`&U'[&GP:_;5^*'Q5T;XL>!=)\:7>@
MV.G:CI`OY)@ENC/-',`B.JN"5C^\#C/&.:_</X<?\$W_`-GWX0-#)X9^"7PI
MT:YMQB.YM_"UDMR/3]Z8]Y_%J_`C_@VA^/4?P8_X*EZ)HMU*(K+XCZ+>>'SG
M[K7"J+F$?B87'N37]+\;`CCI_*OS'C2IB*68N'/+DDDTKNWW;'T^21IRPZ:2
MNKD>F:1::-:+!9VMM:0KT2"(1HOT`&*L-'@G&>?>G(,**6OC')O5GM)6&?9U
MW9QS2K$J]!3J*!B>6OH*01*JX`P*=10`WR@>M#)F@R!>O%,^U(6(#`D4EY`O
M(EI&Z4BRJPR#0S`CK30F?QW?MS_\GP_&O_L?M;_]+9*\P;J/\]Z]/_;G_P"3
MX?C7_P!C]K?_`*6R5Y@W4?Y[U_26!_W6G_A7Y(_,Z_\`%?JS]%/^#6O_`)2K
M1_\`8GZE_P"APU_2=7\V/_!K7_RE6C_[$_4O_0X:_I.K\?XZ_P"1G_VZOU/L
MLA_W;YO]`HHHKXT]L*;)VIU-D[4F)G\GO_!:;_E+!\=O^QB;_P!$15\Q)]T5
M]._\%IO^4L'QV_[&)O\`T1%7S$GW17]%Y/\`[A1_P+\D?G&+_CS]6?6/_!"_
M_E+9\%?^PM-_Z2RU_54/O?B:_E5_X(7_`/*6SX*_]A:;_P!)9:_JJ'WOQ-?F
M/B!_OT?\/ZL^GX=_@R]?T1*GW!]*6D3[@^E+7P9]"%1O]X_Y[5)4;_>/^>U)
M@?S1?\'.G_*636?^Q9TO^4E?`%??_P#P<Z?\I9-9_P"Q9TO^4E?`%?T)P[_R
M+:/^%'YWF7^\S]3V#_@G9_RD,^`W_90-&_\`2I*_K[/3\17\@G_!.S_E(9\!
MO^R@:-_Z5)7]?9Z?B*_/_$+_`'JE_A?YGT7#G\*?J2T445^>'T04444`%%%%
M`!7P?_P<O?\`*$WXT_31?_3YI]?>%?!__!R]_P`H3?C3]-%_]/FGUTX'_>*?
M^)?F;8;^+'U1_*.?O/\`4TB]1_GM2G[S_4TB]1_GM7ZC'H?H*/Z2/^#/S_E'
M%XK_`.QVN_\`T1!7ZOMT%?E!_P`&?G_*.+Q7_P!CM=_^B(*_5]N@K\SS3_>I
M^I\#C/XTO4=1117"<P4444`(W0UB>,?!VE^/O"VHZ+KEA::KHVL6SV=]97,8
MDAN(74J\;*>"I!(-;E,9`W!-%VM@NUJC^4[_`(+J_P#!&[5_^"8/QR&N^&X+
MK4/@OXRN&;0KULN^BSD%FTZX;^\,$Q.?OIQ]Y6KX+D!WYK^V3]IG]FWP;^UI
M\#_$7P\\>:1!KGA;Q-:/:WEO+PR_W98VZI+&V&1QRK*"#FOY,/\`@J3_`,$S
MO&'_``2]_:7N_!>O_:=3\-:B7NO"^OF+;%K-INX!(X$\>0LB]C@XVL*^XR/-
M56C["K\2V\SZC*LQYE[.H]>AY7^RY^TSXP_8X^/GASXE>`]2?3/$OAFY\Z%P
MW[NYB/$MO*O1HI$)5E/4'U%=9_P48_:FT_\`;6_;3\:_%/3-/NM)M/&4EO=F
MSN""]M*L$:2)D=5#JV#W&*\2QM&>H/M29XQ[YKW5A:;J^WM:1Z[PT/:*K;46
MOI7_`((T?\I8OV=_^QWLOYO7S57TK_P1H_Y2Q?L[_P#8[V7\WK#,O]UGZ&>9
M?[M+^NJ/[#T_UM#M@_0TB?>_.G/&"#[U^7]3X-'\C?\`P7P^!-Q\`/\`@K3\
M8-/>W^SV7B'4H_$=AZ20W<2N2/\`MJ)!^%?'PZ>E?O)_P>!_L53ZOX5\"?'G
M1[-I%T1_^$;\0O&F2D$I+VTKD=@^Y,G@;UYYK\&Y/E;GIFOTG)L0JV&BUNM&
M?;9564Z"\C[?_P"#>[]N^U_82_X*/^';O7;XVG@OX@PGPKKDCOMBMO.=3;7+
M]L1SA02>B2R&OZPX#EB#U'4^M?PN/&)8RC#*L,&OZ4/^#<3_`(+46?[87P=T
M[X-?$?6X8_B[X,M!;:=<WDP5_%^G1#$<RD@;KJ)`%E7)9PHER=S[?$XCP#;6
M(@O)_HSR<YP;4O:Q^9^K-%1I*64YQD?K3U.Y0:^23N>`+1111=`&.,4T_(M(
M).#[5QOQP^/'A']F[X7ZOXU\>>(=+\+>%-"A-Q>ZC?R^7'$HZ`=2[D\*B`LQ
M("@D@545=V06>R//?^"A/[=?@_\`X)W_`++GB#XF^,9"]KI8%OI^GQN%GU>^
M<'RK://\3$$D_P`*JS=!7X7_``J_X.X_CO8?'^PU3QCX;\%7_P`.KO4$6]T2
MQM'BNK2S>0*WDW!8EI40Y&X88C!`SQ\P?\%E?^"MOB/_`(*J?M"?VC&M]H7P
MQ\+R20>$]`F(#JC</>W`7@W,P`R,D1IA%)^9G\\_X)>?LBW_`.W7^WO\,?AO
M:VSW&G:CK$6H:Z^#MM]*M6$]V[$`XW1(8U)X,DL:_P`5?783*:-'"2JXE7DU
M?T/H</EL*>'E4K;V/['M.NH[ZPAN(B9(9D5XVP1E2,@X/3@U\6_\%_\`]C2X
M_;._X)J>+[#2;1KSQ5X&EC\8:'&OWII[17$T0]3):27,8']YU/:OMF-0(5P`
MH'0#H*BFA%Q"R,JLD@PRL,AAW!%?+X3$RP]>%>GO%I_<?-5::J0=.74_BBM+
M@7<22J25D0,I(P<'GIVJ:OL+_@N+_P`$[I_^">_[:^KP:3820?#CQ[)+K?AB
M95/E6^]MUQ8Y_O12$E1U\MT_NFOCO)5B#VK^B<OQM/%8>%>F[J2O_7H?G.(H
M2HU'3ET'44#ISUHKL,0HHHH`****`&-U'XU^[O\`P:!W\LW[.WQHM&$GDVOB
MJT>,G[I+V@W8_(9K\(@-QQ]:_H'_`.#2OX=7'AK]A3QMXCEB*IXJ\83>0Y/^
ML2WACCS]-Q(KXWCJ:65M?WE^9[&0K_:EZ/\`$_5:0;@0!U&*_E:_X.;/BQ;_
M`!3_`."O7CB*TE\V#PIINGZ&V#N"2QP[Y!['=)7]0'QC^*>D?!#X5>(_&&NW
M4-EH_AG3I]3O)Y7VI''$C.<G\*_BS_:(^--]^TA\>O&OC_4V8WWC'6KK5G#<
ME%ED+(OX+M'X5^<\-4.:NZO1(_4\DI7K.?9''9RY%?T;?\&IG[/=O^S;_P`$
M[/&'Q?\`%+V^CP>/M0FU,WEV1$EOI5BC()7<](\B9\YQCFOP7_8V_92\1_MO
M?M,^#_A?X7@FDU+Q5?+!+,B%EL;8?-/<-Z*D89CGC@5_2-_P7$^%R_LS?\$#
MO&O@GP%!)8:'X9TO1-$9+8;6735U&SBN.!V>,L'Q_"[D\9KULYJ*K4IX).SG
M)7\C7B'&<E/D7J?*O[8'_!V=<6OC:]TKX&>!=.U30[.4QQ^(?$;R+_:.UB#)
M%;)AEC/\)=@Q'.!FN3_9]_X.V_'.D^-(5^*WPWT'5?#,K@7$_AR62"^M$_OK
M'*2LN.25RI..*_(;:-P''3'7/':E"E6X..G0X_E7W4>#LKC1]ER:_P`S;N?D
M;SC$RJ<ZEIVZ']DW[/G[0/A#]J'X0:%XZ\$:Q;Z[X9\00">SNHOR9'4\I(K9
M5E/(((KMPV,>YK^<O_@V[_X*9G]E']I$?"3Q?J:6_P`//B;<B.QEN)`L.CZP
M1B,\\*DX'EGH-VSUK^C&.4E\9`(-?DF?9/4R[%.C+6+UB^Z_K<^NP&+6)I*:
MWZHL`Y%%%%>,=P4444`,8Y-?GQ_P<V^`[3QE_P`$H?%=Y/'&UQX=U73]3M7/
M5'$P0X^JN17Z#2`J>".E?E]_P=6_M"V/PW_8`TSP(MQ#_;7Q'UZWAC@WCS/L
MMM^^FDV]=H(09Z98"O7R"$Y9C15/?F7_``3CQ\DL/-OL?SQI]T4CC(_E3J;(
MZQ_,Y"JGS,2<``=S[5_0NR/SL_>[_@T.TR>#]D+XN7;;OLMQXZ$46>-S)IMI
MN/I_$H_"OURA_P!6*^#?^#</]G2Y_9Z_X)5>"9=2MY+75?'US<^+[F*1=KHE
MTP%OG//-O'"1_O5]YQ_=K^>N(*\:V8UJD-G+\M#]#P$'##PB^Q\2?\'$'_*(
MGXM_]>]I_P"E4-?R]U_4'_P</_\`*(CXM<-C[/:9]O\`2XN?I7\O:$D<C%?I
M'A^_]AJ?XOT1\WQ!_'CZ?J-;H*_I%_X-93C_`()3Z=Q_S-6L#_R.*_FZ/7!]
M:_HS_P"#5;53>_\`!+IX-Z-_9_C+5H@`.4RT;X/O\_Y$5T<?+_A.7^)?J9Y#
M_O#7D?IA3)AGZT^F2GD8ZBOQ@^UO;4_#W_@[V^"LEOX@^#'Q'@B)BD2^\.7C
MJOW2-L\.X^_[S'T-?C&G"BOZK?\`@M)^QE-^W/\`\$]O''A'2[;[7XHTN-=>
M\/HJY=[ZURZQK[R)OC'O(*_E.C<N@)#(>A5N"A[@^A!X(Z@Y':OV;@;'*M@/
M87U@[?)ZK]3XK/Z')B.?I)&U\/OB)K?P>^(WA[Q?X:N19^(_">IVVLZ5.PRL
M=U;RK)'N_P!DE=K?[+&O[`/V4?VEO#O[7O[.WA#XE>%I3)HGC#3HK^&-R#+:
M.1B2WDQTDBD#1L/[R&OXYR=_<^E?I;_P;S?\%>;;]B7XDS_"GXBZDMI\+O&E
MT)K#4;B3;%X8U)L*68GA;>?Y0YXV.%;HS4N-LDEB\.L317OPOIW77[MRLCQW
ML:GLI[2_,_HU0Y44M4[&_CO+6.:&6.6"55>-T(974C(8$<$$<YJPDA9NN1]*
M_&GYGV5T2444TL=_48H&.HI-W7VJ*6X\E220`HR2>`!0!2\2ZY9>%]%NM2U&
MZALK#3X7N;JXF<)%!$BEG=B>``H))]J_!;]LO_@Z@^)NI?'O48/@G8^&+'X>
M:5<FVLKC5[%KFZUU4.#.WS#RXW(^4#G:<DUK_P#!PI_P7#M?C'%J?P#^#>L+
M=>&8G-OXR\2V,H>'5)%/S:=:NOWHE(_>R@X8_(N0&)_']58*$@ADGE9ECBBB
M4L\KDX6-0.2Q8A0!U)`K]-X5X4INB\7F$;W^&+[=V?+9MFD_:*A0?JU^1_6M
M_P`$N?VW1_P4+_8O\(_%&724T'4]4\^RU.PCD,D4%Y;RM%+Y;'DQL5#+GD!@
M#DBOHH-\V.U?.?\`P2F_9-N/V)O^"?WPQ^'>H1K'KNF:0MYK0`P5U&Z8W%RF
M03G9)*T8;N(P<#.*^C$4=:_.L9[)8F?L/AYG;TZ'T5#G]E'FWZG\>/[<_P#R
M?#\:_P#L?M;_`/2V2O,&ZC_/>O3_`-N?_D^'XU_]C]K?_I;)7F#=1_GO7]%8
M'_=:?^%?DC\YK_Q7ZL_13_@UK_Y2K1_]B?J7_H<-?TG5_-C_`,&M?_*5:/\`
M[$_4O_0X:_I.K\?XZ_Y&?_;J_4^RR'_=OF_T"BBBOC3VPILG:G4V3M28F?R>
M_P#!:;_E+!\=O^QB;_T1%7S$GW17T[_P6F_Y2P?';_L8F_\`1$5?,2?=%?T5
MD_\`N%'_``+\D?G&+_CS]6?6/_!"_P#Y2V?!7_L+3?\`I++7]50^]^)K^57_
M`((7_P#*6SX*_P#86F_])9:_JJ'WOQ-?F7B!_OT?\/ZL^GX=_@R]?T1*GW!]
M*6D3[@^E+7P9]"%1O]X_Y[5)4;_>/^>U)@?S1?\`!SI_REDUG_L6=+_E)7P!
M7W__`,'.G_*636?^Q9TO^4E?`%?T)P[_`,BVC_A1^=YE_O,_4]@_X)V?\I#/
M@-_V4#1O_2I*_K[/3\17\@G_``3L_P"4AGP&_P"R@:-_Z5)7]?9Z?B*_/_$+
M_>J7^%_F?1<.?PI^I+1117YX?1!1110`4444`(OW:^$/^#E__E"7\:/IHO\`
MZ?-/K[O7[HKX0_X.7SM_X(E_&CV&B_\`I\T^NC!?QX>J_,VPW\6/JC^4<_>?
MZFA.U#???ZT5^IKH?H*/Z1_^#/S_`)1Q>*_^QVN__1$%?J^W05^3_P#P9_''
M_!.;Q4/^IVN__1$%?K`PR!7YCF?^]3]3X'&?QI>HZBBBN(Y@HHHH`****`(W
M`<C(R#7S[_P4?_X)X^"?^"E'[-VJ?#SQE;B"5E-QHVLQ1![K0KP#"3Q9ZCLZ
M9`=<@]B/H08*_2E'7U-.G.4)*<79HJ,W&2E'='\4G[7G[)OC7]AS]HKQ'\,/
M'^GFR\0^'YL"5`WV?4K=C^YNX&(&^&11D'J#E3AE(KS-DVO7]9G_``6M_P""
M1>@_\%2_V=Y(+1+/2_BGX3CDN/"FMN,'>?F>RG;J;>;`'/W&VL.A!_E0^)WP
MT\0?!CX@ZUX2\5Z7=:%XD\/7;V6HV%RFV2VE0X(/J.X(X(P1UK]!RC-(XJG:
M7Q+<^ORS'JM#DE\2,*OI7_@C1_REB_9W_P"QWLOYO7S3GFOI;_@C1_REB_9X
M_P"QWLOYM79F7^ZS]#JS'_=Y?UU1_8@H_>#Z4^F+]\4^OR^)\(<'^TC\`O#?
M[4?P0\5?#OQ=9?VAX;\8:=)IU]%CY@K#Y70]G1@KJ>S*#7\?7[?W[#WBS_@G
M=^U3XF^%?B^-S/I#BYTO4-FV+6M-D9OL]Y'ZJP4JP'W9$=#RIK^SY^']L5\C
M?\%<?^"3/@W_`(*K_`8:'JKPZ%XX\/B2X\+>)4AW2Z9,P&^&3'+VTNU1)'GJ
M%8?,HKV,HS+ZK5U^%[_YGH9?C7AZFOPO<_D3K3\(>,-4^'_BW3=>T'4KW1M<
MT>X2[L;^SE,-Q:3*<K(CCD$&O0OVO_V+?B3^PA\8+KP3\3O#=UH&K0LQMIP/
M,L=4B!P)K:8?+(AZ\8(S@@'BO*E&#Z@]*_083A6A>-FG]S/LHSA6A>.J9^Z_
M_!,C_@[&L4T?3/!_[2]A/;W<"K!%XUTF`R1W('`:\MU^96Z9>,$'&=HZU^P_
MP`_:Q^&G[4?AU-4^'7CSPOXQM#&)&.EZA'/)"#_STB!WQ_1E!K^*&I--OIM$
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M+\+6$IDTCPMIKLNG:>>@=@>99<?\M'Y]`!7R^J[1A0`!3T+,RJ`69V"JH!)8
MGC``Y.?05[F"R7#X;WWK+N>IALLHX?WWJ^[&&01HSL0`.23_`#K^DS_@V'_X
M)57?[('P!NOC!XVTZ6S\?_$^T06=I/'MET;2,AXT8'E9)CB1AQ@!!U%?,?\`
MP0-_X-UM4\4>)-%^-W[07AY]/T2R*7WA;P=J"`7%_)D-'>7T9^Y$O5(6^9SA
MF`0!7_?.VA\N,K@`#@#L!Z#VKQ,]S:-1?5Z+NNK/*S3,%4_=TWIU'#(`&,48
M^7UJ6BOE[=CPSYQ_X*<?\$^O#G_!1[]ES5?`6L&'3]63-YH&KF/<VD7Z@^7)
MZF-C\KJ.JL>X%?RJ_'?X$^+/V8OB_P"(?`/CG2I=%\4^%[C[-?6S\J01E)8V
M_CBD4;T;N#[&O[,Y03@``GWKXR_X*]?\$>?"7_!43X:V\ZR6OAKXI>&8'3P]
MXE$9.$8[FLKL+S+;,PR,Y:)B63!9P_V'"O$O]GU/85M:<G_X"^_IW/%S7+%B
M(\\/B7XG\MX;`P>IXI0P-=U^TG^R[X__`&//BO>^"?B3X:O/#7B&R8@1R?/;
MWJ#I-;RCY98R.0RGZX/%<&IPPSFOVFC6IUH*I2=T^JV/C)0<9.,MUT'T445H
M0(QP*4'--?I35(SR>OY4!ZBNLLI"0H\DLIV1(B[FD<_*J@=R20`.Y(K^MK_@
MEE^RT_[&G[!/PW\`7<(BU;3-*2YU5<89;R<^=,I]U9]O_`:_%?\`X-R/^"5=
M]^U5\?=-^-GC/2Y%^&7PZO1=Z.DZ$)XDUB(YBVC^*"V<"5CT:58U^8!P/UH_
MX*Z_\%<_!7_!+#X&R:C?O:ZY\1=>@>/PQX;#_/>R@8\^?:<I;(3EFX+?=7DY
M'Y/QMF7UNO'+\/KRN[MW_P"!U/L>'LOG9U+:RT1\3?\`!V;_`,%*XOAS\(]-
M_9N\+7RGQ!XWCBU3Q9)%)\UAI:/NAMC@\/<2IN(/_+.(Y&)`:_G\B@>>XBBB
MCDFDE=8XXXU+/(S$!551R6)(``ZFNX\6>)_B#^V=^T-J>LZA_;/CSXD?$+5'
MNIQ;6[37>H7,C#Y(XU'RHHPJ(H"(BJ``%`'[W?\`!"'_`(-UH?V3KO2_C%\<
MK&PU7XFQXN="\/';<6GA-L?+/(>5EO?0@%83]TEOF7BA4I97A>63]YZV\_\`
M(_1X5*>!H<N\F>@_\&YW_!&ZX_X)_P#P:N/B1\0].$/Q=^(%FFZTE4%_#&GG
MYUM/:=R0TOH0J?PMG]#?CG\'-$_:$^#7BGP+XEMA=:!XOTNYTC4(>[0SQM&Q
M7T8!L@]B`>U=5'^[&T]<=N].D&5KXZKBJE2K[=OWMU^A\W7J2JR<IZMG\>/[
M9W[(?BG]@_\`:6\1_"[Q?&YU#093+8WI7;'K&GN3Y%[&>ZN%(;'W75U[5YE7
M]5'_``59_P""4O@O_@I]\'8=-U=XM"\<>'UDD\->)8X0\VGR,.891UDMI"!O
M0G@@,.0*_FG_`&N_V*OB3^PE\4Y?"'Q,\-SZ'?EC]BO4_>:?K$8/$MM.!M=3
MUP<..C`$5^U<,\24L?15.H[5%NGU\UW\^Q\%FF6SH3<XKW6>5MRN`S*00593
MM9"#D$'L00"#[5^]W_!"K_@O?I7QG\-:/\&_C;K-MI'C[38X[+P_XCO)1';^
M*8@`$BF=N([Q>%Y.V48(^;(/X(D],@FDEA$T11P'0\;2.E>GG>1T,RH>SJ:-
M;/JG_EY'+@<?/"SYH[/==S^U]&R>>..AJ7(-?R[?L1?\'`/[1/[%&FV6A_V]
M:_$OP;8*(K?1_%9>XGM(P,!(+U3YZJ``%60NJ@```<5^@'PM_P"#O3X?:AI\
M2^-O@YX]T:\``=]$OK/4X">Y'F/"X'X$U^38W@S,J$GR1YX]T_T9];0SG#5%
M=RMZG[$!PP]J0L%[@?A7Y6:Q_P`';'[/EE8AK3P1\8=0F*Y\D:5:18/H6>Y`
M_$9KYX_:)_X.Z/%6O:=<6?PI^$NF^'Y9%*1ZEXGU'[9)'Z,+:`*N0.S2$?6N
M7#\+9G6=E2:\WHC2IFN%@M97]#]DOVI/VI?`G['7P>U3QY\0_$-IX>\.Z2A+
MRRL#+=28RL$$8^:69B,*B@D_0$C^6S_@IW_P40\0?\%+_P!J2_\`'FK6TND:
M#91G3O#>CO)O_LRQ#9&XC@S2'YW(XS@#@5P'[4?[8'Q._;3^()\4?%/QGK'C
M#58P5M4N)!%9Z<A.3';6\86*!3W*J&;')/6O.,[\C))[FOTKAKA2.7OV]9\U
M1]MDO(^9S/-GB5R05HKOU'2-M3KCMDU]'?\`!*C_`()[:K_P4D_:\T7P3%#<
M)X0TR2/4_%M\@.+73U?)BW=I)B/+7V+-VKG/V%/^"?7Q-_X*)_%J#PM\.M&:
M:V5U&JZ]=JR:5HD)8;GFDQ\S#^&),LWI7].G_!.?_@G?X%_X)M?`.U\$>"[?
M[1=3L+O7-;G0?;=>O2,--*1T4#A(Q\J+P.<DG%/$M/!470HRO4DNGV5W?GY%
M95ELJT_:37NK\3W+0](M/#6CVNGV$$=K8V,*6UM!&NU((T4*J*.P"@`#VJ_$
M<QBG45^*/5W/MCY4_P""V'PYNOBC_P`$L_C1I5E&TMROA^6\C1>2QA992/R0
MU_*);2":%9!T=0WYBO[5?$NA6?BCP]?:7J-O'=V&I0/:W,$@RDT3J5=#[%21
M7\FG_!4/_@GSX@_X)P?M7:YX,U"VG/A:_GEOO"FI%#Y5]I[.2B`]/,BSY;+U
M&T'H:_3?#[,8)U,')V;U7GW_`"/F>(,-)\M9;;,^>">,5^VO_!H_^U3I$/A+
MXF?!*_NH;77$U,>,=%C=L-J-M)%';W2IGJ89(HB0.=LX/8X_$HC#8KI/@U\9
M/%7[._Q7T'QWX)UFY\/>+/#%TM[IM_``6B<`JRNI^62-T)1XV!5E8@@YX^WS
M_*WF&"EAT[2=FO5/0\'+L6J%=5'L?V>Y`8#BF.X##H:_)3]CC_@ZV^%GC7PG
M9V/QOT/6/A]XG@C5;G4M,LY=2T6]?H9$\O,T&X\['5@,_?:OI*?_`(.'?V/8
M++S_`/A<FF.,`[4TV\:0?\!\K-?B5?A_,*-1TY4I:=DVODT?;TL?AZD>:,U\
MS[8`!/3GK7\WO_!Q=_P2^N?V._VFKWXJ^$]/=?AE\4;Y[J=88_W6@:U*=\\)
MQPD=PV98^P=G08&VOW)_9"_X*:?`[]NW5-3L/A9X_P!+\3ZGH\0GN[)8Y+>Z
MBB)P)/+E56*9XR`1FO1/CY\!?"?[3OPAU[P'XWT6UU_PMXEM7L[^RG`(=#T9
M3U5U8!E8$%6`(.16V39E7RC&*=2+[26UU\_P)Q>'IXNER)^C/XU@<L/0]/>D
M>-)0590ZL,,I&00:^QO^"K'_``1L^('_``3/\=W6H)#?^+/A1?2G^R_$\49=
MK0$G%O?`?ZN51P'/R/U!!R!\=!L@8(YY'^U]/6OW7`XZAC*:JT9<R?;]>Q\+
M7H3HS<9JS1^B?_!*[_@X5\??L):9IG@CQY9WGQ'^&%J1%;@S_P#$XT&+&`L#
MMQ-$O'[IR"`/E85^X?[)7_!5'X#_`+:MA;/X$^(V@W.I3[0VC7\ZV6J1.>B&
M"0AF/^YN'O7\E83*].:AN;2*[7]]$DN.,.H;/Y]*^9S?@O"8R;JT_P!W)]5L
M_5?Y'HX/.:U&/)+WE^/WG]LWF#('6F2.$!)(`'<U_&MX1_::^)_P^TU;+P_\
M4/B=X?LT4+]GTOQ;J-K"!V`19@HQ[`57\;_M`_$/XG6C0>)_B+\0_$L+#!BU
M;Q1?WL9'H4DE*D?A7S*\.J]_XRMZ,]9\1TE]AG]3/[6?_!7;]GS]C&RN!XQ^
M(^ARZO`#_P`272)UU'4G(_A,,1)0Y'\96OQ-_P""H'_!Q+\1?VXM-U'P9X"M
M+SX:?#:[S#<JEQG6-:B[K-*O$,9'5(SDC@L:_.:"UCMAB*..,#IM4#'O4H/&
M21CN<\`>M?391P7@L'+VE6]22ZO]%_F>3B\[K5URQ]U?B,B@6&)8T555`%50
M!@```8_*OTG_`.#<3_@F//\`M:_M+6WQ=\56+?\`"N/A9>K<V(E3,>N:RAW0
MQKGAHK<@2.>[^6O/S8\<_P""4G_!'+Q[_P`%-?'D%^8;OPQ\);"<+J_B:2+!
MNE&"UM9!N)96'!<96/.2<X!_IH^`_P`!O"O[-?PET/P+X(T:UT'POX<M5M+*
MS@7Y40=68YRSL<EF;)9B2:X.+^):="D\#AI7E+=K[*[7[V.G*,ME4DJ]9:+\
M3M<`@'CGFGE<8^E.7H*:_2OR-)7/KGL?QW?MS_\`)\/QK_['[6__`$MDKS$?
M>'^>]>F_MT#'[</QK_['[6O_`$MDKS%?]8/QK^D\#_NU/_"OR1^:5_XK]6?H
MI_P:U_\`*5:/_L3]2_\`0X:_I.'4U_-A_P`&M/\`RE5C_P"Q.U+_`-&0U_2<
M.IK\=XZ_Y&?_`&ZOU/L<@_W7Y_Y"T445\<>V%(_W32TV1L`>]-">Q_)[_P`%
MIO\`E+!\=O\`L8F_]$15\Q)]T5]._P#!:AMG_!6'XZYXSXB;_P!$15\Q)]T5
M_1&3?[E1_P`*_)'YQB_X\_5GUC_P0O\`^4MGP5_["TW_`*2RU_54/O?B:_E6
M_P""&#8_X*U?!0?]1:;_`-)9:_JI'WOQ-?F7B!_OT?\`#^K/I^'?X,O7]$2I
M]P?2EI$^X/I2U\&?0A4;_>/^>U25&_WC_GM28'\T7_!SI_REDUG_`+%G2_Y2
M5\`5]_\`_!SK_P`I9=9_[%G2_P"4E?`%?T)P[_R+:/\`A1^=YE_O,_4]@_X)
MV?\`*0SX#?\`90-&_P#2I*_K[/3\17\@G_!.S_E(9\!O^R@:-_Z5)7]?9Z?C
M7Y_XA?[U2_PO\SZ+AS^%/U):***_/#Z(****`"BBB@!,Y(KY^_X*B_L=2_M^
M?L'?$?X26VHQZ3J/BS3D&GW<F?*CO+>>*[MO,QSY9F@C5\`G8S8!Z5]`XZ>U
M,EC#$$]O>G";C)2CNAQDU)-'\D6O_P#!OO\`MD^'M:N[-_@=K=ZUO(8_M%GJ
MEA-;S@'[Z-YXRIZC(!]0*J+_`,$#?VR#T^`GBC)/&;_3Q_[<5_70L01/2FE=
MP((&#7OKB3$VV1ZZSFN?#_\`P0!_X)]^+?\`@G1^P7;>%/'J6D'C'Q!JUQKN
MHV=M.)TT[S`BQP%U^5G54!8J2,G`)QFON3H33%4`COCIGM4A;&?:O"K5959N
MI+=GDSFYR<GU%HHHJ"0HHHH`****`"BBB@!C1AAQTK\X_P#@MU_P0-T#_@IC
MIO\`PF_@Z[LO"GQDTRU\B*^G4K9>((D4[+>[V@D,.BS`$J."&&,?HZP&?2D=
M0R8/-:8>O.C-5*;LT:4JLJ<N>#U/Y(_$W_!OE^V/X7UR[LS\#];O_LKE1<6&
MJ6$]O,/[R-YX)!^@/L*^I/\`@B7_`,$$_P!H7PS^WW\/_B-\3?!-S\.O"'P[
MU(:W+)J-W;M=ZC/'&XAMX88W=L&4H6=]H"`XR2!7]&BQ!2<#@]<4YH%+9QDX
M[UZU;/\`$5:;I-+4[:N:UJD'![,<G+`T^F+PU/KPXGFK81EW4WRSCK[4^BJ&
M>4_M5_L9_#7]MCX7S^#_`(F^%-,\5:+-DQK<IMFM'Q@20RKAXG'8J17XK_MO
M_P#!H+XDT&^OM9_9_P#&UMK>GNQDA\.>*)/(NHEZ^7'=JNU\=!YBJ?5N]?OZ
M4W#!I#$`<CK79A<PKX=WIOY=#IP^+JT7>#/XT_V@O^"6_P"T9^RS+.?'7P7^
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MEY'!B,QK5E:3LAT<)5RQ(.1Z4\+C/O2CI17F'`%%%%`"%2>](4Y)IU%*R`\>
M_:__`&'OAE^W3\,9O"WQ-\,V>O:<06@N/]3>V#]I()UP\3#V.#W!K\4/VW?^
M#6#XI?"2_O=5^"6LV_Q*\/#,D6D:G-'8:W;J!]P2-B&?'8Y1CZ'K7]!908([
M&D9,#``->QE>?XS`?P9>[_*]4<.*P%&NOWBU[K<_C,^,_P`"_'G[-NK&P^(O
M@?QCX#NB2JKKVCW%BDONDCJ(Y`>Q1B#7%_\`"16&1_I]C@_]/"?XU_;#>V$.
MH6SPSPQ3PR#:\<B!T<>A!X-<)<?LG_"JYNWFE^&G@"2>1M[2-X>M"S-ZDF/.
M?>OLJ/B+/E_>TM?)GD3X>A?21_(!\)?A=XK_`&@?$BZ-X`\*^)_'6K,?^//P
M]I4^I3+[MY2L$4=RY4`<D@<U^J/_``3K_P"#7KQ5XQU"V\7?M(W4/A#PO:@7
M+^%;&]22^O`/F*W=PA,<$>/O*C,V/XA7[Q:'X=L/#&F1V6FV5II]E%Q';VT*
MPQ(/95``KRO]H7]A?X=_M8SK'\2;#5O&&CH5==#O-8NDT?<#P7M(Y%BE/_74
M./:O.S#CK%XB+IT8JFGUW?\`P#JPN18>G)2F^:Q^?_[:?_!P1\,/V4]"M/@=
M^R+X8MOB_P#$.SMAI6CZ?X3L9+[1-$V_*%06X8W;KUV0Y4L?F?.17Q#\'?\`
M@WY_:W_X*B_&6Z^)G[0FM3>`5UV42W=[K^V?698^HB@L4.VW10<!'*;?[IK^
MA#X/_L^^!/V>?#:Z/X#\&^%_!FE!57[+HFF0V$3!1A<B)5W$#N<FNO$>T9]Z
M^8I9E*BG[&-I/>3U9])1Q/LE:DK>9\M_\$[O^"/?P4_X)HZ$!X$\/_;O%%Q&
M$OO$^K$76K7GR@$"0C$2'GY(PHY/6OJ58O+.<]:?DGO2C./>N"I4E4?--W9A
M.3D[R=Q-F>]`0D<FG45))$\/G+@]*X3]H']F3P+^U5\.;OPG\0_#&C^+-`O,
M[K74(!($;^_&WWD<=F4@BN^(SU-.'%.%24)*479HEQ35GJ?B1^V7_P`&E\;W
M5[JWP%\=_9$)+Q^&_%):6)3U"17B@N!Z>8K?6OS:_:%_X)+?M+?LO7<Z>+/@
MQXUGL(`SG5-`LVUW3P@.-[26N\QCT\Q5/M7]:[(%W'^]UQ2,@QD$_GBOKLOX
MVS##KDJ6FO/?[U_D>1B<DP]1W6A_$U=ZI;V%[):W$J6MS`=LD-R?L\B'T*R;
M2#[5)'<PS#Y)H7XR"'!!'K7]GGCSX.>$?BE#Y?B?PKX;\1H!@+J>FP7@QZ?O
M%->5:W_P2W_9L\2733WOP&^$LTSL69O^$5LUR?7B,5]#2\1H6M4HM/R?_`/.
MGP[_`"R_`_D7>ZB6,EI8PI!Y+@#\SQ4<&L6ES=);Q7$-Q<2G:D4+>;)(W]U5
M7))^@K^NG3?^"5?[-&E7BW%O\!?A''.IRK_\(M9D@_C'7J7P_P#@3X)^$BG_
M`(1;P=X6\-!A@_V3I-O99'OY:K55/$6G;]W1=_-V_((\./[<OS/Y4/V<_P#@
MD_\`M'_M5WMLO@_X.^-/[/NB"NK:W9-HFFA2<;Q+=!-X'?RU8^U?IG^Q1_P:
M:V=C>6FL?'WQI_:ZIMD;PUX8=X+9F[I-=L!(Z^H0+GUK]I43(QR?J:>8Q[\U
M\WF/&V/Q,7&%H)]M_O/2PV2X>D^9ZOSV.0^"7P%\'?LY_#RQ\*^!?#FE>%?#
MVGKB"QT^`0QK[MCEF/=F))]:[%%IVWY0*"=HKY&4Y2;E)W;/6C%15D+11104
M,=2PP.E>.?MH?L-?#K]O3X.W'@KXE:&NK::S^?9W43>3>Z3.!Q/;S+\T;CCI
MP>A!%>RL,C/2FE`XZG\*JE5G3DIP=FNJ)E%27+):'\Y7[:G_``;!?''X!:I?
M:A\*Y+;XO>%8R7AA22*PUR!/[K0N5BF(]8V!/]W/%?GW\5?@;X[^`]\UMX[\
M!^.?!,ZGYDU[P_>6`'N&>,*P/J"17]FIA4-D`<4I13&P(#`]<\U]Q@^/L;1C
MR5XJ?GL_Z^1X=?(*$VW%N)_$F?%&FL<_;K4>G[P`G^M>@?"?]G+XC?'VYCA\
M"?#KQ_XT>;[K:+X=O+R/'3<9$C\M5S_$6`'<U_8^GAG38IA*MA9)*#D.+=`V
M?7.*NJA)X/3\!7=6\1*G+:%+7S?_``#&'#D+WE(_&;_@W\_X(E?%K]EC]HA/
MC3\6(8O!CV>D7&GZ7X=CNTGO;@W&W>]TT9*1JH48C#,2QR<8K]FEAPO8\4>6
M.2>>W6I`O&.U?"9GF=;'XAXBMN]--K'N8;#0H4_9PV,KQ1X3T[QGX?NM+U>P
ML]3TR_C,-S:7<"SP7"'JKHP(8'W%?E)^W1_P:K?#[XK7M[KWP/U]_AGJ]PQF
M?0[Q6O-#E8DD^6,^;;]N%)4?W:_6]ADBF.FYC3R_-,5@I\V&FX]^S]4%?"TJ
M\>6HKG\IW[1__!$3]J3]E^ZG.J?"77_%>EP9(U3P@G]N0NH_B,4/^D*`.3NB
M&*^4_$D<W@S5WT[6[6]T._B^_:ZG:RV4R_5)55A^(K^UT(H;Y?E/?!K/UWPO
MIOBJS^SZEI]CJ-N?^6=U`DR?DP(K[/">(>)BN6O34O-.W^9XU7AZD]82:/XI
MEU^P(_Y"%@/4_:4_QJ73+V/7M1BL]/+ZC>3'$<%G&US+(>P"1AF/X"O[(I?V
M2?A7+=><_P`,_A\\Q.XR-X=M"Q/KGR\YKK?#/@71?!MN8-'TC2])A/\`!9VT
M=NI_!`*[)^(JM[M'7_%_P#'_`%=C_,?RE_LY?\$=?VF_VH[Z)?#?P=\6Z5IT
MI!&J^*+5M!L@AZ.IN0LDB_\`7-&K]3?V$/\`@U0\'?#O4;'7_CQXB'C_`%&`
MK*OAW2P]KHL;#!Q,YQ+<#/8[5/I7Z]NHP`>?J:1%VL>@_K7SV8\:8_%)P@U"
M/EO]^_Y'H8;)J%)\V[\S-\(>"M*\`>&[+1=#TZRTC2--A6WM+&S@6"WMHQT5
M$4``#V%:PBVCWIRC!-+7R;?,[L]=*VP4R5@BC-/IDZ[P!_DTF!_-#^WC_P`$
M.OVH]0_;-^*.K^'?A5J'BWP]XD\47^LZ;JFF:C9^3/!<3-*H*R2JZL-V"".H
MKR8?\$.?VO<Y_P"%"^*1_P!Q'3__`)(K^K7&!P*%78.I(K[;#\>8VG3C!1B[
M*W4\.>1492<FV?B%_P`&[O\`P2=^/'[+W[;>H?$3XF^!IO`^@6/AVYTR!;V^
MMI;B^GFDC("1PNY"JJ$EFQU`%?N!G#FF)$JMD"I!\R\U\UFN:5<PQ#Q%9)/;
M0]+"86&'I\D-A:***\\Z@J*=BK#T^E2TR098>U)O0#^>/_@L5_P1?_:.^)7_
M``42^(_C7P+\-K[QKX3\:7T>J6-_IVH6B^63#&LD<D<LB.C*X(Z$$8(-?,O_
M``X[_:]7_F@OBG_P/T\_^W%?U9,BDY.:DWG;TK[/"\<XVA0A148OE277I\SQ
M*N1T)S<VWKJ?SX?\$8/^"-W[1WPF_P""B/@'QUX\^&]YX)\*>#YI[V]O-1U"
MT8RL8'1(HHXI'=V+..<`#!YK^@R-]V.,$]J<0,=.GO2*F!@'%>#G&<ULQK*O
M625E:R._!X.&&@X1U)$^X/I2TB#"BEKRSL"HW7+FI*C)PYSTI/L!^&/_``<&
M_P#!)SX]_M*?MW+\1/AKX"N?'/AW6-"M+"1K"^MHY[&>#>"LB2R(<$,"&&1U
MZ5\,'_@AY^U[V^`OBG_P/T__`.2*_JS"*Q!]#3S@]J^PP'&F,PM"-",8M15E
M>YXE?):-6HZC;NS^;7_@G-_P0X_:@TK]N+X6^(O%/PQO/!OAGPAXGLM<U/4M
M4U&S*I#;R"4HD<4KN[MM"@`8&<DU_2.IW`]CU%+(!(>>GI2%<*!D<"O&SC/*
M^95%5KI+E5E8[L'@H8:#C"[N344=:*\D[0HHHH`****`"BBB@`HHHI60!111
M3`****`"BBB@`HHHH`****`"BBB@`P/04444`%%%%`!1110`4444`%%%%*R`
M*,#T%%%,`HHHH`****`"BBB@`HHHH`38*7`]!110`4A0$YQ110`M(%`[444`
M`0#L*6BB@`HHHH`****`"BBB@!"H-!4'M110`!`.U&P444``0#M05!HHH`-@
M':EP/0444`%%%%`!1110`4444`&.*0*!110`%`>U`4+T%%%`!L%+110`4444
M`)M&<XYI:**`"BBB@!-H]*7`]!110`4444`%%%%`";!05!HHH``H%+110`44
M44`%%%%`";!1L%%%``%`I:**`"BBB@`H(S110`FP#M1L%%%`"XQ2;`.U%%`"
..T444`%%%%`!1110!_]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>robin.jpg
<TEXT>
begin 644 robin.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``@&!@<&!0@'!P<)"0@*#!0-#`L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+#`Q-#0T'R<Y/3@R/"XS-#+_
MVP!#`0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P``1"`!1`(P#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#W^BBB@`HH
MHH`****`"BBB@`HHI"0!DG`H`6HKBX@M;=[BXFCAAC&7DD8*JCU)/`K%F\0R
M7LDEMH%L+Z525:Y=MMM&?=_XB/1<^^*?;^'$>Y2\U>X;4[M.4\U=L,)_Z9Q=
M`?\`:.6]Z`$&MW>I$#1;!I(B,_;+L&*+ZJ,;G_``>]7+'3[F&9KB\U"6YF88
M"A1'$G^Z@_F23[UHT4`%%%,FFCMX7FF=4C12S,QP`!WH`?15:PU"TU2SCN[&
M=)[>095UZ'_"K-`!1110`4444`%%%%`!13))8X8WDED5(T!9F8X"CU)[5SC:
MMJ/B`^7H`$%GT?4YDR#Z^4A^]_O'CZT`:6J:Y:Z8Z6YWSWLHS#:0#=))[X[#
MW.!6>NCZAKC&37Y!':G[NF0/\G_;5QRY]AA?K6EI6B6FDH[0AY+B4YFN9CNE
ME/JS?TZ"M'%`#8XHXHUCC1411A548`'L*?110`4444`%<EK0;Q#XBBT(9_LZ
MT"W.H'M)_<B/L2,D>@KJ9YDM[>6:0X2-"['V`S7`:"]UJEO/!;[H[K5)C=W]
MRG'D0'A$!_O,HX],DT`=%X=(GU+6;VW7;8S3JL77$CH-KN!Z'A?^`&NAJ*VM
MXK2VBMX(UCAB0(B+T50,`5+0`4444`%%%07=Y;V%L]S=S1PP(,M)(V`*`)ZR
M=6\06FE21VVV2ZOYO]39VXW2R>^.BKZL<`5G?VEJWB(A=(C;3M./74+A/WD@
M_P"F49]?[S?@#6KI.AV.C))]EC8RS'=-<2MOEF;U9CR?IT'8"@#,30+O6IEN
MO$;QR1JP>+3823!&>Q<_\M6^H`]!72````#`':EHH`**,\T4`%%%%`!117.Z
MAK%UJ-Y+I.@,IN$^6YO2-T5K[#^])_L]N_I0!1\;Z\D5A)HUFQ>_NBL3%.1`
M'.,M[GG`[UT.D:3:Z-I\=I:K\JCYG/+.V,;B?6N532;:#Q?I6E6P,BVB/?W<
MSMF220_*K.>YS7<T`%%%%`!1FJ&J:S8:/;B:^N!$&.(TP6>0^BJ.6/L*QA::
MIXG._4!+IND,/ELU;;<3C_IJP^X/]A>?4]J`+%WXE,]U)8:%;C4;R,[9'#;8
M(#_MOZ_[(R?I1:^&O/N4O==N/[2NT.Y$*[8(3_L1^O\`M')^E;-I9VUA;);6
MD$<$*#"QQJ%`_"IZ`"BBB@`HHHH`***0D*"2<`=30`M5[Z_M--LY+R]N([>W
MB&7DD;"BL6?Q,UY(UMX>M?[2F!VM/NV6T1_VI/XOHN3]*DM/#?F746H:W<?V
MC?1G<@88@@;_`*9Q]`1_>.6]Q0!6+:EXH&$$VFZ,W5SE+FY7V'6)3Z_>(_NU
MO65C:Z;9QVMI"D$$8PJ(,`59KG_%]]-;Z0ME:'_3=1D%I![;OO-^"Y/Y4`5_
M"0_M"ZU77F)9;RX\N`GM$GRC'UY-=1573;"+3--M[*$8C@C"+[X[U:H`****
M`,C3_#FGZ??2WX1[C4)2=]W<-ODP3G:"?NJ.F!@<5KT44`%%%%`!1110`4C,
M%4LQ``&22>E1W*SM;R+;.B3E3L:1=R@]B1D9_.L(>%OMIW:[J-QJ@Z^0V(H!
M_P!LU^]_P(F@`D\3F^=H/#]HVI."5:X#;+9".N9/XOHH-(/#=QJ>'\0W[7@S
MG[)!F*V'L1G+_P#`CCVKH(HHX8ECB14C4855&`!["GT`,BBCAB6**-(XU&%5
M!@`>PI]%%`!7!MXATF;QI-?7^IVL-KIZ&VM4=^7D/^L<#L.BY]JZ'Q*FM7-K
M#9:-B%KE]D]X6&;:/'+*#U8]!Z58TC0=.T6P2TL[9%0`!F*@M(?5CU)^M`#(
M_%&@RHCQZQ8,KG:N+A>3Z=:LZAJUAI5L;B^NXH(NQ=NOT'4_A45QX?T:[\SS
M]*LY#(-KL8%R1]<9JM8^$-`TV[%U:Z7`DZ_=D;+E?]W<3C\*`+NE:O8ZW9"\
MT^=9H"Q0D9!5AU4@\@CT-7JP/^$82WUUM5TV]N+%IW#7D$8#17..Y5A\K=MR
KX-;]`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`'__V3\_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
